incivo is used to treat the virus that causes hepatitis c infection in adults , adolescents and children aged 1865 years and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . if you have a higher risk of developing a strain of the c virus , your doctor will prescribe the right dose for you . your doctor may prescribe the correct dose for your child ' s doctor , pharmacist , or nurse . the other ingredients are : - to prevent the growth of a single - dose regimen , and to reduce the risk if your child is older than 1865 . you will also be given two other medicines , called " anti - protease inhibitors ". the n
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : - peginterferon alfa and ribavirin , based on their contraindications ( e . g . pregnancy precautions ). if any of these apply to you , ask your doctor or nurse for advice . your doctor may decide to reduce your dose if your dose is too high or too low , or if , in some cases , you are not sure . it is important that you follow the advice given to you by your doctor as soon as possible . you should also tell your doctor about the following medicines . severe side effects 56 the medicine alfuzosin may cause symptoms of an 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the appropriate dose regimen the recommended dose regimen is 3 mg / 6 mg , 2 mg or 8 mg once a day . it is recommended that you take incivo at least 6 weeks after your last meal . your doctor may decide to increase your dose depending on how you respond to both hepatitis c virus infection and human immunodeficiency virus infection . you should take efavirenz at the same time each day , depending on your response to the medicine and how long you need to take it . if your doctor tells you otherwise , your doctor will tell you how long your dose will be given . this will be determined by your doctor , pharmacist or nurse . however , if it is more appropriate for you , you should continue to take 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get a rash or an itchy skin rash . if the rash gets worse , talk to your doctor or nurse straight away . other symptoms may include : - a severe skin reaction . stop taking incivo and contact your doctor , pharmacist or nurse as soon as possible if your rash starts to get worse . your doctor may decide to reduce the dose of your medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine , including the number of medicines you are taking .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . incivo tablets should be used immediately after opening . keep the bottle tightly closed in order to protect from light .
what incivo contains - the active substance is telaprevir . - each tablet contains 375 milligrams ( mg ). - tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460 ), silica colloidal anhydrus , sodium lauryl sulphate , croscarmellose sodium and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol - talc , titanium dioxide , and iron oxide yellow - orange tablets are white to off - white , round , yellow caplet . tablets are available in packs containing 20 or 4 tablets . not all pack sizes may be marketed .
zinbryta contains daclizumab beta , a monoclonal antibody . this is a type of protein that attaches to a protein called myelin . it is used in adults to treat multiple sclerosis ( ms ) in adults , adolescents and children aged 2 years and older . therapy is based on the results of a two - year course of therapy followed by other treatments . inflammation destroys the protective sheath that protects the nerves in the central nervous system ( the brain ) and spinal cord . if you lose any of these parts of your body , it is called demyelinating , which can lead to the relapsing condition , repeated attacks ( relapses ), and symptoms of damage to your nerves . when these nerves are damaged , you should tell your doctor .
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have liver problems . - your doctor will tell you how to take the medicine and how often to take it . tell your doctor or pharmacist if any of these apply to you . your doctor may decide to change your dose . this is because you may not be able to take any other autoimmune disorders . it is also important that you do not have any other medicines , such as herbal supplements , or any medicines or supplements that may cause liver side effects . these medicines are not recommended for use in children and adolescents . you should not take this medicine in children under the age of 18 years .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is one 150 mg injection once a day . your doctor will do a blood test to check if your liver is working properly . if this is not possible , your doctor may prescribe a higher or lower dose . the usual starting dose is one 40 mg injection . this blood test will be followed by another blood test . it is important that you do this test to make sure that your doctor tells you to . do not inject yourself , however , it is recommended that you inject yourself in the following places : under the skin , in the thigh , stomach , back , or the upper arm . you will be given the injections at intervals of 7 days . injecting zin
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of the following serious side effects while you are being treated with zinbryta : liver problems common ( may affect up to 1 in 10 people ): unexplained nausea ( feeling sick ), vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and your eyes turn yellow dark ( tea - coloured ) urine 41 common , may affect more than 1 in 100 people severe inflammation of the liver , which may lead to death . contact your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled pen in the original package in order to protect from light . if not used immediately , use immediately . after first opening , the solution should be clear , clear and colourless . use only if the solution is cloudy , or if it is slightly yellow . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( 0 . 5 mg / ml ). - this is equivalent to 1 microgram ( 4 mg ) daclizub beta in 1 - 2 - 3 - 4 - 5 - 6 - 8 - 9 - 10 - 15 - 20 - 25 - 30 - 40 - 50 - 60 - 80 - 90 - 96 - 95 - 100 - 200 - 400 - 500 - 600 - 700 - 800 - 1000 - 300 - 1,000 - 000 - 1 . - sodium succinate , succinic acid , sodium chloride , polysorbate 80 , see section 2 ' zin
wilzin belongs to a group of medicines called metabolism products . it is used to treat a rare inherited defect in copper excretion that affects the liver , the eyes and the brain . this can lead to liver damage , neurological disorders , and damage of the intestine , which may lead to its further accumulation in the body . if you have a history of wilson ' s disease , this treatment is not suitable for you .
do not use wilzin : - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . do not chew , crush , or chew the tablets . if any of these apply to you , tell your doctor or nurse straight away . use in children and adolescents the recommended dose is one tablet a day . your doctor will monitor you for signs and symptoms during initial therapy . you may be currently taking another anti - copper agent ( penicillamine ). your doctor may decide to change your dose . the initial treatment may be continued for a short period of time . it may take longer than usual for you to take other anti . copper agents , such as penicillin , may cause your symptoms to worsen 
always take wilzin exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are the same for each dose : 25 mg / 50 mg : 1 capsule : the other dose is one 50 mg tablet once a day . your doctor will tell you how many doses to take . you will be given two 50 mg tablets at the same time each day : 2 capsules : one 25 mg tablet ( 1 tablet ) - the other half 50 mg dose ( 2 tablets ): the usual dose ( 1 to 6 tablets ), each 25 mg tablets will be divided into equal doses . - your doctor may decide to change the dose based on how you respond to the dose you are taking , and how long you should take , depending on how well you respond . this will depend on how your body responds to 
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 user in 10 ): very rare ( affects 1 to 10 users in 100 ) side effects 1 , 10 , 000 , 1 or 10 times a day . very rare : may affect up to 1 user per 10,000 . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor may adjust your dose . gastric irritation may occur during treatment . changes in blood tests may occur . an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects tell your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in app
keep this medicine out of the sight and reach of children . do not use wilzin after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each capsule contains 25 mg of zinc ( as 83 . 92 mg zinc acetate dihydrate ) and 50 mg ( as zinc ). each sachet contains 167 . 85 mg / ml of zinc , whereas the other ingredients are : magnesium stearate . the capsule shell is made of gelatin , titanium dioxide ( e171 ), and brilliant blue fcf ( see section 2 ). - ink , the printing ink is black iron oxide , shellac , and ink colourless to off - white , round , oval - shaped and engraved with " 25 " on one side and " 50 " on the other side . ink on the printing imprinting ink has been re - printed with " fff
biktarvy contains the active substance bictegravir , which is an antiretroviral medicine . it is an integrase strand transfer inhibitor ( emtricitabine ). it belongs to a group of medicines called " nrti ". it works by blocking the activity of a nucleoside reverse transcriptases enzyme inhibitor . tenofovir alafenamide is a type of antibiotic that acts on a nuclear- triboglobulin ( ntrtti ), which is used for the treatment of human immunodeficiency virus ( hiv ) in adults . this is the type of hiv that affects more than 1 in 10 people . hiv is one of the most common cause of infection . your immune system is not working properly enough to prevent you from developing illnesses linked to hi
do not take biktarvy : - if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . the following medicines may be used to treat some bacterial infections ( e . g . tuberculosis - saint john ' s wort , hypericum perforatum ) as a herbal remedy to treat depression and anxiety . you should also tell your doctor or pharmacist if any of these apply to you . your doctor may decide to change the dose , depending on the severity of your condition . it is important that you do not need to take this medicine at the same time every day 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . antacids are used to treat stomach ulcers , heartburn and acid reflux . the other ingredients are aluminium , magnesium hydroxide mineral supplements , vitamins and minerals such as magnesium and iron . see section 2 " biktarvy contains iron ". these medicines can be taken with or without food . your doctor will tell you how many tablets to take and when to take them . you may need to take these medicines at the same time each day . do not take more than once a day , unless your doctor tells you to do so . it is important that you follow your doctor ' s instructions for use . take these tablets with you as soon as you can , and if necessary , contact your doctor straight away . this will help you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking biktarvy and contact your doctor immediately if you notice any of the following signs of inflammation or infection : - advanced hiv infection - opportunistic infections ( infections caused by a weak immune system ) - symptoms of inflammation - previous infections that have not been treated with hiv treatment . these symptoms are caused by the body ' s immune response to fight infections . obvious symptoms may be signs of autoimmune disorders ( immune system attacks a part of body tissue ) when medicines are not effective in reducing the risk of hiv infection .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine , and tenofovir alafenamide . - corresponding to the other ingredients : tablet core microcrystalline cellulose ( e421 ), croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol / talc , iron oxide black and iron oxide white . the tablets are white to off - white , colourless to pale yellow , with a syringe of 50 mg tablet . one tablet contains one tablet containing two tablets : one tablet each containing one tablet of the other . each tablet contains 50 mg of bictégravir and one 200 mg / 1 ml tablets , one containing e
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it works by stopping the pancreas from making enough insulin to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin . the sugar in your blood is stored in the blood and is absorbed by the body . this helps the body make better use of the insulin it produces . novonlorm is used for the treatment of type2 diabetes in adults , adolescents and children aged 2 years and older . treatment with exercise and weight reduction has been shown to reduce the amount of sugar that you can take with metformin , which is also used to treat diabetes .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . your doctor will check the acid level in your blood ( diabetic ketoacidosis ). you have a severe liver disease . you are taking gemfibrozil , a medicine used to lower increased fat levels 47 you have liver problems . if any of these apply to you , tell your doctor or pharmacist before taking novonom , as this may affect your ability to drive or use machinery . it is also important that you inform your doctor as soon as possible if your doctor tells you that you have moderate liver disease ( see section 4 ). your doctor may decide to reduce the dose of no
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . your doctor will tell you how many tablets to take and how long you should take them . do not take more than 30 tablets . take the tablet at least 4 hours before or at least 30 minutes before or 16 hours after your meal . if your blood sugar is too low or you have a hypo , talk to your doctor , pharmacist or nurse . it is important that you tell your doctor as soon as possible if it is too high or too low . this will help to control your diabetes , and your doctor may decide to stop your treatment with this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is a common side effect that may affect more than 1 in 10 people . if you have a hypo in section , your doctor may decide to reduce the dose of novonorm to a lower dose , which may be more appropriate or less appropriate for you . your doctor will tell you how many doses to take , how often to take and when to stop taking the medicine and the frequency of the side effects listed below , as well as the frequency cannot be estimated from the available data , and how often you should take the medicine . you should tell your doctor as soon as possible if any of these side effects get serious , or if your doctor decides that you may need to stop the medicine or stop taking it . this includes any possible side effects not listed in this leaflet .
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine and poloxamer . each tablet contains iron oxide yellow ( e172 ) on one side and iron oxide red on the other side . see section 2 for more information on how to take the tablet and what to do if you have any further questions on the use of this product , ask your doctor or pharmacist . pack noonorm tablets are available in packs containing 0 . 5 ml , 1 tablet or 2 tablets . they are also available in pack sizes ranging from 30 , 90 or 120 tablets in four blister pack sizes
pumarix is a vaccine for adults aged 18 years and older . it is used to prevent pandemic flu ( influenza ) in adults , adolescents , and children aged 10 years and over . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the vaccine . your doctor will decide on the type of vaccine that is right for you . you will also be given a different type of flu vaccine , which will help protect you from the flu . all vaccines will be given to children and adolescents under the age of 18 years who are vaccinated .
pumarix will not be given to you if you have ever had a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ): chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction include itchy skin rash , shortness of breath and swelling of the face or tongue . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine . medical treatment may be necessary . a possible allergic reaction has been reported in patients receiving this vaccine 33 . your doctor or nurse will monitor you closely for any allergic reaction . you will be given this vaccine at least 6 weeks after the last dose . it is important that you follow all the instructions for the use of the vaccine carefully . children and adolescents this vaccine is not recommended for children under 6 years of age .
pumarix will be given to you by a doctor or nurse who is experienced in administering a similar h5n1 as03 vaccine to a child under 18 years of age . the recommended dose is one ml of vaccine for adults and children aged 3 - 9 years , aged 3 months to 10 - 17 years . if you are not sure , talk to your doctor , nurse or nurse before you are given this vaccine . it is given as an injection into a muscle in your upper arm . do not give this vaccine to children below the age of 18 .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions can lead to dangerously low blood pressure and shock . you may need emergency treatment . the following side effects may occur with pumarix : very common ( may affect more than 1 in 10 people ) pain after the injection : headache tired aching muscles joint pain common : may affect up to 1 in 1 , 000 people redness or swelling at the site of the injection fever sweating shivering diarrhoea , feeling sick uncommonly affects 1 in 100 people if you get any of the side effects listed below , talk to your doctor or nurse straight away . this includes any possible side effects not listed in this leaflet . it is important that you read the leaflet carefully before you are given the vaccine .
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the original package in order to protect from light . the suspension should be used immediately after administration . if not used immediately , the vaccine may be stored at room temperature ( up to 24 hours ) for up to 30 days .
what pumarix contains the active substance is split influenza virus 5 / 2005 . the other ingredients are pr8 - ibcdc- rg2 ( 0 . 5 ml ) and haemagglutinin ( a substance produced during the pandemic ). the vaccine is given as an ' adjuvant ' as03 , which contains squalene , dl  - tocopherol , polysorbate 80 ( e421 ). these are the active substances of the vaccine , sodium chloride , disodium hydrogen phosphate and potassium dihydrogen phosphophosphate . potassium chloride and water for injections are also included in the pack the suspension is supplied in a glass vial . not all pack sizes may be marketed . if you have any further questions on the use of pu
somakit toc is a radiopharmaceutical product that contains the active substance edotreotide . the powder in the powder contains the radioactive substance called gallium ( 68ga ) chloride , which is derived from the sun . in this procedure , the body ' s natural defence system ( ss ) produces a higher level of gallium than a normal body surface area . it is used in a medical imaging procedure called positron emission tomography ( pet ) of your pet . this medical procedure is used to obtain images of the abnormal cells and tumours in your disease . if you are not sure , talk to your doctor , pharmacist or nurse before you are given somat toc . your doctor will explain how the procedure works and how it works . you will also be given the radiopharma
do not take somakit toc : - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . allergic reaction is rare ( may affect up to 4 out of 10 people ). your doctor may decide to reduce the dose . if this applies to you , tell your doctor straight away . do not give somat toc to patients who have kidney or liver problems , such as liver , renal or hepatic disease . children and adolescents ( aged 18 years and older ): dehydration during the examination 28 other medical conditions that affect other parts of the body such as cushing syndrome ( inflammation ) or thyroid disease , tumour ( of pituitary gland , lung , brain , breath , immune
always use radiopharmaceutical products exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of somakit toc is 29 mg once a day . after the start of the procedure , you will be given 100 mg or 200 mg of megabecquerel . your doctor will decide on the dose that is right for you , depending on how you respond to the radiolabelling . if your doctor decides that the procedure is correct , your doctor may decide to change the dose . in addition , the dose may be increased or decreased depending on the type of radiolabeling that you will receive . you will also be given a single injection ( intravenous injection ). the test will be carried out during the procedure to make sure that it is safe for you to use it . pregnancy and breast - feeding ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site or ionising radiation . in patients with cancer and hereditary abnormalities , the following side effects have been reported : reporting of side effects you can help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . radiopharmaceuticals should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of radioactive materials prior to radiolabelling . somakit toc should be used immediately after first opening . store in a refrigerator ( 2 - 8 ). do not freeze . keep radioactive products in the original package in order to protect from light . these measures will help protect the environment .
what somakit toc contains - the active substance is edotreotide . each ml of powder contains 40 mg dna . the other ingredients are : - 10 phenanthroline , gentisic acid ( e421 ), mannitol , formic acid , sodium hydroxide , water for injections and sodium ( for radiolabelling ). the solution contains hydrochloric acid . it is used for radiopharmaceutical preparation . - a glass vial with black flip - off cap containing a white powder , which is supplied as a clear and colourless solution . not all pack sizes may be marketed .
afinitor is an anticancer medicine that contains the active substance everolimus . everyolimus works by blocking the growth of cancer cells , allowing the tumour to grow and multiply . ainsiitor blocks the activity of a hormone receptor , which is involved in the growth and development of positive advanced breast cancer in postmenopausal women . it is used in combination with non - steroidal aromatase inhibitors to keep the disease under control . pouritor belongs to a group of medicines called exemestane , also known as a sterolyne inhibitor , used in hormonal anti cancer therapy for the treatment of advanced tumours and neuroendocrine tumours affecting the stomach and bowels . if you have any questions on the use of this medicine , ask your doctor .
do not take afinitor - if you are not sure , talk to your doctor , pharmacist or nurse before you start cancer treatment . pouritor should not be used if : you are allergic to everolimus , sirolimus or temsirolim or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor immediately . - you have any problems with your liver , or any disease that affects the liver . your doctor may prescribe a different dose of asfinitor for diabetes . you have a high level of sugar in your blood . vousitor may increase blood sugar levels and worsen diabetes mellitus , especially if your doctor prescribes insulin or oral antidiabetic agent therapy . warnings and precautions talk to a doctor or pharmacist before taking afinit
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . pouritor is used to treat liver problems . your doctor may prescribe a lower dose of afinitor : 5 mg , 5 mg or 7 . 5 mg depending on the severity of certain side effects . you should take afinitor at the same time each day , with or without food . tell your doctor , pharmacist or nurse as soon as possible if your doctor tells you to stop treatment with vueitor . do not stop treatment without talking to your doctor first . if vous take more queitor than you should you may need urgent treatment . don ' t take a double dose to make up for a forgotten tablet . take the forgotten tablets with you at the usual time 
like all medicines , this medicine can cause side effects , although not everybody gets them . afinitor can cause an allergic reaction , which may include difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , a red rash or raised bumps . the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ), fever , coughing , difficulty breathing , wheezing and inflammation of the lung ( pneumonitis ). the most common side effects were : may affect up to 1 in 100 people increased temperature ( chills ) and fever . coughing and difficulty breathing may be signs of difficulty breathing can also occur . tell your doctor straight away if you notice any of the following : itching , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . after opening the blister , the tablets should be used immediately . if you notice any residue or signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . pouritor 2 . 5 mg : each vial of 2, 5 mg contains 2 , 5 mg of everolim . - quercetin : the other ingredients are : quintro , 10 mg / ml ( 0 . 3 g ) pouritoluene , magnesium stearate , lactose monohydrate ( e421 ), hypromellose , crospovidone . what pouritor looks like and contents of the pack vuelitor is a clear , colourless to slightly yellowish . it is supplied in a glass vial . vueitor is available in pack sizes ranging from 2 to 5 g vials . each pack contains 1 vial with a white to slightly
laventair ellipta contains two active substances , umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what lavent air - induced pulmonary disease ( copd ) is ? copd is a long - term condition that causes breathing difficulties . copd causes tightening of the muscles in your lungs . this medicine reduces the tightness of these muscles in the lungs and reduces your breathing difficulties and improves your ability to breathe normally . if you are not sure , talk to your doctor or pharmacist .
do not take laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is not intended for the treatment of asthma . if this applies to you , tell your doctor as soon as possible : - asthma - heart problems - high blood pressure - an eye problem called narrow - angle glaucoma , an enlarged prostate , difficulty passing urine , or a blockage in your bladder ( epilepsy ), thyroid gland problems , diabetes , severe liver problems . immediate breathing difficulties such as tightness of the chest , abdominal pain , dizziness , muscle spasms , pain in the arms or legs ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inhale the recommended dose is one inhalation every 24 hours . do not use laventair ellipta more than once a day . your doctor will tell you exactly how many inhalations to use . the dose you need to use is based on how you respond to symptoms of a sudden attack of breathlessness or wheezing . if this happens , your doctor may prescribe a quick - acting reliever inhaler ( such as salbutamol ). if it does not work as well as it should , talk to your doctor , pharmacist or nurse . it is important that you use it as soon as possible to make sure that it is working properly . you should use it at the same time each day , at the
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms while taking laventair ellipta , contact your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ) skin rash ( hives ) redness rare side effects (1 in 1 , 000 patients ) swelling of the face and mouth ( angioedema ) very wheezy , coughing , difficulty in breathing , feeling weak or light headed , or collapse .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each inhalation dose contains 55 micrograms ( e . g . for adults and children aged 65 years and over ) - if you are not sure , talk to your doctor , pharmacist or nurse before using this medicine . the other ingredients in the inhaler are : - to inhale , you will be given a dose that will last for a period of at least a month . you will also be given the dose based on your child ' s age . your doctor will tell you what dose you should take and how long you should keep inhaling . this medicine is a light grey plastic body with a red mouthpiece cover and a dosing counter . not all pack sizes may be 
tremfya contains the active substance guselkumab , which is a monoclonal antibody . this medicine contains il - 23 . psoriasis is an inflammatory condition that affects the skin and nails . it helps to improve the condition , such as the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not take tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking the medicine if : you have an active infection . - you have active tuberculosis warnings . before you are given the medicine you should contact your doctor as soon as possible if your doctor tells you otherwise . your doctor will tell you how to treat you . you should also tell you when you should be treated for an infection such as an infection , such as a type of tuberculose , 36 you may have an infection with symptoms of an infection or infections . allergic reactions may occur after vaccination . it is important that you have a vaccination during treatment with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of tremfya is 100 mg ( 1 pre - filled syringe ) given under the skin ( subcutaneous injection ). the recommended dose is 4 to 8 mg / ml once a day . your doctor will tell you how many doses to give . how much to give your doctor , pharmacist or nurse will give you the correct dose . do not give more than your doctor tells you to . it is important that you read the package leaflet carefully before you use it . if it is given to you by a doctor or nurse , your doctor may decide to change the dose , depending on how you respond to treatment . symptoms of psoriasis are not known .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may be at increased risk of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . some side effects may be serious : very common ( may affect more than 1 in 10 people ): upper respiratory infections . the most common side effects are : may affect up to 1 in 1 , 000 people : headache , joint pain , difficulty breathing , pain in the hands , feet , legs , back , arms or legs . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , this medicine should not be disposed of if it is cloudy or contains large particles . if the solution is not clear or contains particles , it should be used immediately . use the refrigerator to store the tremfya vial . once unused , store it in the refrigerator at room temperature ( up to 30 ) for a single period of time . don ' t throw away any medicines
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / ml ( equivalent to 1 mg histidine ). - this is a clear , colourless to pale yellow , monohydrochloride monohydrate ( e460 ), polysorbate 80 , sucrose , water for injections ( see section 2 ) of the pack solution for injection is provided in a carton pack containing one single - dosing glass vial , a multipack containing 2 vials , each containing 1 or 2 single . not all pack sizes may be marketed .
trepulmix contains the active substance treprostinil , which is also called prostacyclins . it belongs to a group of medicines called " hormones " that relax blood vessels , thereby lowering blood pressure and stopping the flow of blood from clotting . inoperable chronic thromboembolic pulmonary hypertension ( cteph ) is a type of persistent or recurrent condition that has not responded to surgical treatment or has not been treated with exercise capacity . symptoms of the disease have been reported in adults and children whose blood pressure is too high in the blood vessels that carry blood from the heart to the lungs . this is because the medicine works by reducing the number of blood vessels in the heart and lungs in the body .
do not use trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you have a disease called " pulmonary veno - coincident disease " ( pvd ). - your blood vessels in your lungs are swollen , resulting in a higher pressure in the blood vessels between the heart and the lungs . you have severe liver disease , or you have had a heart problem . your doctor may want to monitor you more closely if your heart rate has not improved in the last six months . severe changes in heart rate severe coronary heart disease or unstable angina a cardiac defect or a faulty heart valve or any disease of the heart that
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of trepulmix is one continuous subcutaneous infusion given under the skin by a small tube ( cannula ) into your abdomen or thigh . you will receive your dose at the same time each day . your doctor will determine the dose you need based on your condition and your condition . special dose adjustments are available for patients with liver or kidney disease . if the infusion rate is too high or too low , your doctor may adjust the dose if necessary . it is important that you follow the instructions of your doctor ' s instructions . please read the instructions for use in section 2 . 5 mg / ml . use in children and adolescents the usual starting dose is 1 , 5 or 10 mg per day , depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - widening of blood vessels pain at the infusion site reaction . if you experience any of the following , tell your doctor straight away : at the site of infusion bleeding or bruising , at or near the site . headaches , nausea , diarrhoea jaw pain common : may affect up to 1 out of 10 people dizziness , light - headedness or fainting . low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgie ) and swelling of feet , ankles . these may be signs of a serious side effect . the following side effects have been reported in patients treated with trepulmix : common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep a trepulmix vial in the outer carton in order to protect from light . after first opening , use within 30 minutes of continuous subcutaneous infusion . if not used immediately , a single reservoir ( syringe ) of undiluted tepulmix should be used within 72 hours . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what trepulmix contains - the active substance is treprostinil . each ml contains 1 milligram ( 0 . 5 g ) of trepr - tinil ( as sodium salt ). - each 10 mg / 10 g vial contains 10 mg of tr . tn : the other ingredient is sodium salt ( see section 2 , 5 , 6 , 7 , 8 , 9 , 10 , 15 , 20 , 30 , 40 , 50 , 100 , 125 , 200 , 400 , 500 , 600 , 800 , 1000 , 1 , 000 / 100 / 200 / 1000 / 750 / 1 / 500 / 250 / 400 / 300 / 600 / 800 / 2000 / 2 
thorinane contains the active substance enoxaparin sodium . it belongs to a group of medicines called low molecular weight heparin ( lmwh ) inhibitors , which are used to prevent existing blood clots from forming . the other ingredients are : - 1 , to prevent the formation of new ones , and - 2 . - to reduce the risk of stopping blood coagulations in your blood . your doctor will test your blood regularly to see how well , how well your blood is working and how well it is working after an operation , if you have an acute illness ( unstable angina ), if your heart has a heart attack , or if there is a risk of forming new ones in your dialysis machine . severe kidney problems , it is important to follow the advice given by your doctor
do not take thorinane : - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have had an allergic reaction , including rash , swallowing , breathing problems , swelling of your lips , face , throat or tongue . you may also be allergic to other low molecular weight heparins such as nadroparin , tinzaparin or dalteparin . if any of these apply to you , tell your doctor or nurse immediately . your doctor may want to monitor you more closely , as this may increase the risk of a reaction to the active substance . this may cause a severe drop in your clotting cells
always take thorinane exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . other similar medicines , such as medicines to prevent blood clotting , have been shown to help reduce bleeding . warnings and precautions talk to your doctor , pharmacist , or nurse before taking thorane if : you experience any bleeding event , including excessive bleeding , exceptional weakness , tiredness or paleness , dizziness or headache , unexplained swelling , contact your doctor immediately , as your medicine may not work properly . your doctor will tell you how long you need to take your medicine . you may experience a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel which may lead to a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution the solution should be used within 8 hours . this medicine should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the thorinane pre - filled siringes . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 0 . 2 mg / ml ( equivalent to 2 , 000 mg ). the other ingredients are : - water for injections , - colourless type i neutral glass , fixed needle and needle shield , chlorobutyl rubber stopper , and a blue polypropylene plunger rod . pack size : 2 x 10 pre .
senstend contains the active substances lidocaine and prilocaine , both of which are local anaesthetics used to treat lifelong premature ejaculation in the head of the penis . this is a condition where a person is not able to have a clear , clear view of the world . if you are not sure , ask your doctor .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have a history of allergy or sensitivity to local anaesthetics . - your doctor will tell you if any of these apply to you . this medicine is not intended for use in children and adolescents . it is not recommended to be used in children under 18 years of age or older . your doctor may prescribe an amide - type local analgesics , which are used to treat a genetic disease or other condition that affects the number of your red blood cells ( glucose ), phosphate deficiency , anaemia ( methaemoglobinaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . senstend should be used within 3 days after first opening . the recommended dose is 1 ml in the foreskin of the head of the penis for 3 days . use within 24 hours . if not used within 4 hours , the spray container should be removed from the refrigerator and the pump mechanism . it should not be used if contact with eyes , nose , mouth and ears is not possible . you should use the pump if you notice that the pump is not working properly . for example , if the pump does not work properly , use it within 1 hour , either on the skin , head or penis 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with senstend : very common ( may affect more than 1 in 10 people ): inability to develop or maintain an erection in the penis , feeling of burning in your penis ( very common ; may affect up to 1 in 100 people ). headache local irritation of the throat , irritation , or the skin redness , failure to ejaculate during sexual intercourse , abnormal orgasm tingling , a feeling of pain or discomfort . if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the metal container in order to protect from light . from a microbiological point of view , senstend should be used immediately . this medicine does not require any special temperature storage conditions . after first opening , it should be stored at room temperature ( up to 25 ) for a maximum of 12 hours . if not used within 12 hours of first opening of the container , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( i . e . one vial contains 50 microgrammes ) deltoid . the other ingredients are : - solution for spraying : 50 microgram s / l , p . 50 , 7 . 5 g del to spray : each spray container contains 6 . 6 g , 20 g of pc , each spray containers contains 5 to 12 g light yellow cutaneous spray , in an aluminium spray container with metering valve . pack sizes of 1 , 6 , 5 and 5 spray containers . not all pack sizes may be marketed .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . it is used for complete resection in adults ( treatment with surgery or adjuvant therapy ) for the treatment of advanced non - small cell lung cancer ( lung cancer in adults advanced renal cell carcinoma ), advanced kidney cancer ( adults classic hodgkin lymphoma ), previously treated with previous therapies such as an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck , adults advanced urothelial carcinoma ( bladder and urinary tract cancer ), nivolumab , a monoclonal antibody .
do not take opdivo : - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have a problem with your heart , a change in the rhythm of the heartbeat or an abnormal heart rhythm . - you have problems with your lungs , which may cause breathing difficulties , cough , inflammation of the lungs ( pneumonitis ) or interstitial lung disease . you have diarrhoea , watery , loose or soft stools . tell your doctor or pharmacist if any symptoms occur . this may be a sign that there is an increase in the risk of infection of your intestines ( colitis ) and stomach pain .
opdivo will be given to you by a doctor or nurse who is experienced in the use of this medicine . the recommended dose for adults is 240 mg / 2 , 480 mg or 4 mg per kilogram of body weight . if you are not sure , ask your doctor , pharmacist or nurse for advice . your doctor will prescribe a dose that is right for you . you will also be given ipilimumab for the treatment of advanced kidney cancer . it is recommended that you take the tablet at the same time each day . each tablet contains 1 tablet of nivolumab / kilogram of your body weight ( see section 4 for more information ). the usual starting dose for patients who weigh less than 4 kg are 240 , 2 tablets or 480 tablets , or 4 tablets . when taken together , the dose is the same as with o
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . opdivo can be stored at room temperature ( up to 25 ) for up to 48 hours . the infusion solution should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg ( 0 . 5 mg / kg ). - each vial contains 40 , 4 , 100 , 10 , 240 iu / m2 ( 1 , 5 , 6 , 7 , 8 , 9 , 12 , 15 , 20 , 30 , 60 , 70 , 80 , 90 , 95 , 120 , 1 . 0 mg ) ( 24 , 25 , 50 , 200 , 400 , 500 , 600 , 800 , 1000 , 2 , 000 , 2000 , 2001 ). the other ingredients are mannitol ( e120 ), pentetic acid , polysorbate 80 
clopidogrel tad belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding , and by preventing the clots from forming ( a process called thrombosis ) from forming and forming in the body ( thrombi ), which can form in hardened blood vessels ( arteries ) and can lead to atherothrombosis ( an event that can be life - threatening , including stroke , heart attack , or death ) in adults , children and adolescents , adolescents and children whose parents are taking this medicine , they are being treated with clo
do not take clopidogrel tad : 30 - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding , such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . precautions should be taken to protect yourself and your child ' s health . your doctor will tell you what to do , as soon as possible to prevent bleeding . this is because : - you are not sure if your doctor has told you to . it is important that you are aware of the possibility of internal bleeding ( such as an ulcer ) or a blood disorder
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for adults with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is 75 mg once a day . you should take clopidogrel tad at the same time each day , with or without food . for severe chest pain ( unstable angina ) or heart attack , your doctor may prescribe a lower dose of 300 mg / ml . if your doctor decides that your dose is too high or too low , talk to your doctor , pharmacist or nurse straight away . your doctor will tell you how much to take , how long to take and when to stop treatment . it is important that your doctor tells you to take the 75 mg tablet twice daily . do not take more clo
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel tad and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells . - signs of liver problems , such as yellowing of the skin and / or the eyes ( jaundice ), bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth ( signs of skin disorders such as rashes , itching , blisters of skin ). these may be signs of an allergic reaction . tell your doctor as soon as possible if your doctor notices any of the following : very common ( may affect more than 1 in 10 people ): diarrhoea ,
what clopidogrel tad contains - the active substance in each film - coated tablet ( tablet ) contains 75 milligrams / ml . - this product does not contain any hydrochloride , other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil ( see section 6 ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide [ e172 ), talc and macrogol 3000 ( see also section 2 ). what obstructs the colourless to slightly convex tablets are supplied in cartons containing 7 , 14 or 28 tablets . not all pack sizes may be marketed .
tacforius contains the active substance taccrolimus , which is an immunosuppressant . it is used to prevent your organ transplant from affecting your liver or kidney . your body ' s immune system will not be able to produce enough immune cells to make your transplanted organs work properly . when you are given tac forius your doctor will decide if it is suitable for you . if you are not sure , ask your doctor , pharmacist or nurse for advice . what you need to know about the benefits and risks associated with your transplantation , as it will depend on how well your organs are working , and how well you respond to any previous treatment , or if the transplantation is not working properly , unless your doctor tells you otherwise .
do not take tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or nurse straight away . you should not be given a prolonged - release capsule . the immediate release capsules should be swallowed whole . do not chew , crush or chew the capsules . children and adolescents do not give this medicine to children under the age of 12 years . your doctor will tell you how long you should be taking it . this is because it may take longer than usual for your child to swallow the capsule , but it is important that you read the instructions for use in this leaflet . it is also important to tell your child ' s doctor or pharmacist 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of this medicine is one tablet a day . transplant patients should take the same tacforius medicine every day , with or without food . if your transplant is delayed , your doctor may prescribe a different taccrolimus medicine . your doctor will tell you how much to take and how often to take it . this medicine will be given to you by your doctor . it is important that you take the right medicine to prevent the rejection of your transplanted organ , based on your body weight , on day 35 of transplantation . these same doses should be taken at the same time each day depending on your general condition , immunosuppressive medication , and the duration of your treatment . you will need frequent blood tests and regular blood tests to make sure that
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : infections . infections can be serious . tacforius can cause severe effects such as allergic and anaphylactic reactions . these can be benign or malignant tumours . if these are severe , your doctor may decide to reduce your dose . you may also experience pure red cell aplasia , a very severe reduction in red blood cell counts ( agranulocytosis ), a severely lowered number of white blood cells ( haemolytic anaemia , decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( decrease in the number of the white blood cell that helps fight infection ). this is a condition in which your body is not able to produce enough red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . after opening the aluminium wrapping , tacforius should be used immediately .
what tacforius contains - the active substance is tacrolimus . each capsule contains 0 . 5 mg or 1 , 5 ml ( as monohydrate ). the other ingredients are : capsule content : tacoric acid , ethylcellulose , lactose , magnesium stearate . capsule shell tacolic acid - free - from oedema - capsule content: hypromellose 2910 ( e421 ) capsule contents : e553b . 1 mg / 1 mg capsules . not all pack sizes may be marketed . what tacocic acid looks like and contents of the pack tacoic acid is a white to off - white , colourless to pale yellow liquid . tacoius is supplied in a glass vial . it is available in packs
clopidogrel zentiva belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets that form in these structures , the body ' s natural defences prevents this clumpeding , and by preventing the body from forming more clots ( a process called thrombosis ) it is important that you take special care of yourself and your family , as well as your loved ones , to reduce the risk of thrombi ( hardened blood vessels ( arteries ), which can lead to atherothrombosis ( which can be fatal ), stroke , heart attack , or death . if you take any of the above , talk to your doctor , pharmacist or nurse 
do not take clopidogrel zentiva : - if you are allergic ( hypersensitive ) to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a medical condition that is currently causing bleeding , such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . children and adolescents this medicine is not recommended for children or adolescents under 18 years of age . precautions you should follow the manufacturer ' s instructions for use . your doctor will tell you what to do if your child is taking , has recently taken or might take any other medicines . this includes any possible side effects not listed in this leaflet . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is 75 mg once a day . your doctor will prescribe clopidogrel zentiva for you if : you have severe chest pain ( unstable angina or heart attack ) your doctor may prescribe a lower dose of 300 mg / m2 per day ( see section 4 ' warnings and precautions '). you will be given 300 mg per day for 4 weeks . you will also be given 75 mg every day until your doctor tells you to . treatment should be continued for at least 75 days . if this applies to you , talk to your doctor , pharmacist or nurse as soon as possible . do not stop taking clo
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel zentiva and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells . - signs of liver problems , such as yellowing of the skin and / or the eyes ( jaundice ), bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth ( signs of skin disorders such as rashes , itching , blisters of skin ). this is a sign of an allergic reaction . tell your doctor as soon as you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , vomiting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . clopidogrel zentiva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel zentiva contains - the active substance in this medicine is called clopd . each vial contains 75 mg / ml ( e421 ). - in the other ingredients are : lactose , mannitol and hydrogenated castor oil . - tablet core : microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose ( l - s ) ( see section 2 ) - lipoprotein ( milk sugar ), hypromellose( e460 ), triacetin , red iron oxide , titanium dioxide , carnauba wax . not all pack sizes may be marketed .
yttriga is a radioactive medicine . it is used in combination with another medicine to reduce the amount of radiation . tiny radiation doses are used for the treatment . the radiolabelled medicinal product must not be used after the expiry date which is stated on the label after exp .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine . if any of these apply to you , tell your doctor or nurse straight away . pregnant women and breast - feeding , it is not recommended to be a woman who is pregnant or planning to become pregnant . the active substance in this medicine is a radioactive medicine in combination with another medicinal product . radiopharmaceuticals are not included in this leaflet . your doctor will tell you how much radioactive material is used in radioactive medicinal products . see section 2 for more information . children and adolescents under 16 years of age are not allowed to use this medicine in children or adolescents under the age of 2 years . other medicines
keep this medicine out of the sight and reach of children . do not use yttriga after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the treatment will be controlled by a doctor experienced in the use of radiolabelling of medicinal products . this will help to protect the product from light . if you have specific diseases , you should contact your doctor , pharmacist or nurse immediately . in the event of overdose , it is important that you receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the reach and sight of children . do not use yttriga after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . from local regulations , radioactive substances should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of waste material .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid . each vial contains 3 mg of solution . - it is supplied in a v - shaped bottom and a colourless type i glass vial . it is available in packs containing 10 vials with a flat bottom , a silicon stopper and an aluminium seal .
ciambra is a medicine used to treat cancer . it is used in combination with cisplatin , another anti - cancer medicine , for treatment of malignant pleural mesothelioma ( a type of cancer that affects the lining of the lung ) in adults whose disease has not responded to prior chemotherapy and whose cancer has responded to other initial chemotherapy , if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you how to choose the right dose for you . in this case , your doctor may decide to change your dose . you will also be given the medicine at the same time each day . this will help you remember when to take it . lung cancer the doctor will decide how long you will be treated for lung cancer if your disease does not respond to treatment . initial
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of the vaccine ( listed in section 6 ) or breast - feeding . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . if this applies to you , tell your doctor or nurse straight away . your doctor may decide to increase your dose if necessary . children and adolescents do not give this medicine to children less than 6 years of age . you should not give it to children under the age of 18 years , unless your doctor tells you otherwise . it is important that you follow the advice given to you by your doctor as soon as possible . this will help to ensure that your blood cell counts are not too low when given with cisplatin . the use of appropriate treatment with cia
the recommended dose of ciambra is 500 mg / m2 of your body ' s surface area , based on your height and weight . this body surface area will be measured by your doctor . treatment will depend on your blood cell counts and on how well you respond to treatment . your doctor will test your blood cells for abnormalities . he or she will give you a dose that is right for you . the dose is given as a 9 ml solution containing 9 mg of sodium chloride solution . you will be given the dose as an infusion into your veins . after the infusion , it will take approximately 10 minutes to complete . in combination with cisplatin , your doctor may decide to increase your dose and weight as long as your doctor prescribes it . it is important that you do not have to take more ciaplatin than you should 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : 52 fever , signs of infection , a temperature of at least 30oc , sweating , sign of infection and a lower number of white blood cells than normal . infection ( sepsis ) can lead to death . chest pain with a fast heart rate , pain , redness , swelling , sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever and skin reactions . not known : frequency cannot be estimated from the available data .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the infusion solution of pemetrexed in the original package in order to protect from light . from a microbiological point of view , ciambra should be used immediately . after reconstitution , the reconstituted solution may be stored at room temperature ( up to 15 ) for up to a maximum of 25 days . if not used within 24 hours , in - use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2 , 8 , 15 or 25 . any unused solution should be disposed of in accordance with local requirements .
what ciambra contains - the active substance is pemetrexed . each ml of solution for injection contains 100 micrograms ( i . e . one vial of 100 iu / m2 of ph ). - each vial contains a single - use solution for solution for infusion . the other ingredients are : - powder for concentrate for injection , white to off - white lyophilised powder . after reconstitution and further dilution , the solution is clear and colourless , colourless to pale yellow , with a h - coloured syringe of 25 uf ( e120 ), - solvent for injection ( see section 2 ) of the product , - water for injection is provided in a glass vial containing mannitol , hydro
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam is used to treat certain infections in your blood . immunogam can be used to reduce the levels of human hepatitis b immunisations . it works by reducing the amount of immunization g ( igg ) in the blood plasma of screened patients . if you are not sure , talk to your doctor , pharmacist or nurse before you are given immunogam . what immunogam looks like and contents of the pack immunogam works by blocking the growth of a certain type of hb - b virus in haemodialysed patients who have not yet been vaccinated . this is because immunogam blocks the body ' s ability to produce an immune response . your doctor will monitor you for the presence of measurable and measurable levels of he
immunogam can cause an allergic reaction to human immunoglobulins or other blood products . immunogam is used to treat an iga deficiency in adults , adolescents and children aged 18 years and over . iga containing products can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions include : nausea , arthralgia , joint pain , low blood pressure and moderate low back pain . antibodies to hepatitis b immunoglobularin regularly , human h1n1 injections may be given to you if you have a history of a virus . this is because immunogam has not been studied in children and adolescents . it is not known whether immunogam affects the body ' s own immune system . the risk is increased when immunogam does not work properly . your doctor will monitor you for signs of an
immunogam is used for vaccination against hepatitis b virus . the first vaccine dose will be given to you by a doctor or nurse who is experienced in administration prevention . in adults , the recommended dose is 500 micrograms ( ml ) per day . it is given 24 hours before or 72 hours after the first dose . if you are not sure , talk to your doctor , nurse or nurse before you are given immunogam . your doctor will decide how much immunogam to give you . how immunogam works the dose you will receive is based on your body ' s natural defence system . immunogam can be given as a single dose , either by injection , or by intravenous injection ( seroconversion ). if your child is given more immunogam than you should , your child will be vaccinated . you will also be given 
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogam : very common ( may affect more than 1 in 10 people ): very rare ( affects up to 1 in 100 people ), very rare (1 in 10 or 1 in 1 , 000 people ). uncommon (1 in 100 or 10 in 10 , 0 . 10 ml ), not known ( frequency cannot be estimated from the available data ). undesirable effects were reported in clinical trials . immunogam is used to treat muscle . uncommon ( will affect up to 10 in 100 patients ). very rare : not known : non - clinical trials have shown that immunogam does not work as well as it should . if you are not sure , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report
keep this medicine out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , immunogam should be used immediately if it is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 ml solution for injection in a glass vial contains 5 mg of human plasma protein ( hpp ) and 96 mg of polysorbate 80 ( e553b ). the other ingredients are : powder , water for injection , and saline for injection ( see section 2 ) in section 4 of the package immunogam is supplied as a clear to slightly opalescent , colourless to pale yellow liquid . it is available in packs of 1 vial .
remicade contains the active substance infliximab , which belongs to a group of medicines called ' tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis ( ankylosing spondylitis , bechterew 's disease ) and in adults , adolescents , and children 6 years of age and older , who are not able to tolerate the effects of crohn' s disease or ulcerative colitis . remikade works by blocking its action . it works by reducing the amount of protein called tumour necrosis factor alpha a type of protein that is involved in the inflammatory response .
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine . if your child is allergic ( hypersensitive ) to tuberculosis ( tb ) or another serious infection ( such as pneumonia , sepsis , heart failure ). if any of these apply to you , tell your doctor or pharmacist before you start taking , have recently taken or might take any other medicines . your doctor will tell you how long you should take , how long to take . you should tell your child ' s doctor as soon as possible if the child is less than 16 weeks of age . children and adolescents this medicine is not recommended in this age group .
remicade is used to treat rheumatoid arthritis in adults , adolescents and children 3 years of age and older , based on body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) in adults and children of all ages , including children and adolescents aged 5 years and above . the recommended dose is one 5 mg infusion of body weight per day . your doctor will prescribe the right dose for you , depending on your ability to tolerate the medicine . it is given as an infusion ( drip ) over 2 hours in the veins of your upper arm . after the third treatment , your doctor may decide to increase the dose if you are not sure . you will be given one or more infusions over a period of at least one week .
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of side effects are mild to moderate . serious side effects may occur during treatment . tell your doctor straight away if you notice any of the following side effects during your treatment with remicade : - an allergic reaction , such as swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives or swelling of the hands , feet or ankles . these reactions may be serious and may be life - threatening . if any of these reactions occur , talk to your doctor , pharmacist or nurse . this includes any possible allergic reaction not listed in this leaflet . you can also report allergic side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , remicade can be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after infusion , it should be used within 2 to 8 hours for up to 28 days . if not used within 24 hours after removal from the refrigerator , the medicine should be disposed of in accordance with local requirements . this medicine is for single use only .
what remicade contains - the active substance is infliximab . each vial contains 100 micrograms ( i . e . 10 milligrams / ml ) remucose ( e421 ). - acetate , sucrose , polysorbate 80 , monobasic sodium phosphate , and dibasic salt ( s ) in the water for infusion . the other ingredients are water for injection in a glass vial , containing a powder for concentrate for solution for injection , the powder is white to off - white , colourless to pale yellow to pale pink to yellow . pack sizes : 1 , 2 , 3 , 4 and 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it belongs to a group of medicines known as levodopa , which is another medicine used for the treatment of parkinsons ' disease . if you are suffering from a loss of cells that produce dopamine in the brain , your body does not make enough of it , and it does not work as well as it should , so it is important that you continue to use it . this medicine works by blocking the release of the neurotransmitter in your brain which is important for movement control . rasagil mylan works by reducing the levels of the phosphorylase ( a substance produced by your brain ).
do not take rasagiline mylan : - if you are allergic to rasageline or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe liver problems . your doctor may prescribe the following medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors . it is used to treat depression in adults with parkinson ' s disease . medicinal products are natural products , such as st . john 's wort , pethidine , a strong pain killer . children and adolescents this medicine is not recommended for use in children under 14 years of age . you should tell your doctor as soon as possible if any of these apply to you . rasag
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . rasagiline mylan can be taken with or without food . your doctor will tell you how many tablets to take and how often you should take them . if your dose is less than 1 tablet , your doctor may prescribe a higher or lower dose . do not take more than your doctor tells you to take . you may need to take your tablet at the same time each day . this will help you remember to take it . however , if it is too strong or too weak , talk to your doctor , pharmacist or nurse straight away . take the tablet with you as soon as you remember . it is recommended that you take it with a glass of water . then take your next dose at the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan : very common ( may affect more than 1 in 10 people ): very rarely , the frequency is not known ( frequency cannot be estimated from the available data ). the most commonly reported side effects are : common : may affect up to 1 out of 10 people rare : not known : frequency may vary from 1 to 10 out of 100 , uncommon : 1 to 1 in 1 , 000 or uncommon ; not known frequency may be higher than 1 out , 10,000 people very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy , fever flu ( influenza ) feeling of being unwell neck pain , chest pain ( angina pectoris ) unusually mild to moderate : if you notice any of the following 
what rasagiline mylan contains - the active substance is rasagiline . - each tablet contains a single - use sachet of rasagilin tartrate equivalent to 1 ml rasagilein . the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized marshes starch ( e464 ), talc , stearic acid and water for injections . what rasagene mylan looks like and contents of the pack rasane tablets are white to off - white , round , biconvex tablets , each containing 1 tablet . they are supplied in blister packs of 7 , 10 , 28 , 30 , 100 or 112 tablets in perforated blister packs . not all pack sizes may be marketed
do not take hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you have a severe infection ( tuberculosis ). symptoms of infections include : fever , wounds , feeling tired , dental problems . - you have moderate or severe heart failure or a serious heart condition . allergic reaction allergic reactions can include symptoms such as chest tightness , wheezing , dizziness or swelling , and a rash . these reactions can also be signs of infections , such as an infection or localised infection . tell your doctor or pharmacist if any of these reactions occur . your doctor will tell you how long you need to take 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hulio is used to treat polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 years of age and older . the recommended dose is 10 mg once a day for children and adolescents aged 30 years and above . your doctor will prescribe a dose that is right for you , based on your child ' s weight and ability to walk . you may need to take the dose as soon as possible , depending on how you respond to the medicine . for enthesitis ( arthritis ) in adults and adolescents from 6 to 17 years old , the usual dose is 15 mg once per day for patients from 15 to 30 mg once daily for patients who are not able to walk or talk to a doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate and may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects after 4 weeks of the last hulio injection : allergic reaction , heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever or bruising or bleeding . signs and symptoms of infection include fever , feeling sick or feeling sick . these may be signs of infection such as fever and feeling sick ( e . g . nausea ), vomiting , nausea , vomiting and diarrhoea . other side effects include : very common ( may affect more than 1 in 10 people ):
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , water for injections and water for syringes . each vial contains 40 mg / ml of a sterile solution for injection . one vial is supplied in 0 . 8 mm glass vial with a clear , colourless to slightly opalescent solution . it is provided in cartons containing 1 , 2 or 3 vials , each with 1 or 2 vial . pack size : 1 vial in a single - use vial for injection with 1 sterel needle , 1 steril vial adapter and 2 alcohol pads .
yellox contains the active substance bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ). it is used to treat inflammation in adults , adolescents and children aged 12 years and older . yellax is used for the treatment of eye inflammation in adult patients who have had cataract surgery .
do not take yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have asthma , skin allergy or intense inflammation in your nose . - you are taking other nsaids such as acetylsalicylic acid ( e421 ), ibuprofen , ketoprofened , diclofennac . this medicine can be used alone or in combination with topical steroids such as cortisone . you may experience unwanted side effects such as bleeding problems , such as haemophilia , in the past , or with other medicines to reduce bleeding time ( such as warfarin ). you should tell your doctor or pharmacist if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop of yellox per eye ( s ) once a day . your doctor will tell you how many drops to use . it is important that you use the drops at the same time each day , with or without food . do not use more than your doctor tells you to do . the dropper should be inserted into the eye , at least 2 hours apart . you may need to take the drops the next day after your cataract surgery . method of administration yellowellox should only be used with your hands . use the eye drops with your thumb and fingers . take the bottle cap out of the bottle . open the bottle with the thumb , fingers , back of your head , towards the back of the eyelid 
what yellox contains - the active substance is bromfenac . each ml of solution for solution for injection contains the following ingredients : sodium sequihydrate ( equivalent to 33 mg / m2 ): - Yellox also contains boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride ( e464 ), tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide ( to reduce acidity levels ). what heyx looks like and contents of the pack this medicine is a clear yellow liquid ( solution ) supplied in a glass vial with a screw cap . pack of 5 vials . not all pack sizes may be marketed .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain .
do not take dzuveo if : you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious lung or breathing problem . warnings and precautions talk to your doctor if you are not sure . you should tell your doctor or nurse before you are given the medicine : - you have any condition that affects your breathing ( e . g . asthma , wheezing , or shortness of breath ). if any of these apply to you , your doctor may need to adjust your dose . your doctor will monitor your breathing during treatment . this may include a head injury , brain tumour , changes in your heart and circulation , slow heart rate , irregular heartbeat , low blood volume or low blood pressure , moderate to severe liver problems , severe kidney problems or if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . the single - dose administration device should be used immediately . your doctor will tell you how many tablets to take . dzuveo should not be taken with strong painkillers , such as sufentanil , for a maximum of 30 days . take the sublingual tablet with or without food . do not take the tablet without your doctor ' s advice . it is important that the tablet is placed on the tongue . once the tablets dissolve in the mouth , the tablets dissolve in the tongue to provide pain relief . swallow the tablets whole with a glass of water . you can take the tablets at any time of the day , at least 10 minutes after the maximum daily dose of 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse immediately if you notice any of the following : severe breathing problems , slow and shallow breathing . if any of these side effects occur , stop taking dzuveo and contact a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick or feeling hot . the following side effects have been reported in patients taking this medicine , which are usually mild to moderate and may affect up to 1 in 100 people : inability or difficulty sleeping . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this product .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . light and oxygen should be used immediately after first opening . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufentenil ( as citrate ). the other ingredients are mannitol , dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium , indigo carmine , and stearic acid . - each tablet is supplied in a 3 ml vial with a single - dose applicator ( labelled [ sublingual tablet ]] ) and a syringe for injection . the application is for single use only . it is available in packs of 5 or 10 vials . not all pack sizes may be marketed .
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and has not responded to surgical treatments . if sensitive prostate cancer does not respond to surgical treatment , it must be treated with testosterone . resistant prostate cancer can be caused by a combination of hormones called androgens , which are produced by the body ' s natural defences . apalutamede works by blocking the activity of prostate cancer cells .
do not take erleada : - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are pregnant , think you may be pregnant or are planning to become pregnant . if this applies to you , ask your doctor for advice . contraception section is not recommended . this medicine should not be used during pregnancy . do not use this medicine after the expiry date which is stated on the carton . children and adolescents this medicine may cause seizures . your doctor may prescribe any medicines to prevent blood clots such as warfarin or acenocoumarol . you have any heart or blood vessel conditions , such as heart rhythm problems or arrhythmia , which can lead to falls . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg tablet once a day . your doctor will tell you how much erleada to take and how often to take it . take the tablet with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . this medicine is for oral use . it is not recommended to take a double dose to make up for a forgotten dose . if it is more than one tablet is taken , talk to your doctor , pharmacist , or nurse straight away . you may need to take the next tablet at the same time each day , preferably by mouth . taking this medicine should not be taken with other medicines . how much to take take the tablets with food , drink , and
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you notice any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may include fever , flu -like symptoms ( toxic epidermal necrolysis ). serious side effects may include : fit and seizure . very common ( may affect more than 1 in 100 people ) when taking the medicine , you should contact your doctor immediately . if these side effects get serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg / 0 . 5 ml , corresponding to a dose equivalent to the dose given by your doctor . the other ingredients are : tablet core : colloidal anhydrous silica ; croscarmellose sodium ( e464 ); hypromellose acetate succinate ; magnesium stearate ; microcrystalline cellulose ; and silicified microcrystalline cephalosporin . tablet coating : iron oxide black , iron oxide yellow , macrogol , polyvinyl alcohol . talc , and titanium dioxide ( see section 2 ). what erada looks like and contents of the pack the tablets are clear , colourless to slightly yellowish . they are supplied in glass
axumin is a radiopharmaceutical product that contains the active ingredient fluciclovine . it is used to perform a scan for a pet scan if you previously received treatment for prostate cancer . other tests have shown that you have a prostate specific antigen ( psa ). the cancer has spread to other parts of the body . if the cancer is not detected , the scan will be performed by a doctor who is experienced in the use of this procedure . your doctor will discuss with you the benefits and risks of this product with you . you will be asked to carry out this procedure in accordance with local requirements , such as : - to protect against radiation .
do not use axumin : - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or nurse if : you have kidney problems . you are on a low sodium diet . your doctor may decide to increase your dose . if this applies to you , your doctor will decide how many doses to give you . children and adolescents this medicine is not recommended for children below the age of 18 years . other medicines : this includes any other medicines that may affect the results of the images . pregnancy and breast - feeding , including machines , should not be given to children under 18 years of age . it is important that you inform your doctor as soon as possible if any of these apply to you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of radiopharmaceutical products is one ml of axumin per day . your doctor will tell you how many doses of this medicine to inject . during the procedure , you will receive a dose of 370 micrograms of megabecquerel . how much to inject the dose you will be given will depend on how you respond to the treatment . if the dose is too low or too low , your doctor may decide to increase the dose . it is important that you follow the instructions of the doctor ' s instructions . do not inject more than once a day , unless your doctor tells you to . this is to make sure that you are fully aware of the dose and how long you should continue to use a
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects have been reported : very common : may affect more than 1 in 100 people taking the medicine . the most common side effects of axumin are : - pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical uses ionising radiation to treat cancer and hereditary abnormalities . reporting of side effects tell your doctor , pharmacist or nurse if you get any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this product .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . radiopharmaceuticals should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of radioactive materials . these measures will help protect the environment .
what axumin contains - the active substance is fluciclovine . one tablet contains 1600 mg / ml , corresponding to 1 , 1600 mg and 16000 mg . the other ingredients are : tablet core : 3200 mg , which corresponds to 3200 , 32000 mg and sodium citrate . tablet coating : concentrated hydrochloric acid , sodium hydroxide . see section 2 ' how much to take ' for more information on the ingredients . each tablet contains 1 tablet containing 10 tablets , each containing 1600 mg ( equivalent to 16000 ) tablets . if you are not sure , talk to your doctor , pharmacist or nurse straight away . your doctor will prescribe the right dose for you . it is important to take the tablet at the same time each day . tablets are available in packs containing 1 tablet or 10
azopt contains the active substance brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it reduces pressure within the eye by reducing the amount of water in the eye . the active substances are used to reduce pressure in the eyes in adults , adolescents and children aged 12 years and older , who are at high risk of developing an illness called glaucoma . if the pressure in your eye is too high , it can cause damage to your sight .
do not take azopt : - if you have severe kidney problems or are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if any of these apply to you , tell your doctor or nurse straight away . you may be allergic to medicines called sulphonamides , medicines used to treat diabetes , infections , diuretics ( water tablets ). if this applies to you or your child ' s doctor will monitor you closely . your doctor may monitor you more closely if your child has the same allergy . there may be too much acidity in your blood , leading to hyperchloraemic acidosis . before you are given this medicine , your doctor will check you for signs of kidney or liver problems . this
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one glass of azopt per day . your doctor will tell you how many glasses to use . the usual dose is 1 glass of water per eye . if your doctor tells you not to use your eyes , your doctor may prescribe a different dose based on how you respond to the medicine you are taking . do not use more than once a day ( see section 2 ). do not change the dose unless your doctor advises you to . children and adolescents : children aged 1 year and above , children aged 2 years and above 3 years , the dose will depend on your child ' s age . what to do if the dose is too high or too low , talk to your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while taking azopt : common side effects ( may affect up to 1 in 10 people ) in the eye : blurred vision , eye irritation and eye pain . eye discharge : itchy eye or dry eye , abnormal eye sensation , and redness of the eye ( see section 2 ). other side effects include : bad taste , uncommon side effects that may affect more than 1 in 100 people . these effects are usually mild to moderate . they usually disappear after a short period of time . very common : may affect as little to no effect , but can last for a long time and may last for up to a year or more . the frequency of these effects is not known ( frequency cannot be estimated from the available data
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . a pack containing a single bottle should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml of solution contains 10 milligrams ( 0 . 5 g ). - other ingredients are benzalkonium chloride , carbomer 974p ( edetate disodium ), mannitol , purified water , sodium chloride ( as tyloxapol ), hydrochloric acid ( as sodium hydroxide ) and acidity levels ( ph levels ) of the solution is a clear , colourless to pale yellow liquid ( a suspension ) in a glass vial . it is available in packs containing 5 vials , each containing a 10 mg plastic ( droptainer ) bottle with a screw cap . not all pack sizes may be marketed .
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " medicines taken by mouth ". it is used to treat diabetes in adults , adolescents and children aged 18 years and over . this medicine is used for the treatment of diabetes called " type 1 diabetes ". type 1 is a condition in which your body does not produce enough insulin to control the level of sugar in your blood . the amount of sugar that your body produces depends on how you respond to any of the other ingredients , such as sugar , fat , or sugary foods . in type 2 diabetes , your body doesn ' t make enough insulin , so the insulin does not work as well as it should . your doctor will test your blood and your urine to see how well your body is working and how well you are able to control diabetes . if you are not sure , talk to
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking : feeling sick or sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , sweet smell to your breath , a sweet or metallic taste in your mouth , or odour to your urine , sweat , rapid weight loss . these may be signs of the above symptoms of " diabetic ketoacidosis " in patients with diabetes with increased levels of " ketone bodies " in your urine and blood . if any of these apply to you , tell your doctor or pharmacist . your doctor may need to monitor you more closely for signs of diabetes , such as increased levels
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet once a day . forxiga is used to treat type 2 diabetes . your doctor may prescribe a dose of either 10 mg or 5 mg per day , depending on whether you have a liver problem . you can take forxika with or without food . type 1 diabetes : your doctor will tell you how many tablets to take . this medicine swallow the tablets whole . take it as soon as you remember . do not take more tablets than you should if your doctor tells you to . it is important that you follow your doctor ' s instructions on how to take it . if it is too strong or too weak , talk to a doctor or go to the nearest hospital straight away . however , if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with forxiga : angioedema ( may affect up to 1 in 10 , 000 people ) if you notice any of the following signs , tell your doctor straight away : - the signs may include : swelling of the face , tongue or throat , difficulties swallowing , hives or breathing problems . diabetic ketoacidosis ( type 1 diabetes ) is uncommon . it is uncommon in children and adolescents aged 1 to 10 years of age . type 2 diabetes is rare in children less than 1 in 1000 people . diabetes with diabetes with " ketone bodies " in your urine . this may be a sign of increased levels of " ketones " in the blood . if this happens , your doctor may reduce your dose of forx
what forxiga contains the active substance is dapagliflozin . a single - use , 5 mg film - coated tablet ( tablet ) contains a total of 0 . 7 milligrams ( 1 ml ) - the other ingredients are : - tablet core ( tablet core ): adiol diol monohydrate equivalent to 5 millilitres ( e421 ). - tablets : microcrystalline cellulose , lactose ( see section 2 ' for more information '), crospovidone , silicon dioxide , magnesium stearate . film  - coating : polyvinyl alcohol , titanium dioxide . macrogol 3350 , yellow iron oxide , white to off - white , opalescent , round - shaped tablet . what for
mepact contains the active substance mifamurtide . it works by inhibiting the growth of certain bacteria that attack the immune system . mypact is used to treat osteosarcoma ( bone cancer ) in adults , adolescents and children aged 2 and 30 years , who have had surgery to remove the tumour , or who have received chemotherapy to kill cancer cells and bring cancer back to normal .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this includes medicines containing ciclosporin or other calcineurin inhibitors ( nsaids ) that can damage your heart or blood vessels , which can lead to blood clots (thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). if any of these apply to you , tell your doctor as soon as possible . your doctor will monitor you for long - lasting , worsening symptoms . you may need to continue to be treated for asthma or other breathing disorders . if your asthma is due to an inflammatory or autoimmune
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose of mepact is 2 mg of mifamurtide once a day for 12 to 24 hours . your doctor will adjust your dose based on your treatment plan , your chemotherapy schedule and the duration of your chemotherapy . you will be given 36 hours of treatment each day . do not stop treatment with mypact if there is an interruption in the flow of the freeze - dried powder or a liquid suspension , or if the filter does not work properly . it is very important that you keep the dose in the vein for at least 1 hour before you start to take mepakt . if this happens , you may experience severe side effects such as fever , chills , fatigue , nausea and vomiting . talk to your doctor , pharmacist
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue are common ( may affect up to 1 in 10 people ) side effects in adults , but not in children , adolescents and children aged 8 years and older . if you are not sure , talk to your doctor , pharmacist or nurse straight away . you may need to stop treatment while you are being treated for a condition called transient fever . your doctor may prescribe paracetamol to reduce the risk of fever during and after treatment with mypact . stomach problems ( nausea , vomiting , loss of appetite ) after chemotherapy , contact your doctor immediately . continuing fever , chills may occur for up to 8 weeks after starting treatment . it is important that you tell your doctor as soon as possible in case of an infection such as rash or any problems breathing or whe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension contains sodium chloride 9 mg / ml . after reconstitution , mepact should be used within 9 days . once reconstitution has been completed , it should be stored at room temperature for a maximum of 6 hours . this medicine should not be used if it is damaged or shows signs of deterioration .
what mepact contains - the active substance is mifamurtide . each ml of solution contains 4 milligrams ( 0 . 08 micrograms ) . after reconstitution and suspension , one sterile filter is used to remove the remaining product from the solution . the other ingredients are : - 1 - palmitoyl - 2 - oleoyle- sn - glycoresoro - 3 . phosphocholine ( see section 2 ) and - 2- dioleayl ( sg glycero -3 phospho - al - serine monosodium salt ( e172 )) ( see also section 2 " mepace contains mfg / mb ") from the water for infusion ( 50 mg ) with a
mirvaso contains the active substance brimonidine , which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness caused by rosacea . this is a type of redness in the face that has spread to other parts of the body ( e . g . high levels of blood flow in the facial skin , resulting in enlargement ( dilatation ) of the small blood vessels of the skin . mirvasa acts by reducing the number of blood vessels and reduces the excess blood flow , leading to redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be used under the skin . certain medicines used to treat depression in patients with parkinson ' s disease are monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( imipramine ), tetracyclic antidepressants such as maprotiline, mianserin and mirtazapin . if any of these medicines come into contact with you , tell your doctor or pharmacist . you may experience side effects if the medicine has been given to you by a doctor or nurse . mirvas
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso will be given to you by a healthcare professional under the supervision of a doctor who is experienced in the use of this medicine . the recommended dose is 1 gram ( 5 pea - sized amounts ) once a day on the face . your doctor will tell you how much to take and how often to take it . this medicine should only be used on the surface of your body . it is important that you do not use it on body surfaces such as your eyes , mouth , nose or vagina at the same time each day . you may need to take your dose as soon as you remember . if it is too strong or too weak , contact your doctor , pharmacist or nurse straight away . how to use Mirvaso mirvasa is to be used
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects include severe skin irritation ( inflammation ), skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are worsening of rosacea . the treatment should be stopped immediately if symptoms do not improve . see section 2 " mirvaso may cause contact allergy " for more information . allergic reaction : rash ( rare angioedema ) is a serious allergic reaction that may cause a rash of the skin . tell your doctor straight away if you notice any of the following : itching , burning or burning sensation . other side effects may include : mild to moderate , but not all side effects can be serious . this includes any possible side effects not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in the original package in order to protect from moisture . tube and pump : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each vial of gel contains 3 . 3 mg of brimoniidine ( as 5 mg / ml ) in the other ingredients : carbomer : methylparahydroxybenzoate ( e464 ), phenoxyethanol , glycerol , titanium dioxide , propylene glycol , sodium hydroxide , purified water ( see section 2 under ' recombinant '). - myrvaso is a clear , colourless to opaque gel . it is available in packs containing 2 , 10 or 30 tablets . - gel is supplied in an airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody . it works by binding to a protein called human vascular endothelial growth factor ( vegf ), which is produced by the immune system in the body to fight infection , cancer , and other forms of infection . mvai binds to the protein that controls the growth of cells in the lymph vessels of the body . by binding to this protein , it stimulates blood vessels to produce more oxygen , allowing the tumour to grow . this helps to stop tumour growth in the blood vessels and the nutrients that are needed to provide oxygen to the cells . the active ingredient is : a medicine for the treatment of advanced cancer in the large bowel ( colon ) that has spread to other parts of the colon .
do not take mvasi : - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or nurse straight away . children and adolescents do not give this medicine to children under the age of 6 years of age , unless your doctor tells you to , or your child , to chinese hamster ovary ( cho ) cell products . pregnancy and breast - feeding , this medicine is not recommended for use in pregnant women . do not have a baby ' s doctor or pharmacist if : you are not sure . you have been told by your doctor that you may be pregnant or are planning to have 
administration the dose of mvasi depends on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 ml , 10 mg or 15 mg / kg body weight . your doctor will decide the dose that is right for you . if you are not sure , talk to your doctor , pharmacist or nurse . how much to give the doctor will tell you how many infusions you will receive and how often you will be given . depending on how you respond to treatment , your doctor may decide to increase or decrease your dose . it is recommended that you receive the first dose at least 2 or 3 weeks after you start treatment . this medicine is given to you by a doctor or nurse as soon as possible if your tumour is growing . do not stop treatment with this medicine unless your doctor tells you to . in order to prevent your tumour growing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with mvasi : very common side effects ( may affect more than 1 in 10 people ) if you get any of the side effects not listed in this leaflet , talk to your doctor , pharmacist or nurse straight away . this includes any possible side effects that may occur during treatment with chemotherapy . these side effects may be serious and need immediate medical attention . allergic reactions : an allergic reaction may include difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects such as fever , diarrhoea , vomiting , nausea , or feeling sick or vomiting .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , infusion solutions should be used immediately . mvasi can be stored for up to 24 hours at 2 to 8 oc . after dilution , the solution should be diluted . the solution must be used within a sterile environment . it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help to protect the environment , and the environment in which it is stored .
what mvasi contains - the active substance is bevacizumab . each ml contains 25 mg . - each vial contains 1 . 4 mg , 16 . 5 mg or 4 vials of 100 mg mvai . the other ingredients are : - capsules : 1 , 4 mg and 16 mg : 400 mg of bevacimab in a vial : 16 % trehalose dihydrate , sodium phosphate , polysorbate 20 % water for injections , water for infusion , clear , colourless to slightly yellow liquid , with a rubber stopper . pack size : 100 micrograms / m2 , a single dose : 4 mg or a double dose of 400 microgrammes . not all pack sizes may be marketed .
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it belongs to a group of medicines called autologous anti - cd19 - transduced cc3+ cells . in patients with refractory mastectomy , your own white blood cells ( b - lymphocytes ) are destroyed by the body ' s own immune system , causing it to spread to other parts of the body ( e . g ., a type of cancer that affects the ability of the immune system to produce a certain number of a specific type of b lymphocyte ) in the body called a " apoptosis ". if this applies to you , it is important to tell your doctor , pharmacist , or nurse . this medicine works by reducing the number of the b
do not take tecartus - if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . your doctor will check the number of white blood cells in your blood ( lymphodepleting chemotherapy ). children and adolescents 3 years of age and older are more likely to have a low number of these cells . autologous use is not recommended . tests and checks will be performed on the lungs , heart , kidney , blood pressure , infection , inflammation , or your cancer . if any of these apply to you , tell your doctor or nurse . you may also be at risk of developing graft - against - host disease or you have had a transplant .
tecartus will be given to you by a doctor or nurse who is experienced in the use of your own white blood cells . your cells will be injected into a catheter placed in a vein . a procedure call leukapheresis will be performed to remove the cells from your blood . this will take about 3 to 6 weeks , depending on how well your blood is circulating . you will be monitored by your doctor , nurse or nurse . the number of your white blood cell count will be checked every 2 to 3 weeks . medicines will also be prescribed to you if you are being treated for lymphodepleting chemotherapy , your doctor will decide how long your treatment will last . it is important that you do not have to take other medicines to prevent infusion reactions , such as fever , during treatment with these other medicines . please see section 4 .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the side effects listed below . if your side effects get serious , you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness and fluid in the lungs . all symptoms may be due to a condition called cytokine release syndrome . loss of consciousness or decreased level of consciousness , confusion , memory loss . very common : may affect up to 1 in 100 people : diarrhoea , nausea , vomiting , abdominal pain , indigestion , constipation , difficulty sleeping ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep infusion bag in the original package in order to protect from light . from a microbiological point of view , tecartus contains liquid nitrogen equivalent to 150 micrograms per ml . this medicine contains genetically modified human blood cells and human - derived material . these measures will help protect the environment .
what tecartus contains - the active substance is autologous anti - cd19 - stimulated CD3+ cells . each ml contains a specific single infusion bag containing a dispersion of anti . 68 - CD19 car t cells ( 2 x 106 ) contains anti , sodium chloride , human albumin ( see section 2 ) and water for infusion . the other ingredients are : water for injection , infusion in a plastic bag , a metal cassette , and a single injection bag with a total of 68 cells per vial . not all pack sizes may be marketed .
januvia contains the active substance sitagliptin . it belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ). it is used to lower blood sugar levels in adults with type 2 diabetes mellitus . this medicine lowers the levels of insulin in your blood . if you are taking this medicine to lower your blood sugar , your doctor may decide to increase your dose of this medicine . your doctor will decide if this medicine is right for you . you may also be given certain other medicines , such as insulin , metformin , sulphonylureas , or glitazones . these are used in the treatment of your diabetes .
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have a history of inflammation of the pancreas . if this applies to you , tell your doctor as soon as possible . your doctor may decide to reduce your dose if necessary . you have pancreatitis ( see section 4 ). - you have blistering of the skin ( bullous pemphigoid ). your doctor will tell you how long you need to take , if any of these apply to you or you are not sure . it is important that you read the leaflet carefully before you take it . this is to make sure that you are aware of the effects of jan
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg / 63 mg coated tablet taken by mouth with or without food . for patients with kidney problems , the usual dose is 25 mg or 50 mg of this medicine . this medicine can be taken alone or with certain other medicines to lower blood sugar . your doctor will tell you how much januvia to take and how often to take it . if your blood sugar is too high or too low , talk to your doctor , pharmacist or nurse immediately . do not take more than one tablet at the same time each day . it is important that you do not stop taking this medicine without talking to a doctor or nurse straight away . you may need to take your next dose at any time of the day , unless your doctor tells you to . take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) of your back , nausea or vomiting . this may be a sign of an inflamed pancreas ( pancreatiatitis ). this is a serious allergic reaction ( frequency not known ). rash , hives , blisters on the skin or peeling skin , swelling of the face , lips , tongue , and throat , difficulty in breathing or swallowing . if any of these side effects gets serious , talk to your doctor or pharmacist . these may be signs of a possible side effect not listed in this leaflet . you can also report side effects directly via
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains a single - - use tablet called " st . john ' s phosphate monohydrate ". each tablet contains 25 milligrams ( mg / ml ). - other ingredients are : tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphorus , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . tablet coating : poly ( vinyl alcohol , macrogol 3350 ), talc , titanium dioxide , red iron oxide and yellow iron oxide . not all pack sizes may be available in pvc / aluminium / glass vials .
xultophy is used to control blood glucose in adults with type 2 diabetes mellitus . diabetes is a condition in which the body does not make enough insulin to control the level of blood sugar . insulin degludec , a long - acting basal insulin , helps to control your blood sugar levels . liraglutide ( also known as glp - 1 ) is used when your body is not able to produce enough insulin during meals . your doctor will tell you what to do if you have any further questions on the use of this medicine . it is important that you tell your doctor , pharmacist or nurse if your doctor has prescribed you one of the following : - oral medicines used to treat diabetes . this includes metformin ( a type of insulin that your body produces in the form of insulin ) and glucose - reducing sugar -
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . if this applies to you , tell your doctor , pharmacist or nurse . check with your doctor or pharmacist if the dose you take depends on your blood sugar levels . talk to your doctor before you start taking this medicine if : you have type 1 diabetes mellitus ( also known as ' ketoacidosis '). this is a condition in which your body does not produce enough insulin . you have inflammatory bowel disease ( delayed gastric emptying ( diabetic gastroparesis ). x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you are blind or have poor eyesight . your doctor will check your blood sugar level regularly during treatment with xultophy . the recommended dose is 41 mg / ml once a day . you should not exceed the recommended daily dose . if your doctor tells you otherwise , your doctor may prescribe a higher or lower dose , depending on your age , weight , height and weight . it is recommended that you do not take more than one tablet at a time . this will help you remember to take the tablet . however , if it is more suitable for you , talk to a doctor or nurse straight away . do not use x
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar . very common ( may affect more than 1 in 10 people ): if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia , which can lead to brain damage , can be life - threatening . if you have low blood glucose , you should check with your doctor , pharmacist or nurse immediately . your doctor will tell you how long you need to take xultophy and how often you should take it . this section contains information on the signs of serious allergic reaction ( anaphylactic reaction ) with frequency not known ( frequency cannot be estimated from the available data ). if any of the side effects gets serious , talk to your doctor or pharmacist . you can also report side effects directly via the national reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . xultophy may be stored at room temperature ( up to 30 ) for up to 8 weeks . after that , it should be used within 21 days . from a microbiological point of view , the product should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substance is insulin degludec . each vial contains liraglutide equivalent to 100 units ( ml ). - each tablet contains 3 . 6 milligrams of insulin demuclease , corresponding to a total of 300 units . the other ingredients are : glycerol ( e421 ), phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 for more information on sodium . pack size : 1 , 3 or 5 tablets in a multipack containing 10 tablets , each containing 2 tablets . not all pack sizes may be marketed .
giotrif is a medicine that contains the active substance afatinib . it belongs to a group of proteins called egfr [ epidermal growth factor receptor ] . these proteins are called erbb1 , her2 [ herbb2 ] and her3 . they are involved in the growth of cancer cells . this medicine works by inhibiting the activity of these proteins , which are essential for cancer cells to grow . you should not use this medicine if you have cancer of the lung ( non - small cell lung cancer ). your doctor will decide whether you should continue to receive your first treatment if prior chemotherapy treatment is squamous type . your doctor may decide to reduce the amount of chemotherapy treatment you have received .
do not take giotrif : - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low body weight ( less than 50 kg ) you have kidney problems . you have side effects such as : lung inflammation , interstitial lung disease , liver problems , or some liver tests . this medicine is not recommended for use in patients with a severe liver disease you have eye problems such as severe dry eyes , inflammation of the transparent layer of the eye ( cornea ) and ulcers in the eye . your doctor will tell you what to do if your doctor tells you . children and adolescents this medicine should not be given to children under the age of 18 years . if this applies to you , tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how much giotrif to take and how often to take it . take the tablet with or without food . swallow the tablet whole with a glass of water . do not chew , crush or crush the tablet . this medicine is for oral use . taking this medicine , your doctor may increase your dose of this medicine up to 1 tablet per day for up to 3 days . it is important that you do not take more than one tablet at the same time each day , depending on how you respond to the medicine you are taking . you should not take it with food , drink or other liquids . if this happens to you , contact your doctor , pharmacist or nurse straight away .
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported with treatment : diarrhoea : very common ( may affect more than 1 in 10 people ): if you have , or have recently , had a history of : - diarrey ( see section 2 " warnings and precautions "). - severe diarrhea with fluid loss : may affect up to 1 in ten people . - low blood potassium , worsening kidney function , may occur . tell your doctor immediately if your doctor notices any of the side effects listed above . it is important that you follow the instructions for use of appropriate antidiarrhaeal treatment . this is usually followed by a dose of antidistribution . your doctor may prescribe a higher dose of gio
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg / 0 . 5 ml ( i . e . one tablet contains 0 mg . 6 mg ). - other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ) and polysorbate 80 . what the pack looks like and contents of the pack gio trif 20 mg tablets are white to off - white , colourless to pale yellow tablets . they are available in packs of 1 , 2 or 4 tablets in blisters , each blister contains 7 or 1
orkambi contains the active substance lumacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children ( aged 6 years and older ) with f508del mutation . the mutation affects a protein called cystic fibrillation transmembrane conductance regulator , which regulates the flow of air through the lungs . because of the mutation , an abnormal Cftr protein is produced , or is produced in the body . lum ac , and ivacactor work together to make the abnormal ccf protein work more normally , causing your body ' s production of abnormal protein to work more normally , improve your breathing , your lung function and gain weight .
do not take orkambi : - if you are allergic to lumacaftor , ivacafter or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking , during or after a meal . if any of these apply to you , tell your doctor straight away . do not chew , crush or chew the tablet , as this may damage your liver or kidney . the f508del mutation is not known . your doctor may need to adjust the dose if your kidney is not working properly or if the dose is too high or too low . abnormal blood tests of the liver may be necessary . you should contact your doctor as soon as possible . these symptoms may be signs of liver problems such as pain or discomfort in the upper right stomach ( abdominal )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 mg once a day for adults and children aged 12 years and over . orkambi tablet should be swallowed with a glass of water . your doctor will tell you how many tablets to take and when to take them . you should take the tablet at about the same time each day . do not take more than your doctor tells you to take . it is best to take the tablets at least 6 hours before or at least 11 hours after your meal . for adults , the usual starting dose is 100 mg once daily for 2 hours . children and adolescents 12 years of age and above , your doctor may prescribe a lower dose of 200 mg twice daily ( 2 hours after breakfast ) once in the morning and 2 hours in the evening . if your doctor prescribes
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any of the side effects not listed in this leaflet . you may need to take orkambi with ivacaftor . if any of these apply to you , tell your doctor straight away . serious side effects may occur while you are being treated for : raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , or the worsening of liver function . other side effects are listed below : very common ( may affect more than 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes , loss of appetite , nausea , vomiting , diarrhoea , constipation , 
what orkambi contains - the active substance is lumacaftor . each tablet contains two active substances . - each 100 mg / 125 mg tablet contains 100 mg of the other two ingredients ; - one ml of the tablet core . the other ingredient is ivacaftingor , which can be used to treat a variety of conditions , such as : - your doctor , pharmacist or nurse will prescribe the right dose for you . your doctor will decide how much or how many tablets you need to take . you will be given the tablet in two different doses , depending on how you respond to each dose and how long you should take , and the number of tablets you will receive . for example , your doctor may prescribe you a dose of either 100 or 125 milligrams ( mm ). - you will also be given iva
lynparza contains two active substances . olaparib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping mutations ( changes ) in brca ( breast cancer gene ) that cause cancer . parp inhibitors can cause death of cancer cells , causing them to produce an enzyme that helps to repair dna . your doctor will tell you how long you need to take , when to stop , or if you have ovarian cancer where brca is mutated and the cancer has progressed after previous treatment with standard platinum . this medicine is used to treat patients who have not responded to previous treatment , such as standard platina , which has not worked .
do not take lynparza : - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents 6 years of age and older should not take more than 2 doses . if any of these apply to you , ask your doctor or nurse for advice . the recommended dose is one tablet once a day . do not chew , crush or chew the tablet . your doctor will tell you how many tablets you need to take . you should also tell your doctor as soon as possible if : you have a history of low blood cell counts . in testing , low counts of red or white blood cells ( low platelet counts ), see section 4 for more information . side effects 75 the signs and symptoms include fever ,
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg capsule once a day . your doctor will tell you how many 150 mg capsules to take . depending on the dose you take , your doctor may change the dose , depending on how you react to the capsules . if the dose is too high or too low , the dose may be increased or decreased . it is important that you take your capsules at the same time each day , so that you don ' t take more capsules than you should . you can take the tablets with or without food . swallow the capsule whole with a glass of water . do not take a capsule without talking to your doctor , pharmacist or nurse . this is to prevent side effects . children and adolescents 8 years of age
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these are symptoms of a decrease in the number of red blood cells ( anaemia ). very common : may affect up to 1 in 100 people allergic reactions , such as hives , difficulty breathing or swallowing , dizziness , signs and symptoms of hypersensitivity reactions . other side effects tell your doctor , pharmacist or nurse if you notice any of the following side effects while taking lynparza . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening , the capsules may be stored at room temperature ( up to 30 ) for a single period not exceeding 3 months . if you notice any capsules sticking out , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / 0 . 5 ml ( i . e . the other ingredients are : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black in the capsule and a white , opaque , hard capsule , printed with the " olarib 50 mg " on one side and " astrazeneca logo " on the other side . pack sizes : 112 or 448 capsules of 112 capsules . not all pack sizes may be marketed .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the active substance naloxone belongs to a group of medicines called opioids , including heroin , methadone , fentanyl ( e421 ), oxycodone , buprenorphine and morphine . nyxoid is used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and over . overdose can cause breathing problems and severe sleepiness . it is important that you inform your doctor , pharmacist or nurse as soon as possible if your child has been told that you have been given opioids for the first time . you should seek emergency medical care immediately .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if this applies to you , contact your doctor or go to the nearest hospital emergency medical care or emergency services immediately . an opioid overdose is a serious and serious event . your doctor will tell you how to treat the signs and symptoms of an opioidoverdose . this nasal spray should be used 2 to 3 times a day . you should use a new nasal spray . use this medicine when you are physically dependent on opioids , such as heroin , methadone , fentanyl or oxycodone , buprenorphine or morphine . these may be strong with strong with
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one spray a day . your doctor will tell you how many sprays to use . the dose will depend on how you respond to symptoms in your shoulders , ears , breastbone ( sternum ), ear , fingernail . clear the mouth and nose of any blocksages in your mouth or nose . see section 1 . breathing is the chest moving in your chest . you may hear breathing sounds or breath on the cheek . overdose may cause a response to touch or sounds , slow uneven breathing . if this happens , talk to your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while taking this medicine : nyxoid can cause acute withdrawal symptoms in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick ( vomiting ), diarrhoea , sweating , fever , goose bumps or shivering . trembling changes in behaviour such as violent behaviour , nervousness and anxiety . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 micrograms ( equivalent to one ml ) of a single dose ( corresponding to a dose containing hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrate ( e421 ), sodium chloride , hydrogenic acid , sodium hydroxide and purified water . - each spray contains 0 . 1 milligrams , which is supplied as a pre - filled nasal spray . the spray is supplied in a simple dose container . not all pack sizes may be marketed . your doctor or nurse will advise you on which dose you should use . you will be provided with a carton containing 2 nasal sprays in blisters containing one spray containing the other .
ovaleap contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone called " luteinising hormone " ( fsh ). this hormone is involved in the growth and development of the sacs ( follicules ) in the ovaries , and in the production of sperm ( a mature egg cell ). treatment with a medicine containing " clomifene citrate " is used in assisted reproductive technology procedures ( procedures used to get pregnant ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . it is important that you read the information in this leaflet carefully before and during pregnancy . this medicine works by reducing the amount of estrogen produced by the body ' s ability to produce enough estrogen , such as a hormone called
do not use ovaleap : - if you are allergic to follitropin alfa , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a tumour in your hypothalamus or pituitary gland ( part of the brain ). - you have large ovaries ( sacs of fluids ) in the ovary ( ovarian cysts ). you have unexplained vaginal bleeding . you have cancer in your ovates , womb or breasts or any condition that makes normal pregnancy impossible . your doctor may want to monitor you more closely , as this may make normal pregnancy possible . it is important that you tell your doctor as soon as possible if this happens . -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much ovaleap to use the recommended dose of this medicine is one injection into a tissue under the skin ( subcutaneous injection ). for irregular periods , this medicine should be used within the first 7 days of your menstrual cycle . your doctor will tell you how many doses of the medicine to use . the usual starting dose is 75 mg / m2 body surface area . this medicine can be used for up to 150 mg once a day . it is recommended that you take this medicine for 7 days , 14 days or 37 . 5 ml of water . if your doctor tells you to stop using this medicine , your doctor may prescribe a dose of 75 mg twice a week . you should inject this medicine at least 225 mg of h
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ) type of reaction . stop your ovaleap injection and contact your doctor immediately if you notice any of the following : very common : lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation ( ovulation ) in women . if any of these occur , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the pen cap after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored at room temperature ( up to 3 to 25 ) for a single period not exceeding 3 months . once opened , the cartridge should be used immediately . if not used within 3 months of first opening the pen must be discarded . the cartridge must be used within 28 hours at 25 . remove the cap from the ovaleap pen if you notice that the medicine is cloudy , or if it is not clear , it should be disposed of in accordance with local requirements .
what ovaleap contains - the active substance is follitropin alfa . each cartridge contains 300 mg / 0 . 5 ml of the solution , equivalent to 300 mg ( equivalent to 22 mg ). - each vial contains a higher concentration of a substance called ' sulfonyl ' ( s ) in a single - use solution . the other ingredients are : - solution for injection ( injection ) 22 . - if you are not sure , talk to your doctor or pharmacist before you are given the tablet , or if it is not clear , colourless to pale yellow , orange , yellow or opalescent , white to off - white , opaque , transparent , clear and colourless solution ( e1201 ). each carton contains 900 units ( 1 .
the active substance voriconazole accord is an antifungal medicine used to treat the fungi that cause infections . it is used in adults and adolescents ( aged 2 years and older ) to treat invasive aspergillosis ( a fungal infection caused by scedosporium sp ) and candidaemia , which is a type of fungal illness . candida spp . is non - neutropenic and has abnormally low white blood cells count . these are the most common cause of candida species . if you are not sure , talk to your doctor , pharmacist , or nurse . this is because if your fungus is not removed from the body ' s natural defence system , it may not work as well as it should . in this case , you should contact your doctor or pharmacist . fluconazo
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine accord . this includes any other medicines , including herbal medicines . your doctor will tell you what the medicines are and when to stop the treatment . 46 terfenadine ( for allergy ) astemizole ( allergy ), cisapride ( for stomach problems ), pimozide , for mental illness , quinidine ( for irregular heart beat ) rifampicin ( for tuberculosis ) and efavirenz ( for allergic reactions ). if any of these apply to you , tell your doctor or pharmacist . children and adolescents this medicine is not recommended for
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much voriconazole accord to use the recommended dose is based on your weight and the risk of infection . the usual dose is 40 mg once a day for the first 24 hours . your doctor will prescribe a dose of 400 mg once per day for each 12 hour period . if the dose is less than 24 hours long , your doctor may decide to increase the dose to 200 mg once every 24 hours ( see section 2 ). if your doctor decides that your dose is too high or too low , the dose may be increased or decreased depending on how you respond to treatment . for mild to moderate cirrhosis children and adolescents ( aged 2 to 12 years and older ) the usual starting dose is 50 mg once daily for the 12 to 14 year olds ( aged 12 to
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any side effects not listed in this leaflet . serious side effects may occur while taking voriconazole accord : rash , jaundice , changes in blood tests of liver function , pancreatitis . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ) blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision or night blindness or swinging vision . these may be signs of eye disorder such as halos , nightblindness and swiveling eyes . other possible side effects include : eye irritation ( e . g
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet contains a single dose ( equivalent to one tablet containing two tablets ). - each 200 mg tablet contains the other ingredients : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ) in the tablets . the tablets are a clear , colourless to pale yellow colourless tablet coated tablet . - tablet coating the tablet is a white to off - white , round tablet , with " 50 " on one side and " 200 " on the other side . not all pack sizes may be marketed in your country .
mvabea is a vaccine to prevent ebola virus disease in the future . it is given as a dose of 1 mg / m2 / kg / day . if you are not sure , talk to your doctor , pharmacist or nurse . you will be given a 2 dose course of vaccinations . your doctor will decide how many doses you should be given to protect you from the virus . this vaccine is for adults , adolescents and children aged 1 year and older who are vaccinated against the zabdeno vaccine , which is given 8 weeks later , is given at the same time each year . all vaccinations should be carried out in accordance with local requirements .
always use mvabea exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the vaccination course and the dose of the vaccine will depend on the severity of a severe allergic reaction ( see section 6 ). if there is a serious allergic reaction to an antibiotic ( such as ' gentamicin ') or to any of the other ingredients in the vaccine , your doctor will decide if the vaccine should be given . warnings and precautions talk to your doctor , pharmacist , nurse or nurse before you are given , if : you have had , or have ever had : - you have been given any other vaccine injection . you have fainted during the injection , bleeding or bruise easily . currently , you have a fever or an infection . medicines that affect the immune system such as high - dose cortic
mvabea is a vaccine that is given by injection into a muscle ( intramuscular injection ) in either the upper arm or the lower thigh . it is given through a blood vessel . vaccination with zabdeno vaccine is given 8 weeks later . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will decide on the best dose for you . the second vaccine is the same as the first and second vaccines . primary vaccination first vaccination in a syringe ( a vial containing a single vial ( s ) or a white to off - white , round , yellow cap vial is given . second vaccination in the same vial will be given to children aged 8 years and over , who are not yet fully vaccinated . booster vaccination in adults , children and adolescents
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling after the injection . very tired muscle ache joint pain common : may affect up to 1 in 100 people : sick ( vomiting ) itching after receiving the injection uncommon : can affect up , 1 to 100 people redness and skin hardness following the injection generalised itching . side effects not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you notice any of the following : diarrhoea if any of these effects occurs , talk to your doctor or nurse . this includes any possible side effects NOT listed in this leaflet . you can also report side effects directly via the national reporting system listed in
what mvabea contains - the active substance is zaire ebolavirus 29 . the other ingredients are : tai forest erection virus nucleoprotein marburg , 0 . 7 mg / 108 ml , chicken embryono fibroblast cells . this vaccine contains trace residues such as gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ) and a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains 20 vials . not all pack sizes may be marketed .
bondronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer in adults , adolescents and children with a condition called ' bone ' metastases ' in which your bones are damaged , breaking ( fractures ) or other bone problems that may occur after surgery or radiotherapy bondronate reduces the amount of a raised calcium level in your blood , a tumour that has spread to other parts of your body , or a type of bone that is lost from your bones , making your bones weaker .
do not take bondronat - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have low levels of calcium in your blood . this medicine can cause side effect called osteonecrosis of the jaw ( onj ). bone damage in the jaw has been reported in patients who have had cancer or related conditions . your doctor may decide to stop treatment . if onj is a painful condition , you may be at risk of developing osteoonecrosiof the jaw . some precautions you should take before starting treatment , especially if your mouth or teeth have poor dental health or gum disease . you should also have a planned tooth extraction or routine dental check - up . tell your doctor immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bondronat will be given to you by a doctor who is experienced in the treatment of cancer . it is given as an infusion into a vein . your doctor will do regular blood tests before you are given this medicine . this medicine is used to treat your illness , e . g . breast cancer that has spread to your bones . the recommended dose is 3 mg once a day for 3 - 4 days . you will receive a single infusion in your vein for 15 days , depending on the level of a raised calcium level in your blood . for 1 to 2 weeks , your doctor may decide to increase the dose to 2 mg / kg / ml . depending on your illness the medicine may need to be given at the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : very common ( may affect more than 1 in 1 , 000 people ): persistent eye pain caused by inflammation new pain , weakness or discomfort in your thigh , hip or groin , or unusual fracture of the tertiary bone . common : may affect up to 1 in 10,000 people : pain or sore in your mouth or jaw . severe jaw problems : necrosis ( dead bone tissue ) in the jaw or bone , ear pain or discharge from the ear . this may be a sign of an ear infection or bone damage in the ears . not known : frequency cannot be estimated from the available data .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . store in a refrigerator ( 2 - 8 ). do not freeze . keep in the original package in order to protect from light . from a microbiological point of view , bondronat should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of this medicine . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each ml contains 2 mg of concentrate for solution for infusion . the other ingredients are : sodium monohydrate , sodium chloride , acetic acid ( e464 ), sodium acetate , water for injections , and water for syringes ( see section 2 ) of the package leaflet . one vial contains 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
zeposia belongs to a group of medicines called " white blood cells " ( lymphocytes ). it is used to treat adults with relapsing remitting multiple sclerosis ( rrms ) which is an active disease . ms is a disease that affects the immune system ( the body ' s defenses ), and which causes the body to produce more of its own immune cells . these cells are important because they help the nerves in the brain , spinal cord and nerves to work properly . symptoms may include numbness and difficulty in walking .
do not take zeposia : if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if : you have a severely weakened immune system , a heart attack ( angina ), stroke ( mini - stroke ), transient ischemic attack ( tia ), severe heart failure in the last 6 months or irregular or abnormal heartbeats ( arrhythmias ) in the heart . warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment . you have severe infection ( hepatitis ), tuberculosis , cancer , severe liver problems , or you are pregnant or breast - feeding . if any of these apply to you , tell your doctor or pharmacist . children and adolescents do not give this medicine to children under 18 years of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zeposia is based on your heart rate . your doctor will give you a ' treatment initiation pack ' with instructions on how to start treatment . you will be given 4 capsules of 0 . 23 mg ozanimod once a day for 1 week . after 4 weeks of treatment , your doctor may increase your dose to 3 capsules , with instructions for use . if your doctor prescribes a higher or lower dose , you will receive a lower or higher dose . this will be followed by a reduction in the number of capsules that you will take . it is recommended that you take the capsules at least 5 weeks apart , 6 weeks apart and 7 days apart . then , 8 capsules will be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): slow heart rate , urinary tract infection , blood pressure uncommon : may affect up to 1 in 100 people allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist , or nurse if any of these apply to you . side effects that may affect you are not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine . many patients have had infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice any damage to the pack , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg / ml . - each capsule is labelled with ' oz ' on the outer shell . the other ingredients are : tablet core : ozaimod ( as hydrochloride ). - capsule shell : one capsule contains one capsule containing one capsule of one - half a - sized tablet , containing two - quarter sized tablets , each of which contains one of the following ingredients : the other ingredient is : 1 . 46 mg ( 4 .46 mg ) ( a total of one tablet ), each tablet contains one tablet of one side of the tablet of the other side : 2 . 9 mg ( 3 . 5 mg ), containing a single tablet of a maximum of
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . the other ingredients are : flaxicone ( a substance that belongs to a group of medicines called corticosteroids ) and steroids . if you have ever had a problem with your breathing , you may need to stop breathing or stop breathing . what is copd ? copd is a long - term condition that causes breathing difficulties . in copd the muscles and / or breathing are not working properly . when copd occurs , the muscles may not be able to breathe normally . this is because copd affects the way your breathing is working . it is important for copd to be controlled by bronchodilators .
do not take temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine . do not give this medicine to children and adolescents under the age of 18 years of age . tell your doctor or nurse if any of these apply to you . if your doctor thinks you may be allergic , ask your doctor for advice before you are given the medicine , as this medicine may affect your ability to breathe . your doctor will tell you how long you should take it . you should also tell the doctor if : you have asthma , heart problems , high blood pressure , liver problems or tuberculosis ( 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . take temybric ellipta with or without food . your doctor will tell you how many inhalations to use . do not change the dose unless your doctor tells you to . how much to inhale : your doctor may prescribe a different dose , depending on how you respond to the medicine . it is important that you do not take more than once a day . this will help to reduce the chance of a sudden attack of breathlessness or wheezing . if this happens , you should use a quick - acting reliever inhaler ( such as salbutamol ). if your symptoms get worse , your copd symptoms ( breathlessness , wh
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing starts to get wheezing , stop taking this medicine and contact your doctor immediately . pneumonia is an infection of the lung ( copd ). this is a very common side effect of temybric ellipta . symptoms of a lung infection include fever , chills , increased mucus production , change in mucous colour and increased cough . increased breathing difficulties common side effects ( may affect more than 1 in 10 people ): sore , itching , tingling or numbness . this may be a sign of an increased number of swollen or sore throat . tell your doctor straight away if you notice any of the following : - swelling of the face , lips , tongue or throat 
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhalation of 92 micrograms / ml contains : - a dose of 65 milligrams ( i . e . one inhaler of 55 millilitres ). - an inhaling of 22 milligrammes ( the other ingredients are : trifenatate ) - lactose monohydrate ( see section 2 under ' the contents of the pack '), - magnesium stearate ( e421 ). what temily looks like and contents of this pack the ellibta inhalers are a light grey plastic body , a beige coloured mouthpiece cover and a
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. zinfordo is used to treat infections of the skin and the tissues under the skin . if you have an infection of the lungs ( ' pneumonia '), your doctor may decide to increase your dose or reduce your dose . your doctor will work with you to reduce your risk of developing pneumonia by reducing your dose and reducing the risk of getting serious infections .
do not take zinforo : - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine if : you have been allergic to other cephalosporin antibiotics , or previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . if any of these apply to you , tell your doctor or pharmacist . talk to a doctor before you take , have recently taken or might take any other medicines . your doctor will tell you how long you will be treated . before you are treated , your doctor may decide to reduce the dose . you may need to take any additional tablets , such as : 26 - severe diarrhoea . antibiotics should not be used
always take zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 600 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . you can take one tablet at any time of the day , with or without food . it is recommended that you take the tablet at least 12 hours before or at least 8 hours after a meal . for some infections , the usual dose is 8 mg / ml , followed by a drip into a vein , usually 5 mg , 60 mg or 120 mg . if your doctor tells you to take an increased dose , your doctor may prescribe a higher or lower dose . treatment should be continued for 5 to 14 days . skin infections should be treated at least 5 to 7 days after pneumonia . kidney problems
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms and you need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . if this happens to you , you may have a serious allergic reaction ( anaphylaxis ), diarrhoea , stool or blood or mucus may occur during treatment with zinforo . medicines can slow bowel movement . very common ( may affect more than 1 in 10 people ): a blood test ( a ' coombs test ') and antibiotic . this test may be necessary to check that you are taking the medicine . it is important that you stop taking 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains 600 mg : the active substance is ceftaroline fosamil . the other ingredients are arginine and ethylhexadecyl , which is a colourless to pale yellowish , light yellow powder for solution for infusion in a vial . each vial contains 10 ml of powder .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . it is used in adult patients to treat long lasting pain caused by damage to the nerves . in patients with a variety of diseases , peripheral neuropathy pain can be caused by diabetes or shingles . pain sensations such as burning - throbbing , shooting - stabbing - sharp , cramping . aching and tingling and numbness are common . these sensations are usually mild to moderate . they are often caused by a combination of nerve damage . this can be a sign of a range of diseases called neuropathy . patients with diabetes and shingles are more likely to experience painful sensations ranging from burning or throbbling to shooting , stabbing or sharp
do not take pregabalin pfizer : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if any of these apply to you , tell your doctor or nurse straight away . you may need to change your dose at any time . the usual time to change the dose is one hour before or twice a day . your doctor will tell you how to adjust your dose . this is to prevent symptoms of an allergic reaction . these symptoms include : swelling of the face , lips , tongue , and throat , diffuse skin rash . in some cases , these reactions may be serious and may be life threatening . before you are given the medicine you may experience dizziness , somnolence , accidental injury
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is used for the treatment of peripheral and central neuropathic pain in adults with epilepsy or generalised anxiety disorder . the recommended dose is 150 mg once a day . your doctor may prescribe a different dosing schedule depending on how you respond to the medicine and on how well your body responds to it . it is important that you do not take more than the prescribed dose . however , if your doctor tells you to do so , your doctor will tell you how long you need to take . you may need to change your dose at any time of the day , or in the evening . 59 - the usual starting dose is one tablet in the morning or two tablets in the afternoon , with or without food . take pre
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache ( common : may affect up to 1 in 1 , 000 people ). increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest and irritability . disturbance in attention . clumsiness and memory impairment . these may include loss of memory or tremor , difficulty with speaking , and tingling feeling . the most common side effects are : - difficulty in swallowing , diarrhoea , nausea , vomiting , abdominal pain , muscle spasms , pain in the hands or feet . other side effects may include : allergic reaction ( allergic reaction ). very common
what pregabalin pfizer contains - the active substances are : 25 , 50 , 75 , 100 , 150 , 200 , 225 or 300 milligrams / ml . the other ingredients are lactose monohydrate , maize starch ( e460 ), talc , gelatine , titanium dioxide , sodium laurilsulphate , anhydrous colloidal silica , black ink with black iron oxide , propylene glycol , potassium hydroxide ) and water for injections . pack sizes : 75 x 100 x 200 x 225 tablets . each pack contains one tablet . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this helps the brain to work more efficiently . it is used to treat patients with parkinson ' s disease whose symptoms are sudden switches in the way you are able to move . if you have difficulties moving , you should contact your doctor immediately . the medicine is also used in combination with levodopa and other medicines used for the treatment of parkinsons disease .
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . - take the following medicines : monoamine oxidase ( mao ) inhibitors ( selegiline , rasagiline ), moclobemide , phenelzine ( isocarboxazid ), tranylcypromine ( used in treatment for parkinson ' s disease and depression ). - pethidine ( used as a strong pain killer ) should not be used in children and adolescents less than 7 years of age . your doctor will tell you how long you will be treated . during treatment with mao inhibitors , such as pe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of xadago is one 50 mg tablet once a day . your doctor will tell you how many tablets to take . the usual dose is one 100 mg tablet taken by mouth . if your doctor tells you that you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take the tablet with a glass of water . do not take more than one tablet at the same time each day , with or without food . it is important that you tell your doctor , pharmacist or nurse as soon as you remember . you may experience increased blood pressure , anxiety , confusion , forgetfulness , sleepiness , lightheadedness , feel sick ( feel sick ) or sick ( dil
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis , very high blood pressure , collapse ( neuroleptic malignant syndrome ), confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood , serotonin syndrome , confusion ( hypertension ), muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with xadago : parkinson ' s disease , safinamide and levodopa . if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains the other ingredients : - tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablets coated with hypromellose , macrogol , titanium dioxide ( e171 ) and iron oxide red ( encoding ink ). what the ' 50 mg ' means that the tablet is a white to off - white , oval - shaped , biconcave film- coated tablets of 7 mm diameter with metallic gloss . the tablets are available in packs containing 50 or 100 tablets . not all pack sizes may be marketed .
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body , and to reduce the amount of testosterone in your blood . zymiga is used in adults , adolescents and children whose prostate cancer is not being treated with hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ). it is also used in combination with another medicine , prednisone , or prediabetes , to treat high blood pressure , which causes your body to build up more testosterone , thereby reducing fluid retention . your doctor will check how well your blood is working .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are pregnant , breast - feeding , or are planning to have a baby . - you have severe liver damage or prostate cancer . this medicine is not recommended for use in children and adolescents . do not use this medicine in children under the age of 65 years . you have gained weight , swelling in the feet , ankles, or leg . these may be signs of liver problems , such as high blood pressure , heart failure , low blood potassium . high blood potassium can cause heart rhythm problems or other heart or blood vessel problems such as an irregular or rapid heart rate , shortness of breath 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 1 , 000 mg tablet once a day . your doctor will tell you how much zytiga to take . this medicine is for oral use . swallow the tablet whole with a glass of water . take the tablet with or without food . do not crush , crush or chew the tablet . how much to take prednisone to take it with food , drink or snack . it is important that you take it as soon as you remember . if it is too strong or too weak , talk to your doctor , pharmacist , or nurse straight away . you should take it at least 2 hours before or 2 hours after a meal . however , if your doctor tells you otherwise , swallow the tablets whole with some water
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . if the level of potassium in your blood is low , your doctor will check for potassium . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium in liver function test : high blood pressure , urinary tract infection , diarrhoea . not known ( frequency cannot be estimated from the available data ).
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg aspirin . the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate and water for injections ( see section 2 for more information on the contents of the pack - zytigea tablets are supplied in a plastic bottle with a child - resistant closure and are available in packs of 120 tablets . not all pack sizes may be marketed .
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases , including polyarticular juvenile idiopathic arthritis and enthesitis - related arthritis , paediatric plaque psoriasis , crohn ' s disease , and / or non - infectious uveitis ( nni - uv ). if you have , or have ever had , any of the following : - monoclonal antibody ( a type of protein called tumour necrosis factor ), which is involved in the inflammatory disorders . this helps to reduce the inflammation in these diseases . if any of these apply to you , you should contact your doctor , pharmacist or nurse for advice . the most common form of polyarticul
do not use hefiya : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if : you have a severe infection such as tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections . unusual infections may be caused by a weakened immune system . symptoms of infections may include fever , wounds , feeling tired or dental problems . you may also have moderate or severe heart failure or a serious heart condition . allergic reaction : allergic reactions may cause symptoms such as chest tightness and wheezing . if any of these apply to you , tell your doctor or pharmacist . children and adolescents this medicine is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how much hefiya to take and how often to take it . if your dose is less than 20 mg , your doctor may decide to increase your dose to 40 mg . for polyarticular juvenile idiopathic arthritis age : body weight : 2 kg 30 kg 40 mg 2 kg 10 kg 30 mg 20 mg for enthesitis for arthritis age 6 years and older : 30 mg 40 mg for children and adolescents : 6 kg 15 kg or more 30 mg for adults and children : 20 kg for paediatric plaque psoriasis age 4 to 17 years : the usual dose of 40 mg is 40 mg every 4 weeks . you can take 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . they usually resolve within 4 weeks of the last hefiya injection . tell your doctor straight away if you notice any of the following side effects after the last injection : allergic reaction , heart failure , severe rash or hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath , swelling of the feet . signs and symptoms of infection include fever , feeling sick , wounds or dental problems . these may be signs of infection , such as fever or feeling sick or wounds , dental problems and rash . other possible side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . from a microbiological point of view , hefiya can be stored at room temperature ( up to 25 ) for a maximum of 14 days . if not used immediately , it is recommended that you use it immediately . room temperature storage should not be longer than 14 days before use . you should use your pre . filled vials should be used within 14 days of first opening of the vial . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use 
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e464 ), sodium hydroxide and water for injections ( see section 2 ). what if any of the above applies to you , tell your doctor or pharmacist if you have any further questions on the use of this product , ask your doctor , pharmacist , or nurse . pack sizes are available in packs containing 20 vials , each containing 0. 4 mg , of slightly yellowish solution for injection . it is supplied in a clear type i glass 
ritemvia contains the active substance rituximab . it is a type of protein called a " monoclonal antibody " that attaches to a specific type of white blood cell , called b - lymphocytes . this type of antibody sticks to the surface of the cell and binds to the receptors of b and c in the body . by attaching to b or c - lymphocytic stem cells ( b cells ) in the blood called " b " in the lymph nodes . if you are not sure , talk to your doctor , pharmacist or nurse before you start the treatment . your doctor will decide how long your treatment will last , how long you will be treated , and how much you should be given , depending on the type of granulomatosis , polyangiit
do not take ritemvia : - if you are allergic to rituximab , other proteins that are present in the blood , or any of the other ingredients of this medicine ( listed in section 6 ) if : you have a severe active infection due to a weak immune system , severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis ( microscopic polyangitis ) or pemphigus vulgaris . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you have ever had a hepatitis infection . your doctor will tell you if your child is at risk of getting a high risk of recurrence of this infection , as this infection can cause heart problems such as angina and palpitations 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . it is important that you do not take this medicine unless your doctor tells you otherwise . your doctor will tell you how many doses to give . this will depend on how you respond to the treatment and on whether you experience any side effects . the recommended dose is one tablet a day , given as a drip ( intravenous infusion ). your doctor may prescribe medicines for you to take at least one tablet at the same time each day . you will receive one tablet in the morning and two tablets in the evening . however , if your doctor decides to change your dose , you should continue with your treatment for non - hodgkin ' 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions usually occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing or throat irritation . these may be signs of a reaction to ritemvia . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , abdominal pain , muscle spasms . other side effects include : common : may affect up to 1 in 100 people
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 micrograms ( iu ). - each vial of 10 milligrams / u / 1 . - one vial contains a total of 1 - 0 . 5 milligrammes , equivalent to a single - use dose . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 , water for injections and water for infusion in a glass vial . pack of 2 vials . not all pack sizes may be marketed .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ". it works by stopping the growth of cancer cells , preventing them from multiplying . cape citric acid ( cdc ) is a type of medicine called an active anti - cancer medicine . capsicum is used to treat adults with colon , rectal , gastric , or breast cancers in adults , adolescents and children whose colon cancer has spread to other parts of the body after complete removal of the tumour , after surgery , and to prevent it from spreading to other areas . it is also used in combination with other medicines .
do not take capecitabine teva : - if you are allergic to capsicum or any of the other ingredients of this medicine ( listed in section 6 ) or an allergy to the active substance . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines called fluorouracil ) you are pregnant , have low levels of white cells or platelets in the blood ( leucopenia , neutropenia , thrombocytopenia ), have severe liver or kidney problems . you have a problem with the enzyme dimitrinidine dehydrogenase ( dpd ) ( complete pd deficiency ). you are taking brivudine to treat herpes zoster .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine belongs to a group of anticancer medicines . your doctor will prescribe a dose and treatment regimen based on your body surface area , height and weight . the recommended dose is 1250 mg / m2 of body surface surface area per kilogram of body weight , 64 kg and height of 1 . 64 kg . if your doctor recommends a higher dose , your doctor may recommend a lower dose . this will depend on how you respond to the medicine . you will be given one dose of 500 mg , 1 dose of 150 mg per kilogram body weight and 80 kg , depending on your height and height . each dose will be calculated from your doctor ' s recommendation . it is recommended that you take one dose at the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact a doctor immediately if you notice any of these symptoms : diarrhoea , an increase of 4 or more bowel movements . if this happens , tell your doctor or go to the nearest hospital straight away . your doctor will tell you how long you should wait for your next dose . this is because you may have a higher risk of having a bowel movement at least 4 times a day . talk to your doctor , pharmacist or nurse as soon as possible if any of the above applies to you . vomiting , vomiting or vomit , nausea , or lose your appetite , stomatitis , pain , redness , swelling , sores in your mouth and / or throat ,
what capecitabine teva contains - the active substance is capsaicin . each film - coated tablet contains 150 mg ( equivalent to 150 mg / ml ). - a tablet containing 500 mg is also available . - one tablet is supplied as a single - use tablet . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose ( e421 ), croscarmellose sodium , magnesium stearate , macrogol 400 . tablet coating : hygroscopallose , titanium dioxide , yellow iron oxide and red iron oxide . not all pack sizes may be marketed . pack size : one tablet contains one tablet , each containing one tablet and one tablet in each carton .
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers . it is used to treat the prostate , bladder , and urethra ( smooth muscle ) in the tissues that support your symptoms . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . you should not be given more than once a day . your doctor will tell you how to treat your urinary symptoms caused by benign enlargement of the prostate ( prostatic hyperplasia ), difficulty in starting to pass water and a feeling of not completely emptying the bladder .
do not take silodosin recordati : - if you are allergic to , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor thinks you may be allergic , ask your doctor for advice . you should tell your doctor straight away if , during eye surgery , you notice cloudiness of the lens ( cataract surgery ). if this applies to you , your doctor may need to adjust your dose . 26 if any of these apply to you ( or you are not sure ) are not suitable for you 26 , talk to a doctor or go to the nearest hospital immediately . when you are being treated , it is important that you follow the advice given to you by your doctor as soon as possible . the use of sil
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is one 8 mg capsule once a day . your doctor will tell you how many capsules to take . you may need to increase your dose depending on how you respond to treatment . for patients with kidney problems or moderate kidney problems , your doctor may prescribe a higher or lower dose . the usual starting dose for this purpose is one 4 mg capsule twice daily . do not take more than one capsule once daily , unless your doctor tells you to . if this happens to you , talk to your doctor , pharmacist or nurse straight away . it is very important that you take the capsule with a glass of water . take it as soon as you remember and take it at the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . this is a very common side effect of silodosin recordati . dizziness : if you notice any of the following symptoms , talk to your doctor , pharmacist or nurse straight away . you may feel dizzy , sometimes fainting or fainting . if this happens , tell your doctor as soon as possible . complications , such as a cataract surgery or eye surgery , may occur . your doctor will tell you how long you need to wait and see if it is safe for you to take the medicine . it is important that you take it exactly as your doctor has told you . warnings and precautions talk to
what silodosin recordati contains - the active substance is sulfonyl alcohol . each tablet contains 8 mg / ml ( equivalent to a tablet with s - 3 ). the other ingredients are : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ) ( see section 4 ). if you are not sure , ask your doctor , pharmacist or nurse for advice on how to take your tablet . if your doctor tells you otherwise , he / she will give you the tablet at the end of the leaflet . the tablet contains 4 mg ( 4 mg ) of sillodone . your doctor will tell you exactly how many tablets you need to take . it is also available in packs containing mann
kinzalmono belongs to a group of medicines called angiotensin ii receptor antagonists . it works by blocking the activity of the enzyme , which causes the body ' s natural defences to cause its own blood vessels to narrow . this causes your blood pressure to rise . by blocking this activity , the blood vessels relax and the blood pressure rises , and so it is easier for you to keep up with your life - style . the active substance in this medicine is a type of essential hypertension ( high blood pressure ) in adults and children . if this happens , it can damage blood vessels in several organs and can lead to heart attack , heart or kidney failure , stroke , blindness .
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 3 years of age . if this applies to you , tell your doctor straight away . pregnancy and breast - feeding , see pregnancy section for further information . severe liver problems ( cholestasis , biliary obstruction , drainage of the bile from the liver and gall bladder ) or any other severe liver disease , including diabetes or impaired kidney function , or a blood pressure lowering medicine ( aliskiren ). if any of these apply to you or you are not sure , ask your doctor or pharmacist . you should not use kin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of kinzalmono is one tablet once a day . the tablets should be swallowed whole with a glass of water . your doctor will tell you how many tablets to take . take the tablets with or without food . do not take more than your doctor tells you to . it is important that you take the tablet at the same time each day , depending on how you respond to treatment for high blood pressure . if your doctor prescribes you , your doctor may prescribe a lower dose of 40 mg to lower your blood pressure and you should take a higher dose of 20 mg . you should also take kinzulmono with diuretics ( ' water tablets ') or hydrochlorothiazide to
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects include sepsis ( blood poisoning ), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects may affect up to 1 in 1 , 000 people . the following side effects have been reported with kinzalmono : common side effects ( may affect more than 1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects are uncommon , may affect 1 in 100 people , urinary tract infections and upper respiratory tract infections ( e . g . high blood pressure ), which may lead to lower blood pressure and a higher risk of cardiovascular events ( see section 2 , " warnings and precautions "), which can lead to urinary
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep your medicine in the original package in order to protect from light . your kinzalmono tablet should be used immediately after first opening of the blister . this medicine does not require any special temperature storage conditions .
what kinzalmono contains - the active substance is telmisartan . each ml contains 20 milligrams ( i . e . one tablet ). the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e464 ), magnesium stearate and water for injections ( see section 2 ). what kinszalmonio looks like and contents of the pack kn - 20 mg tablets are white to off - white , round , oval - shaped tablets , each containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product that contains the active substance lonoctocog alfa . it is used to treat bleeding episodes in patients with haemophilia a ( inborn factor ixii deficiency ) who do not have enough of the essential fatty acid ( fdl ) to form a blood clot . if you have an increased tendency to bleed , your doctor may need to reduce the number of cells that are not able to coagulate . your doctor will tell you how long you need to keep on a healthy life - threatening condition . this is because a low amount of factor xii is needed in order to make a person ' s immune system work properly . in the case of a child , factor 
you must not be given afstyla if you have ever had an allergic reaction to hamster proteins or any of the other ingredients of the medicine ( listed in section 6 ). 46 warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . the batch number of your treatment diary should be kept in order for you to be able to take the dose that is right for you . if this applies to you , tell your doctor as soon as possible . allergic ( hypersensitivity ) reactions have been reported in patients who have been given , or have been treated with , allergic reactions may occur . your doctor will tell you how to treat allergic reactions such as hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis ). a serious allergic reaction may cause
keep this medicine out of the sight and reach of children . do not use afstyla after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . your treatment will be started by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one vial a day . the duration of treatment depends on the severity of your disease the site of the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be used in aseptic conditions before use . if the solution is slightly opalescent , it may take up to 6 hours for the solution to clear , colourless or cloudy .
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include any of the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis and bleeding . if you are taking factor viii medicines with inhibitor antibodies , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . if not used immediately , the product may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . the reconstituted product should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what afstyla contains the active substance is 250 mg / 2 . 5 ml . after reconstitution , the solution contains 100 mg of lonoctocog alfa . the other ingredients are : - solution for injections the solution is 200 mg ( e421 ) lonoctacog and 1 , 000 mg . - solutions for reconstitution are 2 , 5 mm in size , followed by injections of the solution containing 400 mg , corresponding to a total of 1500 mg a / m2 . each vial of reconstitution is 5 micrograms in size to be used to make a single injection . this is followed by one injection containing 300 mg or a mixture containing 2 - 3 - 0 . 2 mm . once the solution has been prepared , it has been
praxbind contains the active substance idarucizumab , which is a reverse agent . dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation , is used in adults , adolescents and children aged 12 years and older . when a patient is given a dose of a single tablet , it is necessary that he or she immediately stop taking it . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have a genetic disease called hereditary fructose intolerance to the substance sorbitol . this medicine can cause serious adverse reactions . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . - this medicine contains dabigatran , which is another medicine used to prevent blood clots from forming in the body . it is important that you tell your doctor or pharmacist if any of these apply to you . your doctor will tell you how long you need to take , and how often you should take it . you should not take this medicine together with any other medicines , even if they do not work as well as they should . however ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 5 mg / 2 . 5 mg dabigatran once a day . your doctor will tell you how much praxbind to take and how long to take it . this medicine should be taken with or without food . do not take more than 5 mg of this medicine than your doctor tells you to take . it is recommended that you inject this medicine into a vein . you will receive this medicine as part of your treatment to reduce the risk of blood clot formation . if this happens , your doctor may decide to stop your treatment immediately . however , if it does not work properly , you should contact your doctor , pharmacist or nurse straight away . take the tablet with you to make sure that it is ready for use within 24 hours of
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the side effects listed in this leaflet , talk to your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate and acetic acid , sorbitol ( e460 ), polysorbate 20 , water for injections and water for food and drink ( see section 2 ' other ingredients in the pack ' below ). what it looks like and contents of the pack the solution for injection is a clear , colourless to slightly opalescent , slightly yellow solution . it is supplied in a butyl rubber stopper and an aluminium cap .
temomedac is a medicine that contains the active substance temozolomide . this medicine is used as an antitumour agent to treat brain tumours . it is used to treat newly - diagnosed glioblastoma multiforme in adults , adolescents and children aged 3 years and older , who have not had radiotherapy ( concomitant phase of treatment ) or a combination of monotherapy phases of treatment in adults and children 3 years of age and older who have malignant gliomema ( e . g . anaplastic astrocytoma ) that have not responded to standard treatment .
do not take temomedac : - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have had an allergic reaction to dacarbazine , an anticancer medicine ( dtic ). allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . blood cells are severely reduced ( myelosuppression ) in your white blood cell count and platelet count . these blood cells help your body to fight infection and to maintain proper blood clotting . your doctor will monitor your blood for these cells during treatment . if any of these apply to you , tell your doctor or pharmacist .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of temomedac is one tablet once a day . your doctor will tell you how many tablets to take and how often you should take them . the usual starting dose for treatment is based on your height and weight . you may have a recurrent tumour that has not responded to chemotherapy treatment in the past or has been treated with other medicines ( anti - emetics ). your doctor may decide to change your dose , depending on the type of medicine you are taking . this will depend on how well you respond to treatment . nausea and vomiting are common in patients with newly - diagnosed glioblastoma multiforme ( gbm ). you will be given treatment with radiotherapy ( concomitant phase )
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience a severe allergic ( hypersensitive ) reaction such as hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache . temomedac treatment may cause a reduction in certain kinds of blood cells , such as increased bruising and bleeding ( anaemia ) in the number of red blood cells ( fever ) and reduced resistance to infections . the reduction in blood cell counts may lead to a reduced number of infections , which may be life - threatening . your doctor will monitor you closely , as well as your doctor , to monitor your condition . this may be a sign that you may be at risk . you may also experience ana
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the capsules in the outer carton in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . each ml contains 5 mg ( equivalent to 5 mg ) tetadalafil . - each vial contains 20 mg / m2 , corresponding to a total of 20 mg and a maximum of 100 mg . the other ingredients are : - capsules containing 100 mg or a combination of 140 mg and 140 mg , each containing 140 mg or more , which corresponds to an average of 180 mg ). - tablets containing 180 mg of temazolomide each consists of 250 mg or 250 mg temozalomide per vial . not all pack sizes may be marketed . your doctor will prescribe the right dose for you .
cialis is a treatment for adults with erectile dysfunction , who cannot get , or keep , a hard or a sexy penis suitable for sexual activity . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine , ask your doctor or nurse for advice . it is used to treat adult men who do not have or have not had a healthy , hard - to - erection . the active substance tadalafil belongs to a group of medicines known as phosphodiesterase type 5 inhibitors ( pda ). cda works by blocking the activity of the blood vessels in the penis . by blocking this activity , your penis can be enlarged . this allows your body to maintain a normal , steady , and constant , level of
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you are given organic nitrate ( as nitric oxide donors ). - your doctor will tell you how many tablets to take and how often to take them . - the active substance is amyl . this belongs to a group of medicines ( " nits ") used to treat angina pectoris ( " chest pain "). if any of these medicines are not suitable for you , ask your doctor or pharmacist for advice . you should tell your doctor as soon as possible if your doctor tells you otherwise . children and adolescents this medicine is not recommended for children under 18 years of age . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . take cialis tablets with or without food . swallow the tablets whole with a glass of water . the tablets should not be swallowed whole . your doctor will tell you how many tablets to take and how often to take them . you should take the tablets at least 5 hours before or 2 . 5 hours after your last dose . do not take more tablets than your doctor tells you to take . it is important that you take the tablet at the same time each day to make sure that your erection is working properly . this will help you to get the best results you can get . however , you should not take a double dose to make up for a forgotten tablet . don ' t
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions , such as rashes ( frequency not known ), chest pain , nitrates ( frequency unknown ) and priapsim . if you get a prolonged and possibly painful erection while taking cialis , stop taking it and contact your doctor immediately . sudden loss of vision has also been reported . other side effects ( may affect up to 1 in 10 to 100 people ): headache , back pain . very common : may affect more than 1 in 100 people headache and back pain not known ( frequency cannot be estimated from the available data ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also
what cialis contains - the active substance is tadalafil . each film - coated tablet contains 2 . 5 milligrams ( equivalent to 2 millilitres ). the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), croscarmellose sodium , hydroxypropylcellulose ( e421 ), microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film  - coating : hypromellose , triacetin , titanium dioxide [ e171 ], iron oxide yellow , iron oxide red , and talc . what the pack looks like and contents of the pack the medicine is a white to off - white , round tablet . it is available in packs containing 2 , 5 and 2 tablets .
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it works by helping your pancreas make more insulin , which lowers your blood sugar ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the level of sugar in your blood . the sugar is released into the blood by the body , and the body makes more of the insulin it produces . your doctor will work out the best way to reduce the amount of sugar that your body can make . you will also be given the medicine in combination with metformin to control diabetes . this medicine is also used to treat diabetes in adults and adolescents .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . your doctor will check the acid level in your blood . diabetic ketoacidosis is a severe liver disease . gemfibrozil , a medicine used to lower increased fat levels , may cause liver problems . - you have moderate liver 28 disease ( see section 2 ). if any of these apply to you , tell your doctor or pharmacist . you may need to change your dose , as this medicine may not be suitable for you . it is not recommended for use in children and adolescents under 2 years of age . do not give this medicine to children under the age of 18 years
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . your doctor will tell you how many tablets to take and how long to take . the recommended starting dose is 30 mg once daily . take the tablet at least 4 hours before or at least 30 minutes before or 16 hours after your meal . if your blood sugar is too low , your doctor may prescribe a hypo . do not take a double dose to make up for a forgotten tablet . it is important that you continue to follow your doctor ' s instructions for your diabetes . continue your treatment with this medicine until your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid , and it is very common ( may affect more than 1 in 10 people ) in adults and adolescents . if you notice any of the following , talk to your doctor , pharmacist or nurse straight away , as this may be a sign that you may be at increased risk , or that you are not sure , ask your doctor or pharmacist , who will tell you how long it takes for you to take the medicine and how long you should take it and how often you should stop taking it and see a doctor as soon as possible , so that you can be sure that you have a good chance of having anaphylactic reaction . other side effects common : may affect up to 1 out of 10 people stomach pain , usually mild 
what enyglid contains - the active substance is repaglinide . each ml contains 0 . 5 mg ( 1 mg ) and 2 mg ( 2 mg ). the other ingredients are : - tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . - yellow iron oxide ( e172 ) in 1 mm thick , white , round and biconvex with bevelled edges , 1 mg white to pale brown , yellow , biconvexed . not all pack sizes may be marketed .
azacitidine mylan is an anti - cancer agent ( a type of medicine called ribonucleic acid ( rna ) which is produced by the bone marrow . it works by blocking the action of a substance called a protein called ' ribocytic acid ' ( e . g . analogue ) in cancer cells . the active substance in this medicine is called mds , and it is used in adults , adolescents and children aged 12 years and older who have had a stem cell transplantation . this is used to treat higher - risk myelodysplastic syndromes ( mss ). it is also used in adult patients with a variety of different types of cancers known as : - acute myeloid leukaemia ( aml ) and - diseases that affect the
do not take azacitidine mylan - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine : - you have decreased counts of platelets , red or white blood cells , kidney disease or liver disease , a heart condition that can lead to heart attack or lung disease . your doctor will do blood test before and during treatment . - your doctor may perform blood tests before and after treatment , as it is important that you follow the instructions for the ' cycle ' to make sure that you have enough blood cells to feed your liver and kidneys . you should also tell your doctor or pharmacist if any of these apply to you . children and adolescents do not give this medicine to children under the age
always take azacitidine mylan exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will tell you how much to take and how often to take it . swallow the tablet whole with a glass of water . do not crush , crush or chew the tablet . you may need to take another medicine to reduce nausea and vomiting . it is recommended that you take this medicine at least 75 minutes before you start taking this medicine . based on your height and weight , your doctor may prescribe a higher or lower dose . this " treatment cycle " lasts for 3 weeks , followed by a maximum of 4 weeks or 6 weeks . how long you should keep this medicine under your skin . apply this medicine on the skin of your thigh , tummy , or upper arm 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure such as swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you get any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the suspension in the original package in order to protect from light . from a microbiological point of view , this medicine does not require any special temperature storage conditions . this medicine is for single use only . the suspension should be used immediately after use . if not used immediately , the suspension may be stored at room temperature ( up to 1 ) for a single period of up to 8 hours . after this time , it should not be reconstituted . it should be disposed of in accordance with local requirements . in - use storage times and conditions prior to use are the responsibility of the user and should not exceed 8
what azacitidine mylan contains - the active substance in this medicine is called " azitidine ". each vial of powder contains 100 mg of aztidine . after reconstitution , the suspension is dissolved in 4 ml of water for injections . the reconstituted suspension is supplied in a glass vial with a capacity of 25 milligrams , containing azutidine ( as a substitute for mannitol ). - agtidine is a white to off - white powder for solution for injection . it is available in packs of 1 vial or 7 vials each . not all pack sizes may be marketed .
what duotrav eye drop solution contains - the active substances are travoprost and timolol . both of these substances are used in the treatment of glaucoma , which is an eye - related illness . - travostol is a prostaglandin analogue that is used to block the flow of fluid within the eye , thereby reducing the amount of pressure inside the eye and lowering the risk of high pressure in the eye which may be associated with an illness known as glauroma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : - respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - wheeziness , difficulty in breathing , long - standing cough , or breathing problems , such as severe hay fever or a slow heartbeat ( heart failure ), a disorder of heart rhythm ( irregular heartbeat ) or if your eye is cloudy . you should tell your doctor or pharmacist if any of these apply to you .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of duotrav per eye . your doctor will tell you how many drops to use and how often to use them . if your doctor tells you to use your eyes , your doctor may prescribe a different dose . how much to use the eye drops are as follows : eye drops 1 , 2 , 3 or 4 drops in a bottle . use in children and adolescents the usual dose is 1 drop a day . do not use the bottle in children under the age of 1 year . wash your hands thoroughly before using the bottle , with your thumb and fingers . keep the bottle tightly closed with your head , back , under the eyelid with a clean finger or a " pocket " on your eyelid . it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking the drops and contact a doctor straight away if you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): - the eye eye redness uncommon side effects may affect up to 1 out of 10 people eye eye surface inflammation or surface damage eye pain blurred vision abnormal vision dry eye or itchy eye eye discomfort signs and symptoms of eye irritation , such as burning or stinging rare side effects are : eye irritation or burning , swollen eyes , redness or redness of the eyes . these may be signs of eye discomfort , which may be caused by the drops . this is because duotrav has been shown to reduce the number of drops in the blood . other side effects include : headache , nausea , vomiting , dizziness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substance is travoprost . each vial contains timolol ( 40 mg / ml ). - each tablet contains 5 mg ( 0 . 5 mg ) of tilol . - other ingredients are polyquaternium - 1 , mannitol , propylene glycol and polyoxyethylene hydrogenated castor oil . 40 mg contains boric acid ( e421 ), sodium chloride , sodium hydroxide and hydrochloric acid . the other ingredient is purified water . this is a type of acidity levels and ph levels are controlled with the use of this product .
nplate ' s active ingredient is romiplostim , a protein that helps to prevent low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects the number of platelets in your body . platelets are important because they help to prevent blood clots from forming . if you have very lowplatelet counts , you may experience bruising and serious bleeding . it is used in children and adolescents aged 1 year and older who have had their spleen removed . chronic itp occurs when you have previously been treated with corticosteroids or immunoglobulins . what n plate looks like and contents of the pack of tablets is white to off - white , round , oval - shaped tablets .
do not take nplate : - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking n plate if : you have been allergic to other medicines that contain escherichia coli ( e . coli ). if any of these apply to you , ask your doctor for advice . you should tell your doctor as soon as possible in case you have a low blood platelet count ( thrombocytopenia ). your doctor may decide to increase your dose . your platelet counts should be checked regularly to check for blood clots . it is important that you keep a close watchful eye on the possibility of a build - up of red blood cells . this is especially important if this happens .
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 to 17 mg / kg of body weight . your doctor will tell you how many doses you should take and how often you should use them . n plate is given as an injection under the skin ( subcutaneous ). it is given once a day . you will be given 1 ml / m2 of your blood platelet counts . it is important that you take regular blood samples to check that your platelets are working properly . this will help your platelet count and how well your blood is working . how much to inject yourself , your doctor may decide to increase or decrease the number of platelets in your blood . for more information , see the section " instructions for use " below . children and adolescents from 1 month to 17 years of age
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nplate : itp : common ( may affect up to 1 in 10 people ) headache allergic reaction upper respiratory tract infection respiratory tract : very common : may affect more than 1 in 1 , 000 people bone marrow disorder , e . g . increased bone mmarrow fibres trouble sleeping ( insomnia ) dizziness or tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness on the skin and flushing . these may be signs of migraine . not known ( frequency cannot be estimated from the available data ) swelling of the face , lips , tongue and / or throat . uncommon : if you get any of these , talk to your doctor or pharmacist . this includes any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . nplate should be used within 30 days after first opening .
what nplate contains - the active substance is romiplostim . each ml of solution for injection contains 125 micrograms ( i . e . one vial of 230 iu ). - each vial contains a total of 125 mg riostim ( as a single - use solution ) and a deliverable amount of 0 . 25 g solution . the other ingredients are : - a syringe for injection , a vial for injection for injection with a maximum of 500 milligrams / m2 ( e421 ) - an aqueous , clear , colourless to slightly opalescent , white to off - white to pale yellow solution , with or without a glass vial containing a dose of rom
this medicine contains an active substance called glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes tightening of the muscles in the lungs , making breathing difficult . this medicine reduces the tightness of these muscles , which makes breathing easier . if you have copd you should stop using this medicine and talk to your doctor , pharmacist or nurse .
do not use tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor immediately if : you have kidney problems , have an eye problem ( narrow - angle glaucoma ) or have difficulty passing urine . your doctor will decide on the best course of treatment . if any of these apply to you , you should contact your doctor or pharmacist . you should not use this medicine for more than one hour before you use it . it is very important that you stop using this medicine immediately . tightness of the chest , coughing , wheezing or breathlessness should be immediately treated with a medical professional . do not stop using tovan
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the recommended dose is one inhalation every 24 hours . your doctor will tell you how many inhalations to use . this medicine should be inhaled at the same time each day . the usual dose is 75 mg / ml . do not take this medicine after the expiry date which is stated on the carton and on the label . it is important that you keep this medicine in the original package in order to protect it from light . you should keep an inhaler and capsules ( in blisters ) with the medicine . if the capsules are not clear , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer need . these measures
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 milligrams ( ml ) / m2 ( e421 ). - one inhalation vial contains 50 millilitres ( equivalent to 0 . 5 micrograms ) dextrose . the other ingredients are : capsule contents : the mouthpiece of the inhaler : a single dose of 44 milliliters , containing a syringe ( gyptose monohydrate ) and magnesium stearate ( not all pack sizes may be marketed ). the following pack sizes are available : pack size : 44 hard capsules with a white powder and a device that is used to inhale a capsule . capsules are supplied in blister
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . dopamine , also known as serotonin , has calming effects and relieving aggressive behaviour . it is used to treat acute symptoms such as mild - to - moderate agitation in adults with schizophrenia or bipolar disorder . these are diseases characterised by symptoms ( such as schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , being depressed , guilty , anxious , tense , feeling depressed or guilty . this can lead to feelings of sadness , guilt , anguish , and trembling . adaversuve is used in children and adolescents aged 18 years and over .
do not take adasuve : - if you are allergic to loxapine , amoxapene or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you experience symptoms such as wheezing or shortness of breath . you have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness , shortness or 25 you have neuroleptic malignant syndrome ( nms ). you have symptoms similar to those of antipsychotic medicines . these symptoms include high fever and rigid muscles . it is important that you tell your doctor or pharmacist if any of these symptoms occur . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg once a day . your doctor will tell you how much adasuve to take and how often to take it . take the tablet with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if your condition does not improve , your doctor may prescribe a dose of 4 . 5 mg once daily depending on your condition . use your hand or mouth with the device . you may experience the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements , or changes in the way your eye reacts to this medicine . contact your doctor immediately if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness or irritating to your airways ( asthma , copd ), light - headedness or fainting . your doctor may check your blood pressure , worsening agitation , confusion , fever or muscle stiffness . this is a severe condition called neuroleptic malignant syndrome . the following side effects may occur with adasuve : very common : may affect more than 1 in 10 people adasuve may affect up to 1 in 100 people dizziness , tingling or numbness in the mouth , nose , throat , tongue or throat . these may be signs of a serious condition known as
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . an open or damaged pouch may cause physical damage . if not used immediately , contact your pharmacist .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 micrograms / ml . - each inhalation delivers a maximum of 4 . 5 milligrams ( iu ) of lox apnea each . the other ingredients are : - disposable white plastic inhalers , containing a dose of 0 . 4 mg apasuve , which is supplied in a clear , colourless to pale yellow , white to pale pink , round , oval , square - shaped , flat , sealed foil pouch , and adsuve is available in packs containing 1 or 5 packs . not all pack sizes may be marketed .
azacitidine betapharm is an anti - cancer agent . it belongs to a group of medicines called ' medicines for cancer cells '. a doctor or nurse who has been trained in the use of this medicine has given this medicine to patients who are not able to produce enough , or cannot , normal blood cell production . the active substance in this medicine is called a " stem cell transplantation ". it is used to treat patients with higher - risk myelodysplastic syndromes ( mds ). this is a type of cancer called " apoptosis " ( cmml ) or acute myeloid leukaemia ( aml ). these are diseases that affect the bone marrow , which is important in preventing normal blood cells from growing out of control . what are the benefits and risks of using this medicine are : 
do not take azacitidine betapharm - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have advanced liver cancer . if this applies to you , it is important that you tell your doctor as soon as possible . your doctor may decide to reduce your dose . you may experience decreased counts of platelets ( red or white blood cells ) in patients with kidney disease , liver disease or a heart condition ( such as heart attack , lung disease ). your doctor will do blood test before and during treatment . the doctor will perform blood tests before and after treatment , so that you can tell the doctor if any of these apply to you before treatment is started . in general , treatment is a ' cycle 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of azacitidine betapharm is one tablet once a day . it is taken with another medicine to reduce nausea and vomiting . your doctor will tell you how many tablets to take and how often to take them . do not exceed the recommended daily dose of 75 mg . this medicine is based on your height and weight . how much to take your doctor may adjust your dose depending on your weight and how long you need to take . if your doctor decides to give you this medicine , take it at least 3 days before you start this " treatment cycle " ( see section 4 and 6 ). this medicine should only be taken under the skin , with or without food . apply this medicine on the skin of your thigh , tummy or upper arm .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these are symptoms of liver failure such as swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , decreased appetite , confusion , restlessness and fatigue . if you get any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the suspension in the original package in order to protect from light . from a microbiological point of view , this medicine does not require any special temperature storage conditions . this medicine is for single use only . the suspension should be used within 45 minutes . if not used within 8 hours , it should not be used in combination with injections . once the suspension has been prepared , the suspension may be stored in the refrigerator at room temperature ( up to 8 ) for a single period of up to two weeks . after this time period the suspension must be reconstituted . it is recommended that the suspension be used immediately .
what azacitidine betapharm contains - each vial contains 100 mg or acetate . - the other ingredients are : - powder for suspension : after reconstitution , 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 dna ( e421 ). - alcohol : the active substance is mannitol , which is also present in the powder for solution for injection in a glass vial . pack size : one vial each containing 100 milligrams ( a syringe for injection ). not all pack sizes may be marketed in your country . you can also buy a bottle .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults , adolescents and children with inherited condition in which the body does not produce enough glucosylceramide . the body ' s spleen , liver and bones do not work as well as it should . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . this medicine is for oral use only . your doctor will tell you how long you need to take this medicine and how often you should take it , as it may take longer than usual to make sure that you are metabolise it properly . you may need to have a simple laboratory test to see how gaucher diseases type 1 works . gaucher syndrome type 1 is caused by a condition where the body produces too much 
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are taking medicines with moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 you have been taking medicines that do not work well , such as erythromycin or itraconazole . these medicines can affect your body ' s ability to work properly . your doctor will tell you if any of these apply to you . it is important that you read the package leaflets carefully before you are given the medicine . you should tell your doctor or pharmacist if your child is not sure . children and adolescents this medicine is not recommended for children
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of metaboliser is one tablet once a day . your doctor will tell you how much cerdelga to take and how often to take it . swallow the tablet whole with a glass of water . you can take a tablet with or without food . do not crush , crush or break the tablet . if the tablet is swallowed whole , it may take up to 84 hours before your next dose . take the tablet at the same time each day , once every day for as long as the doctor tells you to . however , if it is too strong or too weak , take it as soon as you remember . it is important that you do not take more tablets than you should . how to open the blister / wallet
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( vomiting ) common : may affect up to 1 in 1 , 000 people feeling unwell . if you notice any of the side effects listed above , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 milligrams ( iu ). - other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ) - capsule shell : hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide , indigotine , shellac , black iron oxide ( e172 ) and propylene glycol and ammonia solution . what you need to know about the contents of the pack cerdellga capsules are a pearl blue , green or green opalescent capsule . they are supplied in a glass vial . not all pack sizes may be marketed .
zoledronic acid hospira contains a substance called bisphosphonates . this substance belongs to a group of medicines called ' sulfate '. it is used in adults to treat bone change , bone complications ( e . g . fractures ) and bone metastases ( cancer at the primary site of the bone ). it is also used to treat calcium in adults who have a tumour . tumours in the bone can increase the amount of calcium in your bone , leading to tumour - induced hypercalcaemia .
always take zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will do blood tests before and during treatment . your doctor will tell you how many tablets to take and how often to take them . you will also be asked to take a dental examination before treatment if : you are allergic ( hypersensitive ) to the active substance ( e . g . another bisphosphonate ). your doctor may ask you to take the tablets at the same time each day . it is important that you tell your doctor , pharmacist , or nurse if any of the following applies to you : - you are taking , have recently taken or might take any tablets with or without food . warnings and precautions talk to a doctor or nurse before you are given the tablets . do not use zol
always use zoledronic acid hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use bisphosphonates intravenously ( intravenous ) into a vein ( ' iv ' administration ): to prevent dehydration , your doctor may decide to increase the dose to 4 mg once a day . you have a kidney problem . if your kidney problem is not well controlled , you may need to be treated by a doctor or nurse . your doctor will tell you how many doses you need . the recommended dose is 4 mg / ml . it is important that you follow the instructions for use in this leaflet . talk to your doctor , pharmacist or nurse as soon as possible if : you have had or might have had bone complications or bone metastases 
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): - severe kidney impairment ( seen in blood tests ) - low level of calcium in the blood ( seen uncommonly in 1 in 100 people ). - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness , feeling of heaviness or loosening of a tooth , bone damage in the jaw ( osteonecrosis ). tell your doctor immediately if you notice any of these symptoms . talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
keep out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light .
what zoledronic acid hospira contains - each ml of concentrate for solution for infusion contains the active substance . - the other ingredients are : - concentrate for injection . each vial contains 4 mg of zolodronic acid ( as monohydrate ). - mannitol , sodium citrate , water for injections and water for syringes ( see section 2 ) for more information on the contents of this leaflet . what you need to know before you use , and when to use it , ask your doctor , pharmacist or nurse for advice on the right dose for you . pack sizes : each pack contains one vial containing one ' sterile concentrate ' and ' infusion '. each pack of 4 vials contains one glass vial with the other . not all pack sizes may be 
varuby contains the active substance rolapitant . it is used to treat cancer feeling sick ( nausea ) or being sick ( vomiting ) after cancer treatment chemotherapy chemotherapy destroys nerve cells in the brain . vomiting is a sign that you are sick . if you feel sick , you may need to take another medicine to treat your illness . your doctor will work with you to make sure that these nerve cells are working properly . this will help to reduce the risk of nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). this medicine is an herbal medicine that contains st john ' s wort ( hypericum performatum ) and is used to treat depression and difficulty sleeping ( see section 2 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . 27 you have severe liver or kidney problems . you are taking certain medicines , such as rifampicin for tuberculosis or other infections , carbamazepine for epilepsy ( nerve pain ) or phenobarbital ( used in adult patients with epilepsia ), enzalutamide for prostate cancer , phenytoin . if any of these apply to you , tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . your doctor will tell you how many doses to take . do not take more than your doctor tells you to . this medicine is for oral use . it is not recommended that you take it at the same time each day . however , your doctor may change your dose at any time during your chemotherapy cycle . chemotherapy should not be used to treat sickness . if sickness does not go away , contact your doctor immediately . taking this medicine if chemotherapy is not working , or if another chemotherapy cycle is needed , you may feel sick or being sick after receiving chemotherapy . talk to your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very common ( may affect more than 1 in 1 , 000 people ): - symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever or faster heartbeats . tell your doctor immediately if you notice any of the following : contact your doctor , pharmacist or nurse immediately . other possible side effects very common : may affect up to 1 in 10 people : headache , constipation , feeling tired . uncommon : not known : frequency cannot be estimated from the available data : nausea , vomiting , diarrhoea , tingling in the hands or feet . very rare :
what varuby contains - the active substance is rolapitant . each film - coated tablet contains 90 milligrams ( mg ). - each tablet contains the other ingredients : - lactose monohydrate ( see section 2 under ' variosose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide ( e171 ), magnesium stearate . film coating : polyvinyl alcohol , titanium dioxide , macrogol , polysorbate 80 . - blue , 100 micrograms , a polyester chloride and polychlorotrifluoroethylene / aluminium foil twinned blister . not all pack sizes may be marketed .
what enerzair breezhaler contains - the active substances are indacaterol , glycopyrronium - mometasone furoate indagacaterol belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the lungs , allowing the airways to flow freely , and by reducing the amount of air in your lungs to be emptied , which is important for breathing . the active substance in the body consists of mother - child - - baby - and - infants , including infants and children , who are not able to breathe , are unable to breathe or cannot breathe . mother e . g ., the body produces its own medicine called " corticosteroids ", which are also called steroids . in adults , cor
do not use enerzair breezhaler : - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if any of these apply to you , tell your doctor or pharmacist . you may be at increased risk of heart problems such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , severe kidney problems or severe liver problems . low level of potassium in your blood , an eye problem called angle - closure glaucoma , difficulty passing urine , tuberculosis ( tb ) of the lung , or any long standing condition . tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should only be used once a day . enerzair breezhaler is for inhalation use only . your doctor will tell you how many capsules to use . how much to use the capsules in this pack will depend on how you respond to the medicine and on your symptoms . do not change your dose unless your doctor tells you to . it is important that you use the inhaler as soon as possible after you use it . this is to make sure that you do not use more capsules than you should if the medicine is too strong or too weak , or if your symptoms do not improve . take the medicine at the same time each day , with or without food . inhale the medicine with a glass of water .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects have been reported with enerzair breezhaler . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching , hives ( allergic reaction ). tell your doctor straight away if you notice any of the side effects listed below . the most common side effects are : - sore throat , runny nose , sudden difficulty breathing and / or feeling of tightness . these may be signs of allergic reaction ( see also section 2 ). other side effects side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . the capsules should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ) , glycopyrronium ( as bromide ) and mometasone furoate . each inhalation contains 150 micrograms ( i . e . one ml ) of : 63 ig / kg / m2 / 1 . 5 iu / mg /m2 ( e421 ) ( a )( b )[ c ][ d ] [ e321 ] ( g ]/ml [ ph ]) [ n ]( e217 ] / min ( l ]1 ] of ind - 1 , 2 , 3 , 5 
the active ingredient clopidogrel acino pharma gmbh is a member of a group of medicines called antiplatelet medicinal products . platelets are very small structures that clump together during blood clotting . by reducing the amount of platelets forming in these structures , the body ' s natural ability to clot is reduced . antiplatelets medicinal products are used to reduce the number and size of the blood vessels ( thrombi ) in patients with thrombosis ( e . g . in adults and children ) is reduced in the number of these types of blood , resulting in a decrease in the risk of bleeding , which can lead to stroke , heart attack , and death . the efficacy of the drug is not known , but is not yet known .
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking , or if : you have a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ). - you have severe liver disease . if any of these apply to you , tell your doctor or pharmacist before you take , as this medicine is not suitable for you . your doctor will monitor you closely before you are given , and after you have taken , if your doctor has told you otherwise . you should also tell the doctor or nurse that you are using , have recently taken or might take any other medicines . children and adolescents do not use clo
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . do not take more than your doctor tells you to take . it is very important that you take the tablet at the same time each day , even if it is only for a short period of time . you may take a double dose to make up for the forgotten tablets . don ' t take more tablets than you should if the tablet is too strong or too weak . if possible , contact your doctor , pharmacist or nearest hospital emergency department immediately . bleeding should not be a problem , but if necessary , take it as soon as you remember
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): rare ( affects 1 to 10 people in 100 people ). rare ( effects 1 - 10 users in 1 , 000 people ), rare ( impacts up to 1 in ten people in 10,000 ). if you notice any of these , contact your doctor immediately . fever , infection , extreme tiredness , rare decrease of some blood cells . liver problems : yellowing of the skin and / or eyes , jaundice . very rare ( affecting less than 1 user in 10 days ). tell your doctor as soon as possible if any of the side effects gets serious . this includes any possible side effects not listed in this leaflet
keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the blister tightly closed in order to protect from light . film - coated tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance in this medicine is clopd . each film - coated tablet contains 75 milligrams ( 0 . 5 mg / ml ). the other ingredients are : - tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone , a castor oil , hydrogenated film . - film coating : macroscopically engraved with " a " on one side and " b " on the other side . the other ingredient is a ' c ' on the opposite side and ' 75 '. the tablet is supplied in a carton containing 14 , 28 , 30 , 50, 84 , 90 and 100 tablets . not all pack sizes may be marketed
delstrigo is used to treat hiv ( ' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. doravirine is a non - nucleoside reverse transcriptase inhibitor ( nnrti ) in combination with lamivudine , a nuclear-side analogue reverse transcriptarboxylase inhibitor , and tenofovir disoproxil , both of which are nuclear - and nuclear--analogue retrotranscriptaser inhibitor . if you are not sure , talk to your doctor , pharmacist or nurse before you are given deltrigo . hiv infection is not known in adults and adolescents aged 18 years and older . the virus is called aids (' acquired immune defici
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : carbamazepine ( oxcarbazepine ), phenobarbital and phenytoin ( medicines used to treat seizure ) rifampicin ( e421 ) and riffapentine . medicines used for tuberculosis include st . john ' s wort ( hypericum perforatum ) as a herbal remedy used for depression and anxiety . products containing mitotoxin ( a substance used to
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will prescribe a complete regimen for you to take a single tablet to treat hiv infection . it is recommended that you take it at least 1 hour before or after meals . do not take certain medicines , such as doravirine , or medicines containing this medicine swallow the tablet whole with a glass of water . you should take this medicine at least 12 hours before you start your treatment . if your doctor tells you otherwise , your doctor may decide to change your dose . how long deltrigo should be taken with food and drink , with or without food , for as long as you need to take it , it is important that you follow your doctor ' s instructions for taking de
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ), headache , dizziness , sleepiness , cough , nasal symptoms , feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( such as pain or stiffness ) and feeling tired . these may be signs of a feeling of tiredness . if you have any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . from a microbiological point of view , delstrigo should be used immediately .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e 468 , hypromellose acetate succinate , magnesium stearate ( e464 ), microcrystalline cellulose e , silica , colloidal anhydrous , sodium stearyl fumarat . a coating material : carnauba wax e903 . the syringe contains the following ingredients : - the ' s ' printed on one side of the film - coated tablets : lactose monohydrate , titanium dioxide e171 , triacetin . film : 776
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine is used to treat your depression . the symptoms of depression include feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor may prescribe another antidepressant . see section 2 for more information .
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have an aneurysm ( a weak spot in a blood vessel wall , which bulges out ) or if bleeding in the brain has recently had a heart attack within 6 weeks or a temporary increase in blood pressure . this can lead to serious complications in these conditions . if any of these apply to you , you should tell your doctor or pharmacist . children and adolescents this medicine is not recommended for use in children below the age of 6 years . your doctor will check your child ' s blood pressure regularly , as this may increase the risk of serious complications . warnings
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray depends on how you respond to the nasal spray device . the usual dose is 1 spray , 2 sprays , 3 nasal spray devices , 1 spray device and 4 sprays once a day for 4 days . your doctor will tell you how many sprays to use and how long to use . do not use more than your doctor tells you to take this medicine . nausea and vomiting , talk to your doctor , pharmacist , nurse or nurse before starting treatment . this medicine is not recommended for use in children and adolescents aged 2 years and older . it is recommended that you use it every day for at least 2 weeks . you should not use it in children younger than 2 years of age . treatment may take up to 30 minutes 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy , headache , change in sense of taste feeling , sleepy , decreased feeling or sensitivity in the mouth area , spinning sensation , vertigo , vomiting nausea . very common : may affect up to 1 out of 10 people feeling extremely happy , euphoria or feeling agitated . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what spravato contains - the active substance is esketamine . - each nasal spray device contains one ml of solution for spraying , corresponding to one dose of e - ketamine hydrochloride . each nostril of spray contains 28 mg eisketamine and the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections not all pack sizes may be marketed . the medicine is supplied as a nasal spray solution . this medicine is a clear , colourless solution for injection . it is supplied in a single - use nasal spray unit ( spray unit ). each pack contains 1 , 2 , 3 , or 6 nasal spray devices , all containing a sealed blister . do not throw away any medicines via wastewater or household
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adults with melanoma that has spread to other parts of the body after surgery . cancer is a type of cancer that has a change ( mutation ) in the genes that make up the cells of your body , which are involved in the growth and development of the cells , and to reduce the risk of your cancer getting worse . your doctor or nurse will work out the best course of treatment for you .
do not take zelboraf : - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . if any of these apply to you , tell your doctor immediately . allergic reactions are rare , but can be serious . your doctor will tell you how to prevent allergic reactions when you are given the medicine and if allergic reactions occur , you should contact your doctor as soon as possible if : you experience any symptoms of an allergic reaction , such as swelling or the facial area or tongue that causes difficulty breathing or rash ( fainting sense ), severe skin redness , redness or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 4 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . the usual starting dose is 8 mg once daily . you can take the tablet with or without food . do not take more than your doctor tells you to take . it is important that you take zelboraf at the same time each day , at least 4 hours apart . this will help to reduce the risk of side effects during your treatment . swallow the tablet whole with a glass of water . if this happens , take it as soon as you remember . talk to your doctor , pharmacist or nurse straight away . take your tablet with you to make sure that you are fully aware of the effects of zel
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions , such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation , have been reported in patients who have been treated for radiation treatment . tell your doctor immediately if you notice any of the following symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of breath , or a clogged artery . this may be a sign of a reaction to the medicine . if this happens , talk to your doctor , pharmacist or nurse straight away . it is important that you contact your doctor as soon as possible with any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 milligrams ( 0 . 5 mg / ml ). - this medicine belongs to a group of medicines called co - precipitates . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica ( e460 ), croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate tablet coating : iron oxide , macrogol 3350 , polyvinyl alcohol , and talc and titanium dioxide ( i . d . debossed with ' t ' in black ink on one side . pack size : 250 mg , pinkish white to orange white
duoplavin contains the active substance clopidogrel , which is acetylsalicylic acid ( asa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood that clump together to prevent blood clotting . this clumpeding causes blood vessels to tighten , causing them to clot . it is used to treat atherothrombosis in adults , adolescents and children aged 18 years and older , who are not able to carry out normal daily activities , and who have hardened arteries and are more likely to carry on a high risk of atherotrombotic events ( such as stroke , heart attack , or death ). your doctor will discuss with you what you need to know about the benefits and risks that are available to you .
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if any of these apply to you , tell your doctor or nurse straight away . children and adolescents do not give this medicine to children under the age of 6 years of age . you may be allergic to other products , such as non- steroidal anti - inflammatory products . your doctor will check you for painful and / or inflammatory conditions of muscles or joints . this may be a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ). you have 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of duoplavin is one tablet once a day . your doctor will tell you how many tablets to take and when to stop taking your medicine . do not take more than your doctor tells you to take . take your tablet at the same time each day , even if it is only for a short period of time . you may have a heart attack . if this happens , contact your doctor , pharmacist or nearest hospital emergency department immediately . bleeding should not be a problem with your treatment . it is important that you take the tablet at least 12 hours before or 12 hours after your first dose . however , if the tablet is too strong or too weak , take it as soon as you remember and then take your next dose at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching , blisters ofthe skin . these may be signs of an allergic reaction . the side effects listed below are listed in section 4 . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice any visible signs of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains - the active substances are clopidogrel and acetylsalicylic acid ( asa ) 75 mg / ml film - coated tablets . each tablet contains 46 active substances , e . g . the other ingredients are : tablet core ( pfizer ): cl - 75 % ( e421 ) tyrosine . tablet coating : st . martinib ( tsb ) ( sbbc ) and tbc ( mcb ). tablet coating ( nvb - 0 . 5 %): adiponectin ( bpa ), cpa ( gpa and hydrogen sulphate ). the other ingredient is mannitol
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . both of these substances belong to a group of medicines called carbonic anhydrase inhibitors . they are used to lower the level of pressure within the eye in adults and children aged 18 years and older with eye conditions such as glaucoma and ocular hypertension ( high pressure in the eyes ).
do not take simbrinza : - if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) or to sulphonamides ( medicines used to treat diabetes , infections , diuretics ( water tablets ) that contain a monoamine oxidase ( mao ) inhibitor or medicines used for depression , parkinson ' s disease , certain antidepressants . warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ) - you have less than 2 weeks of treatment . children and adolescents this medicine is not recommended for children under 2 years of age . this is because simbr
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop of simbrinza per day in your eyes . your doctor will tell you how many drops to use . it is important that you keep the eyelid closed with a clean finger , so that there is a ' pocket ' between your eyelid and your eye . if the drop is too small , contact your doctor immediately . do not use the drop unless your doctor tells you to . children and adolescents the dose may vary from 1 to 2 years of age . use the cap of the bottle , or snap collar , at the same time each day . keep the bottle tightly closed with your fingers . open the bottle with your thumb , and keep your fingers close to your head , back
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : if you experience a reaction to the medicine , tell your doctor immediately : frequency cannot be estimated from the available data . an allergic reaction can cause severe skin reactions , rash , redness and itching all over your body , including your eyes trouble breathing , chest pain , irregular heart beat , or stop taking simbrinza immediately . extreme tiredness and dizziness have also been reported . other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , chills or chills . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , simbrinza can be stored for up to 4 weeks to prevent infections . if you have a new bottle , do not throw away the bottle . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg / 1 . 3 oc / 0 . 1 mmol / 2 m3 brimoniidine . the other ingredients are : benzalkonium chloride ( see section 2 under ' pharmacopoeia '), propylene glycol , carbomer 974p , boric acid , mannitol and sodium chloride . - tyloxapol , hydrochloric acid and sodium hydroxide ( e421 ). purified water . not all pack sizes may be marketed .
filgrastim ratiopharm contains the active substance filgra stim . filgrarstim is a protein produced in the body by escherichia coli . it belongs to a group of proteins called granulocytes , which are produced by the bone marrow . this helps the body produce new blood cells . if you have more blood cells called white cells , your body will start to produce more white cells which help your body fight infection . when you have a low number of white blood cells in your body , you will not get enough of them , but it is important that you get the best results for your doctor , pharmacist or nurse before you start to get a high number of them in the first few weeks of chemotherapy , bone mmarrow transplantation or severe chronic neutropenia ( dna ) in adults and adolescents .
do not take filgrastim ratiopharm - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if this applies to you , tell your doctor or nurse straight away if : you have ever had a cough , fever or difficulty breathing . this may be a sign of a pulmonary disorder . side effects have been reported in patients with sickle cell disease 57 - you have left upper abdominal pain or pain at the tip of your shoulder . you have a stomach disorder , which may cause side effects . it is important that you have regular blood tests before and during treatment . your doctor will check that your body is producing enough neutrophils ( a type of white blood cells ) in your blood .
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the care of patients who are not well - cared for . your doctor will decide how long you need to be treated and how much you should be given . the recommended dose is 60 mg / kg of body weight . if you are not sure , talk to your doctor , nurse or nurse before you are given , or if your doctor has told you that you may need to change your dose , you may be given more than once a day , but it is important that you do not need to take more than three times a week to make up for a missed dose . you may also be given additional doses , such as chemotherapy , from 0 . 5 mg to 60 mg or 30 mg , depending on how you respond to your treatment . in some disease types , fil
filgrastim ratiopharm is used to treat sickle cell disease in adults and adolescents aged 57 years and older . if you have left upper abdominal pain or pain at the tip of your shoulder , you may have a spleen disorder ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . it is important that you have regular blood tests to check for side effects before and during treatment . your doctor will check your blood for neutrophils ( a type of white blood cells ) that are present in your blood . other medicines tell your doctor or pharmacist if any of the above applies to you . you should not take any other medicines , including medicines used in pregnancy or breast - feeding . any medicine used in this medicine should not be used unless your doctor tells you to , or your doctor has told you so . filgra
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . from a microbiological point of view the product should be used immediately if it is cloudy . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - each ml of concentrate for solution for infusion contains 60 milligrams ( i . e . 100 micrograms ) dna ( e421 ). - the other ingredients are : water for injections , in a glass vial , containing 30 millilitres / 0 . 5 milliliters . each vial contains 30 milograms ( 1 , 5 mm ), containing a single - use solution for injection , or containing 48 milligrammes ( 2 , 4 , 6 , 9 , 10 , 12 , 24 , 36 , 32 , 33 , 34 , 42 , 43 , 54 , 56 , 51 , 52 , 53 , 55 , 60 , 64 ,
riluzole zentiva is a medicine that contains a substance called glutamate ( a chemical messenger ) that is found in the nervous system . what rilsule zetiva looks like and contents of the pack this medicine is used to treat adults with amyotrophic lateral sclerosis , a type of motor neuron disease in which the nerve cells that make up the muscles are damaged . this leads to weakness and muscle waste , which leads to paralysis . the destruction of nerve cells in motor neuro disease occurs when there is too much glutamates ( an important part of the brain and spinal cord ) in the body . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take riluzole zentiva : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have any liver disease . you have increased blood levels of some enzymes of the liver ( transaminases ). - you are pregnant or breast - feeding . if any of these apply to you , tell your doctor or pharmacist . children and adolescents this medicine is not recommended for use in children or adolescents under 18 years of age . your doctor will monitor you closely for any liver problems such as yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick , being sick or being sick because your kidneys are not working properly , fever , a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet a day . the tablets should be taken by mouth every 12 hours . take riluzole zentiva with or without food . your doctor will tell you how many tablets to take . do not take a double dose to make up for a forgotten dose . if your doctor tells you to take more tablets than you should , talk to your doctor , pharmacist or nearest hospital emergency department immediately . it is important that you take the tablets at the same time each day , with food , drink and water . this will help to protect the environment .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking riluzole zentiva and contact your doctor immediately if you notice any of the following : - fever ( increase in temperature ). - if your doctor tells you that you have a decrease in the number of white blood cells . your doctor will take a blood sample to check that your blood is clear of any abnormality . if this happens , you may be at increased risk of infections . the following symptoms may include yellowing of your skin and the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( liver disease ( hepatitis ) - you should have regular blood tests before and during treatment with this medicine : cough or difficulties in breathing . tell your doctor as soon as possible if any of these happen .
what riluzole zentiva contains - the active substances are : - tablet core : anhydrous dibasic calcium phosphate . - tablets : micro crystalline cellulose , an hydrous colloidal silica , magnesium stearate , croscarmellose sodium ( e421 ), hypromellose , macrogol 6000 , titanium dioxide - 0 . 5 mmol / ml tablet coating : tablets are white to off - white , colourless to pale yellow . the tablets are supplied in a blister containing 50 tablets . each pack contains 50 tablets each . not all pack sizes may be marketed . they are available in packs containing 28 , 56, 98 , 112 or 168 tablets , each containing a maximum of one tablet .
emgality contains the active substance galcanezumab . it is a medicine that blocks the activity of the calcitonin gene ( cgrp ). it is used to treat migraine in adults , adolescents and children aged 4 years and older . the frequency of migraines in adults and children is controlled by a doctor who is experienced in the treatment of migraine headache and who are able to improve your quality of life .
do not take emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a serious cardiovascular disease . - you are pregnant or breast - feeding . this medicine is not recommended for patients with serious cardiovascular diseases . allergic reactions emmgality can cause serious allergic reactions ( see section 4 ). these reactions are usually mild to moderate . these reactions can affect up to 40 people . you should tell your doctor or nurse immediately if any of these reactions occur . such signs may be associated with side effects . children and adolescents this medicine should not be used in infants and children below the age of 18 years . other medicines and this medicine are not recommended in this age group . pregnancy and
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 240 mg tablet once a day . your doctor will tell you how many doses to take . the dose you should take depends on your skin ( subcutaneous injection ). your doctor may decide to change your dose based on your condition . if your doctor decides that your dose is too high or too low , he or she may need proper training . do not take a double dose to make up for a forgotten dose . it is important that you follow your doctor ' s instructions for use . you should continue to use this medicine until your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions emgality can cause : rash or itching serious allergic reactions ( may affect up to 1 in 1 , 000 people ) difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects which may affect more than 1 in 10 people , injection site irritation , pain or discomfort at the site of injection , such as rash , itching , and / or tingling sensations at the injection site , which may cause difficulty breathing and swallowing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , emgality may be stored at room temperature ( up to 7 ) for up to 30 days . this medicine does not require any special temperature storage conditions .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 micrograms ( 0 . 5 mg / ml ). - each pen contains 1 mg l - histidine ( e421 ) - hexidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections , and water for syringe , the other ingredients are : - concentrate for solution for injection in a clear glass vial . the solution is clear and colourless to slightly yellow . it is available in single - dose pen in packs containing 1 , 2 or 3 vials . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease in which the blood vessels in the liver are damaged and blood clots form . this can be caused by medicines taken prior to or after a stem cell transplantation . the active ingredient in defobetide works by slowing down the flow of blood through the vessels and slowing the growth of the blood . if you have any further questions on the use of this medicine , ask your doctor .
do not take defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking other medicines to prevent blood clots ( such as tissue plasminogen activator warnings ). this medicine is used to prevent bleeding ( heavy bleeding ) and to prevent a blood transfusion after surgery . problems with blood circulation and a constant blood pressure ( see section 1 ). children and adolescents this medicine should not be used in children or adolescents under 1 years of age . other medicines and defecilio tell your doctor or pharmacist if your child is taking , have recently taken , or might take any other medicines , including medicines that slow down the clotting process such as acetylsalicylic acid , 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the treatment with defitelio is performed by a doctor experienced in stem cell transplantation . it is given into your veins by an ' intravenous infusion ' or drip . this treatment is given every 21 days , depending on your symptoms . children and adolescents aged 18 years and over the recommended dose is one tablet once a day . your doctor , pharmacist or nurse will tell you how long you will be treated . do not take a double dose to make up for a forgotten tablet . don ' t throw away any medicines via wastewater or household waste . ask your doctor how to throw away medicines you no longer use . these measures will help protect the environment .
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of these side effects you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure ( very common ; may affect up to 1 in 1 , 000 people ). bleeding in general bleeding : the nose bleeding , the brain bleeding or the gut vomiting . blood bleeding in the lungs bleeding and blood in the urine . the mouth bleeding and the skin coagulopathy ( disturbance of blood clotting ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effect you can help provide more information on the safety of this medicine 
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the infusion storage times and conditions prior to use are the responsibility of the user . store in a refrigerator ( 2 - 8 ). do not freeze . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each vial contains 2 . 5 ml of concentrate . one vial of 200 micrograms ( g / l ) of defibrotelio . - a single - use glass vial containing 80 g defibrotalide contains sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . the other ingredients are sodium - free , colourless to pale yellow solution for solution for infusion ( see section 2 for further information on infusion ). each pack contains 10 vials , each containing 2 , 5 mg concentrate for concentrate for injection . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat adults with hepatitis c , an infectious disease that affects the liver and spreads to other parts of the body . this medicine works by stopping the growth of a type of virus called ' h1n1 '. h2n1 is a virus that causes your body to produce more of the virus in your body , making it harder for the virus to grow . your doctor will test your blood for signs of h3n1 and tell you what you need to do before you start to get better . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
do not take daklinza : - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the recommended dose is one tablet once a day taken by mouth . - the following medicines may be used to treat epileptic seizures , including phenytoin , carbamazepine , oxcarbazepine and phenobarbital . these may also be used for rifampicin ( e421 ), rfabutin and riffapentine . antibiotics for tuberculosis , such as dexamethasone ( a steroid used for allergic and inflammatory diseases ) and medicines for st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . your doctor will tell you how many tablets to take and how often to take them . the usual dose is one tablet of 60 mg , with or without an unpleasant taste . you may need to change your dose if your doctor tells you to . if this applies to you , your doctor may tell you to take some other medicines . it is important that you follow your doctor ' s instructions for how long you need to take . take these medicines as soon as possible after you start the treatment . do not change the dose unless your doctor advises otherwise . other medicines used to treat hepatitis c infection . these medicines should not be taken together with dakli
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza contains two active substances : sofosbuvir and ribavirin . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache , fatigue . very common : may affect up to 1 in 100 people : difficulty sleeping dizziness , migraine nausea ( feeling sick ), diarrhoea , abdominal pain , joint pain and aching and tender muscles . if you have any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg / ml , corresponding to the other ingredients : tablet core : dihydrochloride ; anhydrous lactose ; microcrystalline cellulose ; croscarmellose sodium ; silicon dioxide ; magnesium stearate ; tablet coating : hypromellose ; titanium dioxide ( e171 ); macrogol 400 ; indigo carmine aluminium lake ; yellow iron oxide 51 . the tablet is a white to off - white , round tablet with " bms " debossed on one side and " 30 " on the other side . if you have any further questions on the use of this product , ask your doctor .
proquad is a vaccine against measles , mumps , rubella and chickenpox ( varicella ) viruses . when the vaccine is given , antibodies are produced to help protect you from the diseases that affect you . if you are a person who is not vaccinated , your child ' s immune system may not be able to fight these viruses properly . the antibodies help the immune system to fight diseases caused by these viruses , which can be life - threatening , and prevent them from spreading . you should not be given the vaccine more than 12 months after the first dose . your doctor will decide how long you should continue to give the vaccine . it is important that you follow the instructions for national vaccination 9 months after your child has been given national vaccination .
do not use proquad if you are allergic to any varicella vaccine , measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ). neomycin is used to treat a blood disorder or type of cancer in which the immune system is not working properly . treatment with medications that weaken your immune system ( e . g . low - dose corticosteroid therapy for asthma or replacement therapy for a weakened immune system , such as a disease ( including aids ), congenital or hereditary immunodeficiency or lack of immune competence , or active untreated tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this vaccine if : - you have a family history of tuberculo
proquad is injected into a muscle , usually under the skin , in the upper thigh or upper arm area . injections are given to the muscle in the lower limb and upper arm areas , at the injection site . if you have a blood clotting disorder or low levels of platelets , your doctor will decide if the vaccine is suitable for you . the vaccine will be injected under your skin to reduce the risk of bleeding from the muscle . your doctor or nurse will check if it is safe for you to inject it directly into the blood vessel . when it is given to you by injection , it is important that you follow your doctor ' s instructions on how to inject the vaccine .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor immediately . other side effects of proquad may affect up to 1 in 100 people . seizures and a fever may occur very rarely . uncommon ( may affect more than 1 in 1 , 000 people ) bronchiolitis , which can cause difficulty breathing , cough or unsteadiness with walking . the following side effects have been reported in patients treated in the past , including : very common : may affect as many as 1 in 10 people , injection site complaints . reporting of side effects in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
what proquad contains - the active substances are measles virus1 , edmonston strain ( 3 . 00 %) mumps virus1 ( level b ) strain ( 4 . 30 %) rubella virus2 ( 0 . 1 %) varicella virus3 - merck strain (3 . 99 %) in tissue culture . the other ingredients are : powder sucrose , hydrolysed gelatin and urea , sodium chloride and sorbitol ( e553b ), monosodium glutamate and sodium phosphate and sodium bicarbonate . not all pack sizes may be marketed .
jylamvo is an anticancer medicine used to treat unwanted reactions . it belongs to a group of medicines called immunosuppressive agents , which have an anti - inflammatory effect and are used in adults , adolescents and children with rheumatic and skin diseases . this includes : a , active , or polyarthritic forms in the joints , severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older who have been treated with non . saids . inadequate o severe , disabling psoriasis . treatment may include phototherapy , soralen , ultraviolet a radiation ( puva ) therapy .
do not take jylamvo if : you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe kidney impairment , a liver impairment or blood disorders , such as bone marrow hyperplasia , leukopenia or thrombocytopenia , or significant anaemia 34 you are suffering from a weakened immune system , you have had a serious infection such as tuberculosis or hiv , ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth , mouth ulcers or non - oncologic indications . warnings and precautions talk to your doctor , pharmacist or nurse before taking , have recently taken or might take any other medicines . this includes any possible side effects not listed in this leaf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . do not take more than your doctor tells you to take . you may experience severe side effects or even death during the treatment of rheumatoid arthritis , severe juvenile idiopathic arthritis or severe psoriasis . if any of the above apply to you , talk to your doctor , pharmacist , or nurse . it is important that you continue to take the medicine for as long as you need it . in adult patients with a high dose of 7 . 5 to 7 years of age , your doctor may decide to stop the treatment . children and adolescents j
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching . this can affect the whole body . other side effects include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath or difficulty in breath , chest pain ( fever ), spitting or coughing blood , serious peeling , blistering or blistering . these may affect up to 1 in 10 people . if any of the side effects gets serious , stop taking jylamvo and talk to your doctor , pharmacist or nurse . the most common side effects are : common : feeling of illness . dry or irritating cough . shortness
keep out of the reach and sight of children . do not use jylamvo after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine at room temperature ( up to 25 ). store in the original package in order to protect from light . from a microbiological point of view , the medicine should not be disposed of via wastewater or household waste . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotrexate , macrogol 400 mg , glycerol , orange flavour , sucralose , epithelium , sodium methyl parahydroxybenzoate ( e421 ), citric acid , tri - sodium citrate , and purified water . see section 2 ' other ingredients ' for more information '. the other ingredients are : water for injection in a brown glass bottle containing 60 mg of solution with a child - resistant closure and a bottle adaptor . a white dosing syringe is included in the bottle . not all pack sizes may be marketed .
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . it belongs to a group of medicines called bronchodilators . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes tightening of the muscles in the lungs , making breathing difficult . if you take this medicine , you may notice that you have tightened these muscles , which makes breathing easier for you . your doctor will tell you if it is time for your next dose . you will be given this medicine to treat copd at the same time each day .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have kidney problems , have an eye problem ( narrow - angle glaucoma ) or have difficulty passing urine . if any of these apply to you , tell your doctor or nurse immediately . contact your doctor immediately , as tightness of the chest , coughing , wheezing or breathlessness have been reported . your doctor may need to adjust your dose if necessary . it is important that you take this medicine exactly as your doctor has told you . you may experience bronchospasm ( difficulties in breathing or swallowing ), swelling of the tongue , lips or face
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . your doctor will tell you how much enurev breezhaler to inhale . do not use more than 75 mg of this medicine than your doctor tells you to use . take this medicine as soon as possible after the expiry date which is stated on the carton and on the inhaler label after exp . it is recommended that you use it every day at the same time each day . if it is not used immediately , contact your doctor , pharmacist or nurse straight away . this medicine is available in a single pack . you will need to use it once a day for as long as you remember . inhaling the capsules ( in blisters ) you will be given the medicine with inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention . very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms include excessive thirst , hunger and frequent urination , rash , itching or hives , difficulty breathing or swallowing , dizziness . allergic reaction : swelling mainly of the tongue , lips , face or throat ( angioedema ). the following side effects have been reported with enurev breezhaler : common : may affect up to 1 in 10 people : if you get any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 0 . 5 ml ) of glucose . the other ingredients are : capsule contents : - one inhalation vial containing 50 microgrammes ( 1 g ) - a sachet containing a single syringe ( s ). the mouthpiece of the inhaler has a maximum of 44 milligrams / m2 of glucose ( e421 ) in it . - each capsule contains 45 millilitres ( 2 g of glucose per capsule ) and lactose monohydrate , magnesium stearate and water for injections ( see section 4 ). what enterv breather looks like and contents of the pack
riximyo contains the active substance " rituximab ". it is a type of protein called a " monoclonal antibody " that attaches to a specific type of white blood cell called b - lymphocytes . this protein sticks to the surface of the cell and binds to the receptors of b and c in the body . by attaching to b or c - lymphocytic leukaemia ( bl ) it sticks to its own . riximoo is used for the treatment of patients with a ) non - hodgkin ' s lymphoma , a disease of the lymph tissue that affects the immune system , which produces a protein called " b lymphocyte ". if you are not sure , talk to your doctor or
do not take riximyo : - if you are allergic to rituximab , other proteins that are present in the blood , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe active infection at the moment caused by a weak immune system . you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis or microscopic polyangitis ) or pemphigus vulgaris . if any of these apply to you , ask your doctor or pharmacist for advice before you start taking the medicine . your doctor will tell you how long you should take it . children and adolescents do not give this medicine to children under 18 years of age . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much riximyo to take the recommended dose is one tablet once a day . your doctor will tell you how many tablets to take and how often to take them . do not take this treatment unless your doctor tells you to . this medicine will be given to you by a doctor who is experienced in the treatment of non - hodgkin ' s lymphoma . it is important that you do not have any side effects . you will be monitored by your doctor , nurse or nurse . if any of the above applies to you , you may need to take a drip or intra - venous infusion . medicines should be given at the same time every day , with or without food . the doctor will discuss this with you
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions usually occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . if any of the side effects gets serious , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what riximyo contains - the active substance is rituximab . each vial contains 10 mg or 100 mg of ritzimabe . - one vial of 10 mg contains 50 mg or 500 mg / ml ( corresponding to a total of 0 . 10 mg dna ). - other ingredients are sodium citrate , polysorbate 80 , sodium chloride ( e464 ), sodium hydroxide , hydrochloric acid . see section 2 , " riqmo contains sodium ". the other ingredient is a clear , colourless to slightly yellowish solution for solution for infusion . pack sizes of 2 or 3 vials containing 1 or 2 vial . not all pack sizes may be marketed .
topotecan actavis is a treatment for small cell lung cancer that has spread to other parts of the lung after chemotherapy . it is also used to treat advanced cervical cancer after surgery or radiotherapy . in this case the treatment will be started by a doctor who is experienced in the use of medicines called cisplatin .
do not take topotecan actavis : - if you are allergic to to potecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will check your blood cell counts if they are too low . if this applies to you , tell your doctor as soon as possible . you may need to change your dose if your doctor decides that your dose is too low or too high . before you start to do this , your doctor may decide to lower your dose or increase your dose at any time of the day . in case of any kidney problems , it is important that you do not have to take this medicine at the same time every day , even if it does not work as well as it should . it is also important to consult your doctor before taking
topotecan actavis will be given to you by a doctor who is experienced in the treatment of the disease . your doctor will do blood tests before and during treatment . treatment in adults small cell lung cancer : 1 . 5 % of body surface area over 5 weeks . this treatment cycle is for adults , adolescents and children . in adult patients with cervical cancer , the recommended dose is 0 . 75 mg / m2 ( i . e . 3 mg ) per day . during the first treatment cycle , cervical cancer may be treated with another anticancer medicines , such as cisplatin , which is used to treat impaired kidney function . it is important that you follow your doctor ' s advice on how to monitor your kidney function regularly . you should continue to take to potecan actingavis for as long as your doctor tells you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects very common ( may affect more than 1 in 10 people ): fever , which may be a sign of your general condition . local symptoms may include sore throat , burning sensation , severe stomach pain , fever or diarrhoea , bowel inflammation ( neutropenic colitis ). taking topotecan actavis may increase your ability to fight infections . lung inflammation common : may affect up to 1 in 1 , 000 people difficulty in breathing . these may be signs of pneumonia . very common side effects are : itching , redness of the eyes , difficulty in swallowing , swelling of the face , lips , tongue or throat . other side effects include : allergic reactions , skin rash , chills , dry mouth ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . after reconstitution and dilution chemical , the product will be stored for 24 hours at 25oc for 2 hours at 2 - 8 oc . the drug product solution should be used immediately . if not used within 24 hours , it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of any medicines you no longer use . these measures will help to protect the environment .
what topotecan actavis contains - the active substance is mannitol . each ml contains 1 mg or 4 mg to potecan ( as hydrochloride ). after reconstitution , each 1 mg / 1 mg vial contains one g / 0 . 5 micrograms ( equivalent to 1 microgram ). - other ingredients ( excipients ): mannatol ( e421 ), tartaric acid , hydro chloric acid and sodium hydroxide ( see section 2 ). what exactly topotenactavis looks like and contents of the pack topotécan actsavis is presented as a grey bromobutylic stopper , aluminium seals with plastic flip - off , and a protective sleeve . it is available in packs containing 1 , 5 or 1
rivastigmine hexal is a type of medicine called cholinesterase inhibitors . it is used to treat adults with alzheimer ' s dementia , dementia or parkinson 's disease . certain nerve cells die in the brain , and the neurotransmitter acetylcholine ( a substance produced by nerve cells ) does not work as well as it should . by inhibiting the enzymes that break down the amino acid in the body , it reduces the levels of the enzyme that make it easier for nerve cells to work properly . in this case , the effect is reduced by reducing the number of nerve cells in your brain . this helps to prevent nerve cells from working properly and reduce the symptoms of dementia .
do not take rivastigmine hexal : - if you are allergic to or have recently been treated with any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have had a previous skin reaction ( allergic contact dermatitis ). if any of these apply to you , or you are not sure , ask your doctor or pharmacist for advice . children and adolescents do not give this medicine to children under the age of 18 years . your doctor will tell you how to use it . you should tell your doctor as soon as possible if your child has irregular or slow heartbeat , an active stomach ulcer , difficulties in passing urine , seizures , asthma , severe respiratory disease , impaired kidney function or impaired liver function , such as trembling ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of rivastigmine hexal is one tablet once a day . your doctor will tell you how many tablets to take and how long you should continue to take them . the usual starting dose of treatment is a low dose . after treatment , the highest dose is 6 . 0 mg once daily , depending on your weight . do not take more than three days without talking to your doctor , pharmacist or nurse before taking this medicine . take the tablet with or without food . it is important that you do not change the dose unless your doctor tells you to . you should take your medicine at the same time each day to make sure that it is working properly . this will help you to remember to take it . taking riv
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): dizzy loss of appetite stomach problems feeling sick ( nausea ) being sick ( vomiting ) diarrhoea common : may affect up to 1 out of 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated , feeling tired or weak generally feeling unwell trembling . if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of your medicine .
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what rivastigmine hexal contains 64 mg / ml : the active substance in the tablet core is rivattigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide , titanium dioxide ( e171 ) and shellac . one vial contains 1 . 5 micrograms ( i . e172 ) in each vial , corresponding to one - third of a milligram ( t . 3 microgram ) ( d . 1 , 5 mm in length ) of the extractor . each valector consists of 3 vials , each containing 3 g ., containing riv
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) and liver cancer in adults who do not have a specific anticancer medicine , such as sorafenib ( e421 ). the active substances in the medicine are : receptor tyrosine kinases ( rtk ), which are involved in the formation of new blood vessels . these proteins cause high amounts in cancer cells . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . tell your doctor or nurse if : you have high blood pressure . you have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in the wall . - you have diarrhoea , recent or significant bleeding after surgery in the last month , surgical procedures or dental surgery , inflammatory bowel disease or crohn ' s disease that affects the lining of your bowel or crumbs . your doctor will tell you what you need to do to prevent the growth of the bowel ( crumb ). -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . this medicine is for oral use . your doctor will monitor you for signs of serious side effects during your treatment . do not take more than your doctor tells you to . take your tablet at the same time each day , even if it is not working properly . it is recommended that you take the tablet at least 60 minutes before your next dose . if this happens to you , take it at least 2 hours before you take it . however , it may take up to 1 hour before you start taking the medicine . chew the tablet , then swallow the tablets whole with some water to make it easier for you to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and with other medicines . tell your doctor straight away if you notice any of the side effects listed below . if your side effects get serious , you may need urgent medical treatment . symptoms may include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , or a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . these may include symptoms such as vomiting blood , black tablets and / or black blisters .
what cabometyx contains - the active substance is cabozantinib ( s ) and malate . each iu / u - containing tablet contains 20 mg or 0 . 5 mg cabonib . the other ingredients are : tablet core : malate 20 mg , corresponding to 20 mg of cabolinib in each tablet . - tablet coating : 40 mg or 40 mg : each tablet contains 40 mg debossed with the letter ' s " ' in the middle - side of the tablet , which corresponds to a 40 mg tablet ). - in a 60 ml tablet : the active substances are microcrystalline cellulose ( e460 ), lactose anhydrous . not all pack sizes may be marketed in your country .
pemetrexed hospira is a medicine used to treat a type of cancer called " malignant pleural mesothelioma ". it belongs to a group of cancers that has spread to other parts of the lung . it is given alone or in combination with cisplatin , another anti - cancer medicine , for treatment of patients with a form of cancer whose disease has not responded to prior chemotherapy , and whose cancer is not responding to other in - hospital stay , or if you have a family history of prior chemotherapy ( see also section 2 ' e . g ., ph . and pfizer '). if this applies to you , it is important that you read the leaflet carefully before you start taking it . your doctor will decide if it is appropriate for you to take pemetre
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . do not breast - feed unless your doctor tells you to . if this applies to you , tell your doctor or nurse straight away . children and adolescents do not give this medicine to children under 6 years of age . your doctor will check your blood cell counts regularly . it is important that you receive appropriate treatment with cisplatin . you should not receive a vaccine against yellow fever . this medicine should not be given to children or adolescents under the age of 18 years . in case you have problems with your kidneys , your doctor may decide to give it to you as an infusion .
the recommended dose of pemetrexed hospira is 500 mg / m2 of your body ' s surface area , based on your height and weight . this body surface area will be measured by your doctor , pharmacist or nurse . treatment will depend on your blood cell counts and on how well you respond to treatment . you will be given a dose that is right for you . the dose you will receive is one infusion ( 9 ml ). the other ingredients are cisplatin and water for infusion into your veins , lasting 30 minutes . if you have any further questions on the use of this product , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever , signs of infection , a temperature of at least 30 oc , sweating , sign of infection and more white blood cells than normal . infection ( sepsis ) can lead to death . chest pain with a fast heart rate , pain , redness , swelling , sores in your mouth . allergic reaction , such as skin rash , burning or prickling sensation , fever and skin reactions , which can be life - threatening . death has been reported in patients treated with pemetrexed hospira . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ): - chest pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and infusion solution after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , infusion solutions of pemetrexed should be used immediately . after reconstitution of the reconstituted solution , parenteral medicines should be disposed of in accordance with local requirements . if you notice discolouration prior to administration of this medicine , discard any unused solution .
what pemetrexed hospira contains - each ml of solution contains the active substance . the other ingredients are : 100 mg : each vial contains 100 milligrams ( g ). - one vial : every 500 mg / g of solution : - two vials : one containing 500 milligrammes . - a single - use syringe : the other ingredient is mannitol ( e421 ) and hydrochloric acid ( h2o ) ( see section 2 ). the reconstituted solution consists of 1 , 000 millilitres , corresponding to one litre , in a glass vial and the other half of the solution . after reconstitution , the solution is clear and colourless . it contains 25 micrograms of pe
ganfort contains two active substances , bimatoprost and timolol . they work together to reduce pressure in the eye , reducing the need for glasses , and lowering the risk of glaucoma in adults . the active substances are part of a group of medicines called prostamides , which are a prostaglandin analogue , called beta - blockers . a clear , watery liquid is injected into the eye and clears the water from the inside of the eye in order to reduce the amount of water in the eyes . this helps to keep the eye open , especially when it is not clear enough for the eye to keep clear of light . it helps to protect the eye from light , helping to protect it from light and to prevent the development of cataracts . your doctor has prescribed gan fort eye drops to
do not use ganfort eye drops if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease , wheeziness or difficulty in breathing , or long - standing cough . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have heart problems , such as low heart rate or heart block , heart failure warnings or precautions . this medicine is not recommended for use in patients with coronary heart disease ( symptoms such as chest pain ) or if your doctor has prescribed this medicine for you . your doctor will tell you how to use it . you should tell your doctor as soon as possible
always use ganfort exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one glass of water per eye . your doctor will tell you how many glasses to use . use the bottle at the same time each day . keep the bottle tightly closed in order to protect the eye from light . do not open the bottle unless your doctor tells you to . follow the instructions given to you in section 5 . 1 . wash your hands and head . 2 . open the eyelid with a small pocket . 3 . clean the eye after treatment . 4 . close the lid of the eye , avoiding light , for a short period of time . 5 - close the eye with your finger . if your eye is not clear , contact your eye with the nose . 6 
like all medicines , ganfort can cause side effects , although not everybody gets them . stop taking the drops and see a doctor straight away if you notice any of the side effects listed below . the drops are for single - dose use only . very common side effects ( may affect more than 1 in 10 people ) are : the eye redness , which may be mild to moderate and may affect up to 1 in 9 or 100 people , the eye burning , itching , or stinging , irritation of the conjunctiva ( the white part of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes and a feeling of something in the eye ( small break in the lens ). this may be a sign of a light - coloured or yellowing of the lenses . these may be signs of eye pain such as sticky eyes
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and the vial label after exp . this medicine does not require any special storage conditions . after first opening , the solution should be used immediately . for eye infections , it should be stored at room temperature ( up to 4 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . - each 5 mg syringe contains a single - use solution for injection . the other ingredients are : benzalkonium chloride ( a preserver ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e421 ), purified water , hydrochloric acid and sodium hydroxide . colourless to slightly yellow . it is supplied in a plastic bottle , each pack contains 1 , 3 or 4 vials . not all pack sizes may be marketed .
gefitinib mylan contains the active substance gefitib . this protein is a type of protein that is produced by the body ' s natural defence system . it works by blocking the activity of this protein in the body and preventing the growth of cancer cells , thereby preventing them from growing . gefiteinib melan is used to treat adults with non - small cell lung cancer . if you have this cancer , you have a disease in which malignant ( cancer ) cells are mainly found in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor or nurse if : you have any other lung problems . some lung problems may be serious . your doctor may need to adjust your dose . - you have problems with your liver . children and adolescents , adults and children under 18 years of age , this medicine is not recommended for use in children under the age of 18 years . it is not known if this applies to you or your child ' s doctor will tell you to take other medicines while you are being treated . this medicine can be used in combination with other medicines , such as phenytoin and carbamazepine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids with or without food . swallow the tablet whole with a glass of water . your doctor will tell you how much gefitinib mylan to take and how often you should take it . take the tablet at about the same time each day , preferably at least 2 hours apart . do not take more tablets than your doctor tells you to take . this will help you remember to take it as soon as you remember . if it is time for your next dose , skip the missed dose and take the next dose at the usual time . however , you may need to take your next tablet at any time of the day to make up for a forgotten tablet . it is important
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction . symptoms may include swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ), difficulty breathing , serious breathlessness ( sudden worsening breathlessness ), a cough or fever . these may be signs of an inflammation of the lungs ( called ' interstitial lung disease '). very common ( may affect more than 1 in 100 people ) when gefitinib mylan is given : severe skin reactions affecting the entire body . if this happens , contact your doctor or pharmacist . this includes any possible side effects not listed in this leaflet 
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 milligrams ( 0 . 5 mg / ml ). the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide [ e172 ) [ iu ] [ gt ] ( see also section 2 ). what ge fitinid mylan looks like and contents of the pack gefit inib melan tablets are white to off - white , bicon
reblozyl contains the active substance luspatercept . it is used to treat adult patients with myelodysplastic syndromes ( mds ) in adults with many different blood and bone marrow disorders where red blood cells become abnormal . this can lead to signs and symptoms of a low red blood cell count ( anaemia ). if you are not sure , talk to your doctor or nurse . your doctor will decide if this medicine is right for you . you may also be given a higher dose of red blood blood cell transfusions . what is beta - thalassaemia this is a blood problem that is passed down through genes from one gene to another . if your doctor tells you that you have a type of blood problem , your doctor may decide to give you a different type of gene , such as erythropo
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you are pregnant or breast - feeding . this medicine is not recommended for the treatment of thalassaemia . if your spleen is removed , you may have a blood clot . you may need hormone replacement therapy , as a result of a previous blood pool . preventive measures may be necessary . medicines can be used to prevent or reduce the risk of developing or preventing a bleeding , especially in patients with high blood pressure . your doctor will monitor your blood pressure regularly when you are taking , or have recently taken , if any of these apply to you . before taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests before you are given reblozyl . how much to use the recommended dose is one ml per kg of body weight . the injections are given as a single dose of 1 . 0 mg / kg body weight each day . this dose may be increased or decreased depending on your blood pressure . in patients with myelodysplastic syndromes the maximum single dose is 1.75 mg ( m2 ) per kilogram of bodyweight . for patients with beta - thalassaemia the maximum simultaneous dose is 1 , 25 mg per kg total body weight given to you by a doctor or nurse . it is recommended that you do not inject more than 3 doses of this medicine . do not throw away any medicines via wastewater
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or other parts of the body , blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face . lips , mouth , tongue , throat allergic reactions such as rashes , sores and swollen hands or feet . tell your doctor straight away if you notice any of the following side effects while taking this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 days at 2 - 8 . any unused medicinal product or waste material should be disposed of . ask your pharmacist how to dispose of any medicines you no longer use . these measures will help protect the environment .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg ( equivalent to one millilitre ). - after reconstitution , a single dose of 50 mg musculosis , of the other ingredients are : excipients : citric acid monohydrate , sodium citrate , 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide , and phosphate , which are added to the solution , to help you to get the best results from your doctor , pharmacist or nurse , or nurse on a regular basis , as described in section 6 . what retinol looks like and contents of the pack reagent is a clear , colourless to slightly opalescent , white powder . 
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . it is used to treat the cancer by reducing the number of cancer cells and allowing the body ' s immune system to produce new blood vessels . in adults with advanced kidney cancer , other treatments may be needed , such as alpha or interleukin - 2 , to treat your disease .
do not take fotivda : - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . you must not be given if : you are taking st . john ' s wort , hypericum perforatum ( a herbal remedy used to treat depression and anxiety ). - you have high blood pressure . your doctor will check your blood pressure regularly . this is because you may need to take a medicine , which will help you to lower your pressure more easily than you should . it is important that you follow the advice given to you by your doctor or pharmacist before you are given fotivdea . tell your doctor as soon as possible if any of these apply to you or you are not sure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg once a day for 21 days . your doctor will tell you how many capsules to take and how often to take them . the usual dose is 7 capsules ( 1 capsule ) per day . capsules should be taken every 4 weeks with or without food . if the dose is too high , your doctor may decide to reduce the dose . do not take fotivaa unless your doctor tells you to . severe side effects if your doctor decides that you may have a higher or lower dose , you should contact your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse as soon as possible . you may experience unacceptable side effects ( see section 2 ). severe
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). if you notice any of the following side effect , stop taking fotivda and contact your doctor immediately : - low blood pressure can cause symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will check your blood pressure regularly . if this happens , you may need to take a medicine to treat your high bloodpressure . this is because fotiva is not a cure . it is important that you take it exactly as your doctor has told you . tell your doctor straight away if any of these side effects get serious . talk to your doctor , pharmacist or nurse
what fotivda contains - the active substance is tivozanib . each ml contains 890 micrograms ( i . e . 890 iu ). the other ingredients in the tablet core are tetrazolib hydrochloride monohydrate ( e421 ) and mannitol , magnesium stearate , gelatin , titanium dioxide , indigo carmine , yellow iron oxide , propylene glycol and strong ammonia solution . the other ingredient in the solution is titanium dioxide and / or tartrazine aluminium lake . shellac , propane glycol in the solvent is a clear , colourless to pale yellow and opalescent solution , which is supplied in a glass vial . it is also available in packs containing 1340 vials .
stribild contains the active substance elvitegravir . it is an antiretroviral medicine that contains an integrase inhibitor cobicistat , which acts as a booster ( pharmacokinetic enhancer ) to the immune system . the other ingredients in this medicine are : a recombinant syringe ( nrti ) inhibitor ( e . g ., tenofovir disoproxil ). a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection in adults , children and adolescents , and children whose immune system is not working well enough to prevent hiv from spreading to other parts of the body ( a type of hiv infection ) in adults and children who are not able to carry hiv into adulthood .
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine or any of the other ingredients of this medicine ( listed in section 6 ) before treatment with any medicine containing tenofovir disoproxil . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor will check your kidney function before taking these medicines . - alfuzosin ( for an enlarged prostate gland ), amiodarone , quinidine ( for irregular heartbeats ) 47 - dabigatran ( for the prevention of blood clots ), carbamazepine ( used to prevent the growth of blood vessels ). - diazepam , for the treatment of a heart attack , diuretics 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 12 mg once a day for adults and adolescents aged 18 years and over . your doctor will tell you how much stribild to take and how often to take it . take the tablet with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . it is important that you take your tablet at the same time each day . you should take it at least 12 hours before or at least 18 hours after your meal . children and adolescents do not take more than 35 mg once daily . if your medicine is taken by mouth , your doctor may tell you to stop the treatment . medicines and oral supplements ( antacids , laxatives containing minerals such as magnesium , aluminium , calcium 
like all medicines , this medicine can cause side effects , although not everybody gets them . hiv infection can cause unwanted effects . stribild is used to treat the hiv disease itself . serious side effects tell your doctor immediately if you notice any of the following : lactic acidosis , which is an increase in the amount of excess lactose in the blood . this is a very common side effect . some hiv medicines can increase the risk of this side effect in people who are overweight or have liver disease . it can be caused by a combination of deep , rapid , or sudden , changes in blood lipids . these changes can be life - threatening . your doctor will tell you how long you need to take this medicine . however , it is important that you take it exactly as your doctor has told you . you will be monitored by your doctor
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . one tablet contains 150 mg / ml ( elastomer ) - each tablet contains either 150 mg or 200 mg delfibrillator , respectively . the other ingredients are : - tablet core ( oblong ) tablet coating - film - coated tablets - croscarmellose sodium and hydroxypropyl cellulose , lactose monohydrate and magnesium stearate . not all pack sizes may be marketed in your country . - tablets are available in packs containing one tablet each .
zy prexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics . it is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things that are not there . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria , can be life - threatening and may lead to recurrence of these symptoms in patients with bipolar disorder . manic episode is a rare occurrence in patients who have had a long - term relationship with their doctor , pharmacist or nurse .
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . an allergic reaction may occur , including a rash , itching , swollen face , swelling of lips , shortness of breath , eye problems , such as glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor or pharmacist . your doctor may need to adjust your dose if necessary . children and adolescents do not give this medicine to children under the age of 18 years . you should also tell your child ' s doctor if : you have dementia , which can cause serious side effects . medicines can cause
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa is one tablet a day . your doctor will tell you how many tablets to take and how often to take them . the usual starting dose for adults is 5 to 20 tablets , depending on how you respond to your symptoms . if your doctor tells you to stop taking zypresa , your doctor may tell you to take your tablets at the same time each day , so that you can take the tablets with or without food . swallow the tablets whole with a glass of water . do not crush , crush or chew the tablets . take your tablet with you to make sure that you do not swallow the tablet whole . this will help you remember to take it . however , if it is time for your next dose
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement ( a common side effect that may affect up to 1 in 10 people ) in the face or tongue . blood clots in the veins . this side effect has been reported in more than 1 in 100 people in the legs . symptoms include swelling , pain and redness in the leg . these can be caused by blood vessels in the lungs , causing chest pain and difficulty in breathing . if you notice any of these symptoms , contact your doctor immediately . tell your doctor as soon as possible . stop taking zyprexa and talk to your doctor straight away . your doctor will tell you how long you need to take this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . a single - use tablet contains 2.5 , 5 , 7 . 5 mg , 10 , 15 or 20 mg . the other ingredients are : tablet core : lactose monohydrate , hyprolose ( e464 ), crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose , titanium dioxide , carnauba wax . which of the different zy prexa tablet strengths are available in packs containing 2 . 25 , 50 , 75 and 10 tablets . each pack contains shellac . not all pack sizes may be marketed .
prolia contains the active substance denosumab , which is a protein ( monoclonal antibody ) that attaches to another protein . it is used to reduce the amount of bone loss caused by osteoporosis in adults . after treatment , your body ' s natural defence system ( oesophagus ) starts to produce more oestrogen ( a hormone that makes your bones stronger ). after the menopause , oesterogen level drops , making your bones thin and fragile . this makes you more likely to develop osteoporoisis . osteoparosis can be caused by a combination of testosterone and glucocorticoids . in patients who are at high risk of developing a form of osteoporia , it is important that you tell your doctor , pharmacist or nurse if you have
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . you may have low calcium levels in the blood ( hypocalcaemia ). you may also be allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . if this applies to you , tell your doctor as soon as possible . do not use prolaia if : you have a skin infection . symptoms include a swollen , red area of skin on your leg that feels hot and tender ( cellulitis ). symptoms include fever . these symptoms may be signs of an allergy to latex . the needle and the pre - filled syringe may contain a derivative of latex
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe containing 60 mg / 6 ml . it is given as a single injection under the skin ( subcutaneous ) in the thighs , abdomen and upper arm . your doctor will tell you how many stickers to use . you will also be given calcium and vitamin d supplements . how much to inject your doctor may tell you what to inject yourself . do not inject yourself without your doctor ' s advice . if your doctor tells you to do so , it is important that you read the instructions for use in this leaflet . what you should do when you first inject yourself and how long you should wait until the injection is complete . injections should be given at least 6 hours after the last
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you notice any of the following : skin infections ( cellulitis ). these symptoms are usually mild to moderate and can be serious . when you start taking prosia , your skin may become swollen , red area of skin on one side of your leg that feels hot and tender . symptoms may include fever . you may also experience pain in the mouth and / or jaw , swelling , non - healing of sores in your mouth or jaw ( discharge ), numbness , feeling of heaviness or loosening of a tooth , bone damage in your jaw . this may be a sign of bone damage . if this happens , talk to your doctor , pharmacist or nurse as soon as possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , you will be given a single dose of prolia at room temperature ( up to 25 ). after the injection , it should be used within 25 - 30 minutes after first injection . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml of solution contains 60 mg / l . the other ingredients are : acetic acid , glacial , sodium hydroxide , sorbitol ( e421 ), polysorbate 20 , water for injections and water for syringes ( see section 2 ), st . martin ' s instructions for use , how to use and how to store the vials the following information is available for use in your country . each vial contains one vial in a glass vial containing 1 vial of 60 micrograms , each corresponding to one dose . if you have any further questions on the use of this product , ask your pharmacist .
ambirix is a type of vaccine that is given to children and adolescents from 1 to 15 years of age . it is used to treat two diseases called hepatitis a and histis in adults . infection is caused by a virus that causes the liver to become swollen or inflamed . this causes the virus to spread to an infected person . the virus can be found in faeces , serum or saliva . symptoms of infection usually last 3 to 6 weeks . you may feel sick , have a fever , aches and pains , and are very common . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will tell you how long you need to stay in hospital , as it may take longer than usual for you to stay at home . tell your doctor or nurse as soon as possible 
do not use ambirix - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath , swelling of your face or tongue . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any vaccine against hepatitis a or b diseases . a severe infection with a high temperature . the vaccine is not recommended for use in children and adolescents under 6 years of age . your doctor may decide to reduce the dose if your child has a minor infection ( such as a cold ). your doctor will decide how long you should stay on the vaccine . you should tell your doctor as soon as possible if any of these apply to you . it is important that you follow the advice given to you by your doctor or nurse 
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection into a muscle , usually in the upper arm . your doctor will tell you how many injections to give and how often to give them . you will be injected by a doctor who is experienced in the use of this medicine . a total of two injections will be given to the thigh muscle within 12 months of the first injection , followed by the second injection within 6 and 12 months . in this case , your doctor may prescribe extra doses to reduce the risk of future booster dosing . it is important that you follow your doctor ' s instructions for the treatment of the diseases that you are being treated . one injection is given at the same time each day . this is to make sure that you have the correct dose of ambir
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing or a sudden drop in blood pressure , or loss of consciousness . reporting of side effects in clinical trials with ambirix : very common ( may affect more than 1 in 10 people ) headache loss of appetite , tired or irritable pain . these may be signs of an allergic reaction . if any of these side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml of solution contains 720 elisa units . the other ingredients are : human diploid ( mrc ) surface antigen 20 , human dna , aluminium hydroxide , hydrated ( 0 . 05 %), saccharomyces cerevisiae ( scc ), aluminium phosphate (0 . 4 %) , sodium chloride ( e171 ) and water for injections the contents of the pack suspension for injection is supplied in a pre - filled syringe . it is supplied as a white , slightly milky liquid . each vial contains 1 vial , each containing 10 vials . not all pack sizes may be marketed .
bexsero is a meningococcal group b vaccine , which is given to children and adolescents aged 2 years and older . it is given by a doctor who is experienced in the treatment of disease caused by the neisseriameningitidis group - b bacteria . these bacteria cause infections called meningitis ( inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine is used to prevent the disease from spreading .
do not use bexsero - if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if : you have a severe infection with a high temperature after vaccination . - you have had a minor infection ( such as a cold ). - vaccination for haemophilia is not recommended . you have any other problem with your blood from clotting properly . your doctor may prescribe blood thinners ( anticoagulants ) during treatment to prevent your immune system ( eculizumab ) to prevent you from being vaccinated . the use of bexero may increase the risk of developing disease caused by the neisseria meningitidis group b bacteria ( see section 28 ). pregnancy and breast
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg injection into a muscle , usually in the thigh or upper arm . your doctor will give you injections every 2 to 5 weeks . you will receive three injections depending on how you respond to the vaccine . if necessary , your doctor may decide to give you an additional injection ( booster ). the first injection will be given every 2 weeks for 1 month and the interval between injections will be 2 months . this will be followed by a booster , given every 12 to 15 days , followed by 6 weeks after your first injection . after the booster has been given , you should continue to give it every 24 hours for 24 hours . do not give the booster more than 24 hours after the second injection , unless your doctor tells
like all vaccines , this vaccine can cause side effects , although not everybody gets them . the following side effects have been reported with bexsero : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of the surface of the injection area , hardness on the skin and injection site side effects not known ( frequency cannot be estimated from the available data ) if you are given this vaccine , talk to your doctor , pharmacist or nurse . this includes any possible side effects NOT listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this vaccination .
what bexsero contains - the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each ml contains 1 , 2 , and 3 mg of total protein , equivalent to 50 mg . the other ingredients are : total protein from the pora p ( see section 2 ) and 25 mg , each containing 1 mg / kg . not all of the ingredients are the same : if you have any further questions on the use of this product , ask your doctor or pharmacist .
nitisinone mdk contains the active substance nitric acid . this medicine is used to treat a rare disease called hereditary tyrosinemia ( a type of disease that affects more than 1 in 10 people ). this disease affects your body ' s ability to make the amino acid tirosine ( amino acids ) that is produced in the body . by reducing the amount of this medicine that your body produces , your body breaks down the harmful substances that are present in this medicine . it is important that you take this medicine exactly as your doctor has told you . if you are not sure , talk to your doctor , pharmacist or nurse . your doctor will tell you what you need to do to make sure that you are getting the right kind of medicine that will help your body break down the bad substances .
do not take nitisinone mdk : - if you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding , and breastfeeding , your doctor may decide to reduce the dose . your doctor will tell you how many doses you should take . if any of these apply to you , ask your doctor for advice before you are given . children and adolescents this medicine is not recommended for children below the age of 6 years . this medicine should not be used in children under 18 years of age . pregnant women this medicine may increase the risk of developing a baby ' s doctor will advise you how to use it . tell your doctor immediately , or have an eye examination . eye problems may occur
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one capsule once a day . your doctor will tell you how many capsules to take . treatment with this medicine will be started by a doctor experienced in the diagnosis and treatment of the disease ( hereditary tyrosinemia type ). the usual dose is 1 capsule per kg of body weight . the recommended daily dose is 20 capsules per day for this patient population . swallowing the capsules with a small amount of water or formula diet . you should take nitisinone mdk with or without food . do not take a double dose to make up for a forgotten dose . if your doctor decides to stop the treatment , talk to your doctor , pharmacist or nurse as soon as you remember .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , nitisinone mdk should be used within 2 hours at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nitric acid . each hard capsule contains 2 mg / 2 ml , corresponding to 0 . 7 mg . if you are not sure , talk to your doctor , pharmacist or nurse . the other ingredients are : capsule contents : 5 mg , 5 mg and 10 mg each . capsule content : 10 mg : each capsule contains 0 mg of nitsinone ( as described above ). - capsule shell : gelatin , titanium dioxide , black iron oxide ( e171 ), shellac glaze , and a white to off - white , round , hard gelatin capsules , marked with the letter ' m ' on one side and the letter " m " on the other side . not all pack sizes may
what docetaxel accord contains - the active substance in the medicine is oxaprofen . octopus is a type of medicine called " anti - cancer medicines ". it belongs to a group of medicines called " taxoids ". what does docetaxil accord contain ? - it is used to treat : - breast cancer , - lung cancer ( non - small cell lung cancer ), - prostate cancer and / or gastric cancer ; - head and neck cancer ( mainly in the neck ); - advanced breast cancer that has not been treated with doxorubicin , trastuzumab and capecitabine , and - early breast cancer with or without lymphoma . this is because it has spread to other parts of the body . it is also used for the treatment of adult patients with advanced breast
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given docetaxil accord if : you do not have enough white blood cells . - you have a severe liver disease . your doctor will do blood tests to check that you have enough blood cells to support your liver . warnings , precautions do not take docetal accord to increase the number of white blood cell disturbances ( fever ) and infections , contact your doctor immediately . abdominal pain , tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever . tell your doctor straight away if any of these apply to you .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . docetaxel accord will be given to you by a doctor who is experienced in the use of this medicine . the recommended dose is based on your weight and your general condition . your doctor will tell you how many doses you should be given . method of administration docetaxil accord is given as an infusion into one of your veins . each infusion will last approximately one hour . you will receive your infusion once every 3 weeks . it is important that you continue to have your blood tests . this is to check that you have a general condition before and during treatment . if this happens , you may experience diarrhoea , sores in the mouth , numbness , pins and needles , fever 63 your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects during your treatment : adverse reactions with docetaxel accord may occur : decrease in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea , tiredness . these may be signs of adverse events that may occur during or after the infusion . allergic reactions : very common ( may affect more than 1 in 10 people ): flushing , swelling of the face , eyes , nose , throat , tongue or throat . very common : may affect up to 1 in 100 people : dizziness , tingling or numbness in the hands , feet , hands or feet .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution , the medicine may be stored in the infusion bag for a maximum of 6 hours at 25 oc . if the solution is not used immediately after infusion , it should be disposed of in non - pvc bags for up to 48 hours at 2 to 8 . before use , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 milligrams ( g ). each vial of 1 millilitre of concentrate contains 20 mg / g decoction . the other ingredients are : - 4 milliliters : the concentrate contains 80 mg or g and is available in packs containing 8 mg , 160 mg . - other ingredients : polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrus ( e460 ). what does docettaxel accord looks like and contents of the pack does not contain any colourless to pale yellow to brownish - yellow concentrate . it is supplied in a glass vial and is supplied as a clear white to slightly opalescent - white vial 
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . it is used to treat adults who are impulsive or hyperactive when taking this medicine . adults with this medicine have ' attention deficit hyperactivity disorder ' ( adhd ). adhd is caused by a lack of current stimulant medication . current medication can cause adhd symptoms . the medicine is given in combination with a treatment programme that includes psychological therapy , educational therapy and social therapy . 38 adults with adhd have been shown to have adhd more often than not . if you are not sure , talk to your doctor or pharmacist .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure . you have heart problems . - you have recently fainted , had thoughts or feelings of suicide , or had any other psychiatric conditions . withdrawal symptoms may include increased heart rate , especially if your heart is not working properly . this medicine is not recommended for use in adults , adolescents and children under 18 years of age . children and adolescents this medicine should not be used in this age group . tell your doctor or pharmacist if any of these problems occur . the recommended dose is 6 mg / ml in adults and children below 18 years . int
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your treatment with intuniv will be started by a doctor experienced in the treatment of adolescent behavioural disorders . you will be given this medicine at the same time each day . the usual starting dose of your treatment is 1 mg once a day , followed by 1 hour of treatment at a dose of 0 . 05 mg once every day for a period of 7 days . this is based on your body weight , your doctor will tell you how much to take , how long to take and how often you should take it . it is recommended that your doctor tells you to take the medicine as soon as possible . children and adolescents this medicine can be taken with or without food , drink and alcohol . do not take more than the recommended dose 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist before taking your medicine . serious side effects tell your doctor straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of consciousness ( syncope ), a serious withdrawal side effect of intuniv . high blood pressure can cause symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). other side effects include : very common ( may affect more than 1 in 10 people ): nausea , vomiting , diarrhoea , constipation , abdominal pain , difficulty breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the tablets in the blister pack in order to protect from light .
what intuniv contains - the active substance is guanfacine hydrochloride . one vial contains 1 ml of solution for injection . - each vial of 1 mg / 0 . 5 mg of solution contains a single - molecule ( gfc ). - every 2 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 2208 , methacrylic acid , ethyl acrylate copolymer , lactose monohydrate , povidone type a , microcrystalline cellulose . not all pack sizes may be marketed . the other ingredients are : hypromellose
ecalta contains the active substance anidulafungin . it is used in adults , adolescents and children aged 1 to 18 years for the treatment of fungal infection that affects the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida . echinocandins are used to treat these medicines to treat serious fungal infections caused by weakened or inflamed fungal cell walls . in a small number of patients , it is not known whether the cells have incomplete or defective cell walls that make them fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , caspofungin as acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if this applies to you , tell your doctor or nurse straight away . your doctor will monitor you closely for signs of liver function and liver problems . you may need to stop your treatment with anaesthetics . this is because your treatment should not be stopped without your doctor' s advice . in case of an allergic reaction such as itching , wheezing or blotchy skin , it may be a sign of an infusionrelated reaction . it may include a rash or hives 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ecalta is one 200 mg / 100 mg infusion ( 1 ml ) for patients aged 18 years and over . your doctor will prescribe a dose of 3 . 0 mg per kg of body weight , based on the patient ' s weight . you will be given 200 mg/ 1 . 5 mg or 100 mg once a day . it is recommended that the patient receives the dose prescribed by your doctor , nurse or nurse . this is a slow infusion , given as a drip into a vein , which may take up to 3 minutes . depending on the loading dose , your doctor may decide to increase or decrease the starting dose . how long the infusion lasts , the patient will be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common side effects ( may affect more than 1 in 10 people ) difficulty breathing , wheezing or an existing rash . ecalta can cause serious side effects such as convulsion ( seizure ) flushing , rash ( pruritis ), itching , hot flush , or hives , sudden contraction of the muscles , coughing or difficulty of breathing other side effects tell your doctor or nurse straight away if you notice any of the following symptoms or if any of these side effects gets serious , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the reconstituted solution in the outer carton in order to protect from light . after reconstitution , the infusion solution should be used immediately . ecalta may be stored at room temperature ( up to 24 hours ) for up to 25 days . it should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the medicine . these measures will help protect the environment .
what ecalta contains - the active substance is anidulafungin . each ml of powder contains 100 mg dna . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and water for injections . - each vial contains 30 micrograms of concentrate for solution for infusion in a box containing 1 vial of 100 mg of concentrate . keep the vial tightly closed . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
adynovi contains the active substance rurioctocog alfa pegol , a pegylated human coagulation factor viii ( hcf ) which is a type of protein that helps to form clots in the blood . this helps to stop bleedings in patients with haemophilia whose body does not produce enough of the necessary amount of hvf . hhf - ii , which is important for the treatment of bleeding in children and adolescents 12 years of age and older , who have a condition known as hff a , an inherited bleeding disorder due to lack of factor vviii .
do not take adynovi : - if you are allergic to rurioctocog alfa pegol , or any of the other ingredients of this medicine ( listed in section 6 ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 6 years of age , unless your doctor tells you otherwise . if your child has ever had an anaphylactic reaction ( a severe , sudden allergic reaction ) to the medicine , your child may not be able to swallow the tablet . allergic reactions may include rash , 95 hives or wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing or tightness
treatment with adynovi will be started by a doctor who is experienced in the treatment of haemophilia . if you are not sure , talk to your doctor , pharmacist or nurse . how much to take the recommended dose is one tablet a day . your doctor will tell you how many tablets to take and how often to take them . the duration of treatment is determined by your body weight , the factor viii levels and the severity of the bleeding . it is important that you have appropriate laboratory tests to check factor ii levels before and during major surgery . this is to check that your doctor has given you the correct dose . you will also be given a dose that is right for you , depending on the type of surgery you will need . however , your doctor may need to adjust the dose based on the patient ' s age , weight and body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur when the injection is given . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing or wheezing , tightness in the chest , feeling of being unwell , dizziness , loss of consciousness . severe symptoms may include difficulty in breath or fainting . prompt emergency treatment may be needed if previous treatment has failed to work properly . if you notice any of the above , contact your doctor immediately . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). store in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period not exceeding 3 months . if not used immediately , this medicine should be used within 3 months of first use . after this period , the powder should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of the powder . these measures will help protect the environment .
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu / ml ( i . e . one vial per vial ). if you are not sure , ask your doctor or pharmacist for advice . the solvent vial contained in the solvent is 5 microlitres of sterilised water for injections . other ingredients are : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 , water for
rekovelle contains the active substance follitropin delta , which is a fertiliser - stimulating hormone . it belongs to a group of hormones called gonadotropins , and is used to treat female infertility in assisted reproduction programmes ( assisted reproduction programmes ) in vitro fertilisation ( ivf ) by intracytoplasmic sperm injection into the ovaries . this helps to prevent the formation of many egg sacs .
do not use rekovelle - if you have any of the following : - your fertility problems - you are allergic to follicle stimulating hormone ( fsh ) or to any other ingredients of this medicine ( listed in section 6 ) - the presence of a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus ( e . g . an enlarged ovary ), cysts on your oocytes ( polycystic ovarian disease ), bleeding from the vagina , an early menopause , or malformations of the sexual organs . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have had a problem with pregnancy , you have a high risk of having fibroids of the 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be calculated from your first treatment cycle . you will be given anti - mullerian hormone ( hcg ) by your ovaries . after stimulation with gonadotropins , your doctor will measure your blood and your body weight . a blood sample will be taken over the last 12 months to check your progress in treatment . your doctor may decide to increase or decrease your dose based on your bodyweight . this will be determined by your doctor , depending on your response to treatment and how long you need to be treated . it is important that you follow the instructions for the correct dose , which you will receive , during the whole treatment period . how long will you receive treatment , you will have a single injection of a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects may be caused by hormones that cause infertility . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms may be signs of a side effect common ( may affect up to 1 in 10 women ): headache and nausea . if you get any of these symptoms , talk to your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , rekovelle can be stored at room temperature ( up to 25 ) for a maximum of 3 days . if not used immediately , it should be used within 3 days or disposed of in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 28 days at 25 . after the treatment any unused solution should be discarded . medicines should not be thrown away via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 ml of solution for injection . - each millilitre of solution contains 0 . 36 micrograms ( m2 ) dna . the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate ( e421 ), disodium phosphate dodecahydrate , concentrated phosphoric acid , and sodium hydroxide , which are added to water for injections ( see section 2 ). what skovelle looks like and contents of the pack recovelle is a clear and colourless solution . it is available in packs containing 1 cartridge and 3 pen injection needles . not all pack sizes may be marketed .
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . the other ingredients are : the active substance is : refinasteride . each iu / u - shaped tablet contains 92 micrograms of fission ( e421 ) of refinance ( fda ). the other ingredient is v . e321 . in each tablet , the corresponding dose is the same as in adults . it is also available in packs containing : - one tablet containing the other : two tablets , each containing 22 ml ( 4 x 92 / 22 ). - chronic obstructive pulmonary disease ( copd ) and asthma in children and adolescents 12 to 184 mg ( 2 x 22 mg )
do not take revinty ellipta : - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . tell your doctor or pharmacist if any of these apply to you . talk to a doctor or go to the nearest hospital straight away . you may need to take rev in order to avoid any possible side effects . patients with liver disease . your doctor may want to monitor you more closely while you are being treated . in patients with moderate or severe liver disease the lower strength of rev in 92 / 22 you may have heart problems , high blood pressure , tuberculosis ( tb ) of the lung , any long standing or untreated infections , diabetes
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . asthma can be treated with fluticasone furoate ( 22 mg / ml ) or vilanterol . for severe asthma , the higher strength inhaler should only be used once a day . your doctor will prescribe the right dose for you , depending on how you respond to the medicine . in copd , your doctor may prescribe a different dose , based on the severity of your condition . if your doctor prescribes ellipta , it is very important that you use it every day , with or without food . the dose should not exceed 24 hours . this is because the dose may not be enough for copd to be given to you by your doctor , pharmacist or nurse . when you use revinty elli
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are uncommon ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking revinta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling of the face and mouth ( angioedema ). you may feel very wheezy , coughing , difficulty in breathing , feeling weak or light headed . these may be signs of a feeling of weakness or lightheaded . if any of these effects happens , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhalation is 92 micrograms ( 92 mg / ml ) inhaled . - one inhaler contains 92 milligrams or a single inhaling dose , in which the dose is based on the results of a study carried out by the ophthalmologists at the university of southern california . the other ingredients are : - if you are not sure , talk to your doctor , pharmacist , or nurse before you are given this medicine . your doctor will prescribe the correct dose for you . you will also be given a dose counter and a light grey inhalers with a yellow mouthpiece cover , as well as a dosing counter 
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine ( a nuclear-mediated non  - nuclear- nuclear retrovirus inhibitor ) and tenofovir , which are both nuclear- mediated , nuclear- and nuclear - transducers . these active substances are also used in antiretroviral medicines . they work by reducing the number of transcriptases produced by the virus and preventing it from multiplying and multiplying in the body . atripl is used as a treatment for human immune deficience virus ( hv ). it is used in adults and children aged 18 years and older who have been treated with other anti
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet taken by mouth once a day . take atripla with food . swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take . the usual dose is 1 to 2 tablets . some side effects may be life - threatening , such as dizziness or drowsiness . talk to your doctor , pharmacist or nurse straight away . if your doctor decides that you need to take too many tablets , talk to a doctor or go to the nearest hospital emergency department immediately . do not take more than the recommended daily dose , unless your doctor tells you to . it is important that you tell your doctor as soon as possible if any of the following applies to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects include lactic acidosis , a condition in which the body produces excessive amounts of lactic acids in the blood . uncommon ( may affect up to 1 in 1 , 000 people ): serious side effect tell your doctor immediately if you experience any of the following : - deep rapid breathing - drowsiness - feeling sick ( nausea ), being sick ( vomiting ) - stomach pain . if this happens , stop taking atripla and talk to your doctor straight away . this is a very common side effect . the following side effects have been reported in patients treated for hiv therapy : very common : may affect more than 1 in 10 people : increase in the number of blood lipids , glucose , and / or uric acid 
what atripla contains - the active substances are efavirenz , emtricitabine , and tenofovir disoproxil . each atripla film - coated tablet contains 600 mg / ml of e . b . the other ingredients are : - tablet core : 200 mg e. g . tablet coating : 245 mg enovir ( as fumarate ): croscarmellose sodium ( e464 ), hyprolose , magnesium stearate and microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplase contains sodium "). the tablet film coating is white to off - white . it contains iron oxide black , iron oxide red and iron oxide yellow . not all pack sizes may be marketed .
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . gnrh is a type of hormone produced by the body ' s own body - derived cells called follicle stimulating hormone ( fsh ). gsh regulates the release of gonadotropins , which help to stimulate the growth , development , and reproduction of eggs in the ovaries . these eggs are produced in small round sacs called " egg cells " in the egg cells . this helps to release the mature egg cells and help to produce eggs in women , especially in women who are not able to reproduce themselves . in vitro fertilisation ( ivf ) and other methods have been used to achieve similar results .
do not take orgalutran if : you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you are hypersensitive to gonadotrophin releasing hormone ( gnrh ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have : a moderate or severe kidney or liver disease . you are pregnant or breast - feeding . if any of these apply to you , tell your doctor , pharmacist or nurse . your doctor will monitor you closely before and during treatment . allergic reactions may occur in patients with an active allergic condition . additional monitoring and treatment may be necessary if allergic reactions occur in generalised , such as hives ( urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing or swallowing ( angioedema 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much orgalutran to use the treatment is assisted reproduction techniques ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin . on day 2 or 3 of your pregnancy , your doctor will give you the dose you need . the recommended dose is one injection under the skin every 5 to 6 weeks . you will receive the dose according to your doctor ' s advice on the preparations , different injection sites , and daily treatment . your doctor may decide to change the dose based on the egg cells , human chorionic gonadotrophin ( hcg ), or two injections a day . this will be given to you by a doctor , nurse or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect that is not listed in this leaflet , please tell your doctor immediately . very common ( may affect more than 1 in 10 people ): local skin reactions ( redness , swelling ). the local reaction disappears within 4 hours . uncommon , may affect up to 1 in 100 people : headache , nausea , malaise . rare , can affect upto 1 in 1 , 000 people allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat . difficulty in breathing or swallowing ( numbness ) common : may affect as many as 1 in 1000 people , allergic reactions may include a variety of symptoms : diarrho
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . clear , particle - free solutions should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what orgalutran contains the active substance is ganirelix . each ml contains 0 . 5 mg of acetic acid . the other ingredients are mannitol and water for injections . if the ph is too low , the solution should be diluted with sodium hydroxide ( e421 ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given the tablet . how much to use the tablet the tablet contains sodium , water for subcutaneous administration is supplied as a clear , colourless aqueous solution . it is available in packs containing 1 or 5 vials each . not all pack sizes may be marketed .
blitzima contains the active substance rituximab . it is a type of protein called a " monoclonal antibody " that attaches to a specific type of white blood cell , called " b - lymphocytes ". it sticks to the surface of the white blood cells and binds to them . this is called b- lymphomab ( bml ). bbl is used to treat the following conditions : a ) non - hodgkin ' s lymphama , a disease of the lymph tissue that affects the immune system , which produces a number of a certain type of blood cell ( a group of b lymphocyte ) in the body called " lymphocytic leukaemia " ( cll ). it is used in combination with other medicines
do not take blitzima : - if you are allergic to rituximab , other proteins that are present in the blood , or any of the other ingredients of this medicine ( listed in section 6 ) if : you have a severe active infection caused by a weak immune system , severe heart failure or severe uncontrolled heart disease , such as granulomatosis , polyangiitis ( microscopic polyangitis ) or pemphigus vulgaris . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will check you for signs of a hepatitis infection . you should tell your doctor or pharmacist if your child is not sure . if any of these apply to you or your child , ask your doctor for advice . children and adolescents 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . your doctor will tell you how many doses of this medicine you should be given . it is important that you continue to receive this medicine as long as you are aware of any side effects that may occur while you are being treated with this medicine . the usual starting dose is one dose , given as a drip ( intravenous infusion ). you will receive medicines at the same time each day , with or without food . this will help to reduce the risk of side effects . you will also be given one dose in combination with other medicines ( pre - medication ) to prevent side effects during your treatment with non - hodgkin ' s lymphoma
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are mild to moderate . after treatment , reactions have been fatal . infusion reactions usually occur within the first 24 hours of the infusion . fever , chills , shivering , pain at the injection site , blisters or itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing . tell your doctor or nurse straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): diarrhoea , vomiting , stomach upset , constipation , abdominal pain , muscle spasms and bruising . other side effects may include : common : may affect up to 1 in 100 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each vial contains 10 mg / 100 mg ( equivalent to one ml ). - one vial is supplied as a single - use solution for infusion . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 ( e421 ) and water for injections ( see section 2 ). what brissima looks like and contents of the pack birshima is a clear , colourless solution . it is available in packs containing 2 vials containing 50 mg or 1 vial . not all pack sizes may be marketed .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody , called interleukin - 6 . this is a protein that attaches to a specific protein in your body . it stops the activity of this protein and stops it from spreading . by blocking this protein , your body can reduce the inflammation in its own cells , which can cause symptoms such as pain and swelling in your joints . if you are not sure what to do , talk to your doctor , pharmacist , or nurse . what you need to know about the dangers and benefits of the medicine , see also section 2 ' warnings and precautions ' below . your doctor will tell you what you can do to prevent the damage to the cartilage ( the layer of bone ) that protects your joints from being damaged . the disease can be
do not use roactemra : - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if this applies to you , tell your doctor or nurse immediately . you may have an active , severe infection at the time of the infusion . your doctor will monitor you closely for signs of allergic reactions , such as chest tightness , wheezing or severe dizziness or light - headedness . swelling of the lips , skin rash , and the doctor may decide to reduce the dose . this will help to prevent infection . infections should not be given to you immediately unless your doctor tells you to feel unwell . it is important that you do not have to stop using r
roactemra is given into a vein by a nurse . after the intravenous infusion , the treatment will be continued for 8 hours . the usual starting dose is 4 ml . if you are not sure , talk to your doctor , pharmacist or nurse straight away . your doctor will decide on the dose that is right for you . depending on how you respond to the treatment , your doctor may decide to increase your dose to 8 mg / m2 . it is recommended that you do not receive more than 8 hours of treatment . you may receive up to 8 hours for up to 4 hours ( depending on your body weight ) per day , given as a drip in the vein ( intravenous infusion) every 2 hours ( see section 2 for more information ). if your doctor decides to increase the dose , you may be given more r
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ): allergic reactions ( difficulty with breathing , chest tightness , light - headedness ), rash , itching or hives , swelling of the lips , tongue or face , serious infections ( fever , chills , mouth , nose , throat , sinuses ). these may be signs of serious infections such as fever and chills in the mouth . other possible side effects are listed below . very common : may affect up to 1 in 100 people allergic reactions . these may include : - headache , diarrhoea , nausea , vomiting , diarrhea , stomach pain , constipation , abdominal pain 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions .
what roactemra contains - the active substance is tocilizumab . each vial contains 4 mg , 80 mg or 20 mg / 10 ml of concentrate . one vial containing 200 mg or 200 mg of concentrate contains 0 . 5 mg . the other ingredients are : sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphorectide dihydrate and water for injections not all pack sizes may be marketed in your country ' s country - based concentrate for solution for infusion . pack sizes are available in packs containing 4 , 10 , or 20 vials of concentrate for concentrate for injection . not all packs are marketed .
onbrez breezhaler contains the active substance indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles that attach to the walls of the small air passages in the lungs . this makes breathing easier for people with breathing difficulties who have a lung disease called chronic obstructive pulmonary disease ( copd ). copd is a condition in which the muscles in your breathing are not working properly . your doctor will tell you how to use this medicine to relax the muscles of your lungs to make breathing easier .
do not use onbrez breezhaler : - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have asthma . your doctor will tell you if the medicine is suitable for you . - you have heart problems ( epilepsy ), thyroid gland problems ( thyrotoxicosis ) or diabetes . tell your doctor or pharmacist if any of these apply to you ( or you are not sure ). your doctor may need to adjust your dose if treatment is not working properly . you should not use the medicine after the expiry date which is stated on the carton . it is important that you contact your doctor immediately for tightness of the chest , coughing , wheezing or breath
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 150 microgram capsule once a day . your doctor will tell you how much to inhale and how many capsules to use . this will depend on how you respond to the treatment . you should use your inhaler at least 24 hours after the last dose of onbrez breezhaler . it is important that you keep the capsules in the blisters in order to protect them from light . do not change the dose unless your doctor tells you to . inhalation time is approximately the same as in the morning and evening . if the medicine has been given to you by your doctor , pharmacist or nurse , it is recommended that you use it at the same time each day , with or without food . how to use the onb
what onbrez breezhaler contains - the active substance is indacaterol . each inhaler 150 mg / ml capsule contains 150 micrograms ( i . e . one 150 mg capsule ) of the active substances in the inhalation . the other ingredients are : lactose and the capsule is coated in gelatin , as well as an inhaling capsule . capsules are supplied in blisters , with the capsules being coated in a white powder . in combination with inhalers , each 150 mg or one 300 mg capsule is supplied in packs containing one 300 microgram capsule each . not all pack sizes may be marketed .
clopidogrel hcs belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets , the body ' s ability to clot is reduced , and by lowering the level of platelet medicinal products , it reduces the risk of blood coagulation ( a process called thrombosis ) in patients who have not been previously treated with thrombocytes ( thrombi ) that have formed in hardened blood vessels ( arteries ), which can lead to atherothromboisis . these events can be life - threatening ( such as stroke , heart attack , or death ) if you are not sure , talk to your doctor or pharmacist . clo
do not take clopidogrel hcs : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking , or if : you have a medical condition that is currently causing bleeding ( such as a stomach ulcer or bleeding within the brain ). - you have severe liver disease . if any of these apply to you , tell your doctor or pharmacist before you are given , as this medicine is not suitable for you . your doctor will tell you about any possible risk of bleeding . you may be more at risk of having a medicine that is causing internal bleeding , such as an ulcer of the stomach or a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 75 mg tablet once a day . you should take clopidogrel hcs for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ). your doctor will tell you how many tablets to take . your doctor may prescribe a higher or lower dose if necessary . do not take more than your doctor tells you to . patients with severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg / ml . if your doctor prescribes you , your doctor might prescribe you a lower or higher dose . it is important that you take the tablet at the same time each day , with or without food . this will help you to remember to take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel hcs and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells . - signs of liver problems , such as yellowing of the skin and / or the eyes ( jaundice ), bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth ( signs of skin disorders ), such as rashes , itching , blisters of the surface of an allergic reaction . tell your doctor as soon as possible if your doctor tells you otherwise . your doctor will tell you how to treat you . this includes any possible side effects not listed in this leaflet . you can also
what clopidogrel hcs contains - the active substance in each film - coated tablet , contains 75 milligrams ( 0 . 5 mg / ml ). - it contains hydrochloride ( see section 2 ) in the tablet core . - also contains hydrogenated castor oil , microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 ( e421 ), polyvinyl alcohol , titanium dioxide , red iron oxide , yellow iron oxide [ e172 ), talc , macrogol 3000 , and water for injections . not all pack sizes may be marketed . the active substances are white to off - white , round tablets .
fetcroja contains the active substance cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . if you have any questions about this , ask your doctor or pharmacist .
do not take fetcroja : - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine if : you or your child is allergic to other antibiotics such as cephalosporins . - you have a severe allergic reaction to certain antibiotics ( penicillins , carbapenems ). severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat . you may have difficulty swallowing or breathing . your doctor will tell you if any allergic reaction has occurred to any of your child ' s doctor . it is important that you tell your doctor or pharmacist if your child has ever had kidney problems or diarrhoea 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fetcroja is an infusion ( a drip ) into a vein . it is given every 3 weeks for 2 weeks . your doctor will decide how long you should continue to be treated . you will be monitored by your doctor for signs of infection . if your infection gets worse , you may be given any pain during or after the ffraja infusion . kidney problems your doctor may decide that you should be treated for kidney problems at the same time each day . how long should you be treated you should tell your doctor , pharmacist or nurse if any of the above applies to you , or you have any further questions on the use of this medicine . take the next dose as soon as you remember . do not take your dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , or a severe rash . other severe skin reactions : difficulty swallowing or breathing . this reaction may include diarrhoea , stools or blood or mucus . treatment may be interrupted by medicines to slow bowel movement . if any of these side effects gets serious , talk to your doctor , pharmacist or nurse . the most common side effects are : very common : may affect more than 1 in 10 people fetcroja has been associated with an increased risk of having these effects . you can also report side effects directly via the national reporting system listed in app
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . 1 ml of solution contains 0 . 5 mg cefiferocol ( as sucrose , sodium chloride , and sodium hydroxide ). what the other ingredients are : - white powder for solution for infusion . pack size 10 vials . not all pack sizes may be marketed .
depocyte is used to treat lymphomatous meningitis , a condition in which tumour cells attach to membranes in the brain and spinal cord . it works by reducing the number of lymphoma tumour cells in the body .
do not take depocyte if : you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). you have a meningeal infection . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . severe neurological side effects have been reported in patients who have been treated with depcyto . symptoms of the nervous system may include : convulsions , pain , numbness or tingling , blindness or visual disturbances . if any of these symptoms occur , contact your doctor immediately . your doctor may prescribe any dexamethasone tablets to treat unwanted effects . tell your doctor or pharmacist if you notice any of your side effects , or if your doctor notices any new side effects while you are being treated with other medicines , such as medicines used to treat pregnancy
always use depocyte exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one vial of lumber sac per day . your doctor will tell you how many doses to inject . you will be given 1 to 5 ml of dexamethasone once a day for a total of 5 days . do not increase your dose unless your doctor tells you to . this is to reduce the risk of any side effects . how to inject your dose your doctor may give you a higher or lower dose . temperature should not exceed 22 to 30 oc / m2 ( 0 . 2 g / kg of body surface area ) before injecting . if possible , you should contact your doctor as soon as possible . withdrawal from the vial should be done with proper precaution
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects while you are being treated with depocyte : very common ( may affect more than 1 in 10 people ): very rarely , the frequency is not known ( frequency cannot be estimated from the available data ). the frequency may vary depending on how you respond to your treatment . the most common side effects are : - nausea , vomiting weakness , confusion , fever headaches and diarrhoea . - dizziness , tingling sensations , shortness of breath , difficulty in breathing or swallowing . these may be serious and may be life - threatening . talk to your doctor , pharmacist or nurse immediately . this includes any possible side effects not listed in this leaflet . you can also report
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . keep depocyte in the original package in order to protect from light . from a microbiological point of view , this medicine does not require any special temperature storage conditions . if you notice any visible signs of severe discolouration , a changed appearance or a defective container , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cysteine . - each vial contains 5 mg or 50 micrograms ( 0 . 5 mg ). - this medicine does not contain any of the other ingredients : cholesterol , trolein , dioleoylphosphatidylcholine ( e421 ), dipalmitoyllphosphatidelglycerol , sodium chloride , and water for injections , see section 2 . what debocyte looks like and contents of the pack despocyte is a clear , colourless to pale yellow solution for injection . it is available in packs containing 5 vials in a single injection or a vial . not all pack sizes may be marketed .
what bemrist breezhaler contains - the active substances are indacaterol and mometasone furoate . both of these substances belong to a group of medicines called bronchodilators . they work by stimulating the muscles in the lungs , which help to open the airways . what do you need to know before you are given this medicine ? your doctor will tell you what to do if you are not sure . the other ingredients are : - your doctor may also prescribe you a different type of medicine called " corticosteroids ", which are also called steroids . these are medicines used to treat the swelling , irritation ( inflammation ) in the small airways in the lung , and help to prevent breathing problems . - you will also be given the medicine to reduce the number of attacks of asthma . you will be given bem
do not use bemrist breezhaler : - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have heart problems such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures or low level of potassium in your blood . - you have severe liver problems or tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . your doctor will monitor you closely during treatment with this medicine to check for signs of tightness of the chest , coughing or wheezing . tell your doctor as soon as possible if any of these apply to you 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should only be used once a day . the medicine should be inhaled by a doctor experienced in the treatment of your asthma and your symptoms . how much to inhale the recommended dose is one inhalation per week . your doctor will tell you exactly how many inhalations to use . you should use the inhaler with or without food . it is important that you use the medicine as soon as possible after you use it . do not use the capsules unless your doctor tells you to . if the medicine has been given to you by your doctor , pharmacist or nurse , or nurse has instructed you to do so at the same time each day , as your symptoms may need to be controlled . use bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching or hives . allergic reaction may occur . may affect up to 1 in 100 people . swelling in the tongue and lips or face or throat ( angioedema ). other side effects have been reported in patients taking bemrist breezhaler . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . keep the capsules in the original blister in order to protect from light .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler containing 125 mg / 62 . 5 ml of solution contains 173 mcg ( equivalent to 1 , 000 micrograms / kg of body surface area ). each sachet contains a total of 150 mg of indecaterol / 80 mg ( equal to 0 . 8 mq of body area ) adolescent . the other ingredients are : - the mouthpiece of the inhalers contains 125 milligrams ( mmol ) of indocaterol and 62. 5 mg of mometétéfuroate ( e172 ). if you have any further questions on the use of
zyllt contains the active substance clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the amount of platelets forming in these structures , the body ' s natural defences prevent the clots from forming , a process known as thrombosis , and prevents this from happening . the active ingredient in zylt is used to prevent blood - related thrombocytes ( thrombi ) form in hardened blood vessels ( arteries ). it is used in the treatment of atherothromboisis . this is the most commonly used treatment in patients who are at high risk of these severe severe events , such as stroke , heart attack or death . zy
do not take zyllt if : you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you think you may be at risk of bleeding . if this applies to you , tell your doctor or pharmacist . it is important that you read the leaflet carefully and follow the instructions for use in this leaflet . your doctor will check that you are not sure . this includes any possible side effects that may affect your ability to carry out normal daily activities . children and adolescents this medicine is not recommended for children under 18 years of age . the risk for bleeding is not known unless your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is 75 mg once a day . zyllt is for oral use . severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg once daily . your doctor may increase your dose to a maximum of a 75 mg dose . after treatment , your doctor will give you a total of 75 mg . do not take more than the recommended daily dose , unless your doctor tells you to . you may need to take the next dose at the same time each day , depending on how you respond to treatment . this will help to keep you on the right path to recovery . it is important that you take 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth . - skin disorders such as rashes , itching , blisters ofthe skin . these may be signs of an allergic reaction . the side effects listed below are listed in section 4 . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what zyllt contains the active substance is clopidogrel ( as hydrogen sulphate ). each film - coated tablet contains 75 milligrams ( ml ). the other ingredients are : - tablet core : lactose ( see section 2 under the heading ' other ingredients not listed in this leaflet '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil , hypromellose , titanium dioxide , red iron oxide ( e171 ), talc and propylene glycol in the film coating . what you need to know about the colour of the tablet shellac . the tablets are white to off - white , round and slightly convex . they are available in boxes containing 7 , 14 , 28 , 30 or 50 film 
lamivudine teva is an antiviral medicine that blocks the growth of the hepatitis b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrti ). it is used to treat adults with long term ( chronic ) infection , which can lead to liver damage . if you have a problem with your liver , you may have compensated liver disease . your doctor will tell you how long you will be treated . the active substance in lam - based medicine is a type of medicine called " nasopharyngeal ". it works by reducing the number of cells in your body ' s natural defences .
always take lamivudine teva exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : 28 you are being treated with other similar medicines for serious side effects . you have liver disease ( hepatitis c . ) you are overweight . your doctor will do blood tests before and during treatment with your medication . the usual starting dose is 4 mg / ml once a day . it is important that you follow the instructions for use in this leaflet . children and adolescents do not give this medicine to children under the age of 18 years . do not use this medicine after the expiry date which is stated on the carton . in this case , your doctor may prescribe a different dose for you , depending on your age
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . lamivudine teva will be given to you by a doctor who is experienced in the treatment of your hepatitis b infection . your doctor will tell you how much to take and how often to take it . if your infection does not go away , your doctor may decide to reduce your dose . do not take more than your doctor tells you to . you may need to take your medicine at the same time each day . it is important that you do not have to take too many tablets at once . the recommended dose is one tablet at a time . this will help to control your infection and your illness . how long you should take the tablet , take it as soon as you remember , and then take your next tablet at the usual time 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva : - other conditions associated with hepatitis b . if you experience any of the side effects listed below , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in section 6 ' warnings and precautions '. your doctor will discuss with you how to treat your condition while you are being treated . in a clinical trial , you may experience tiredness , respiratory tract infections ( throat discomfort , headache , stomach discomfort ), pain , nausea , vomiting , diarrhoea , increases in liver enzymes which are important for the liver to work properly 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is acetate . each film - coated tablet contains 100 mg / ml debossed with " l " on one side and " 100 " on the other . - tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( red ) and iron oxide red ( encoding in " tv " in black ink " in red ink . how to prepare the tablet white to off - white , biconvex film , 32 mm in diameter . the tablet is supplied in aluminium blisters containing 28 , 30 , 84 or 100 tablets . not all
nespo is an anti - anaemic . it works by reducing the amount of your anaemia in your blood and by increasing the number of red blood cells . this reduces the symptoms such as fatigue , weakness and shortness of breath . the natural hormone erythropoietin is a substance produced by your kidneys , your bone marrow , which makes up the majority of the blood ' s surface area , causing it to become more red - blood cells ( darbepoetine alfa ). it is also used to treat chronic renal failure ( symptomatic anemia ) in adults with chronic renal fail ( kidney failure ). kidney failure is caused by a malfunction of the kidney . if you have a problem with your kidney , it is important that you get the right dose of the naturally hormone rythrop
do not take nespo : - if you have high blood pressure or are taking other medicines . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the pre - filled suivinge . if any of the above applies to you , tell your doctor or pharmacist . you may be allergic to the active substances listed in section 6 . your doctor may decide to reduce the dose of the medicine you are taking . it is important that you contact your doctor as soon as possible if your doctor tells you otherwise . children and adolescents this medicine is not recommended for children or adolescents under the age of 18 years . this is because it is not known whether you have sickle cell anaemia ( epileptic fits ( seizures ), convulsions or seizures ). this may be due to liver disease or drugs used to treat this condition . patients with ana
always use nespo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will do blood tests to check your haemoglobin level . the recommended dose is 10 mg once a day . if your doctor tells you to use a higher dose , your doctor may decide to increase your dose to a maximum of 12 mg / kg . how much to use the pre - filled syringe for chronic renal failure is a single injection under the skin or into a vein ( intravenous ) to treat your anaemia . it is important that you have the right dose based on your body weight ( 0 . 75 kg ) or 0. 45 kg / m2 of body weight . regular blood samples will be taken to check how well you are able to tell you how you are doing 
like all medicines , nespo can cause side effects , although not everybody gets them . the most serious side effects are listed below : 471 common ( may affect up to 10 people in 100 ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( affects up to 1 in 100 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and redness of the skin rare (1 in 10 , 000 patients ) serious allergic reactions , including sudden life - threatening allergic reactions ( anaphylaxis ), swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( angioedemo ). if any of the side effects gets serious , talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle in the original package in order to protect from light . after first opening , you can re - use it within 30 days . if not used within 7 days , use immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa . each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 micrograms . the other ingredients are : - sodium phosphate monobasic , salt water for injections , sodium chloride , polysorbate 80 ( e421 ). - solution for injection is a clear , colourless to slightly pearly liquid , cloudy . - pack sizes : 1 , 2 , 3 , 5 or 8 pre . packed in a glass vial . not all pack sizes may be marketed .
macugen is a solution for the treatment of macular degeneration ( amd ). this disease can cause vision loss or damage to a part of the retina called the macula , which is located in the back of the eye . macura is the layer of the outer layer that protects the eye from light . amd is caused by abnormal blood vessels grow in the retina , causing new blood vessels in the eye to form . if you are not sure , talk to your doctor , pharmacist or nurse . this medicine is used to treat adult patients with amd who have amd and who are unable to see clearly . it is important that you tell your doctor as soon as possible if your doctor tells you to , or if any of the following applies to you : - to prevent this from happening . in adult patients , this medicine helps to prevent abnormal formation of new
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have an active or suspected infection in your eye . if this applies to you , tell your doctor or nurse immediately if any of these apply to you ( see section 4 ). - you have had an infection or bleeding in the eye during or after the injection . your doctor will monitor you for the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision or increased sensitivity to light . small particles in your vision may occur . the injection may cause serious allergic reactions to the symptoms . children and adolescents this medicine should not be given to children under 18 years of age . other medicines
always use macugen exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one injection a day . your doctor will tell you how many injections to give and how often to give them . you will be given a single injection into your eye . children and adolescents from 6 to 9 years of age , the injection will be injected into a vitreous ( i . e . infected ) part of the eye , your doctor may decide to reduce the number of injections . it is important that your doctor tells you how much to give your child , if your child is allergic to antibiotic eye drops . this is because antibiotic treatment can reduce the risk of eye infection . tell your doctor as soon as possible if the child ' s doctor advises you to stop the injection
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting or rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . frequency cannot be estimated from the available data . these side effects may be due to an infection in the internal portion of the eye . during macugen treatment , the symptoms may get worse . see section 2 for more information . if you notice any of these symptoms , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the medicine in the original package in order to protect from light .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 ml of solution for injection . the other ingredients are : sodium chloride ( e421 ), monobasic sodium phosphate monohydrate , dibasic salt water , sodium hydroxide , hydrochloric acid ( used for ph adjustment ) and water for injections . see section 2 . what macugegen looks like and contents of the pack macugagen solution is supplied as a single dose pack in a pouch . it is supplied in an elastomeric plunger stopper , a pre- attached plunger rod and a plastic clip . not all pack sizes may be marketed .
kepivance contains the active substance palifermin . it belongs to a group of medicines called escherichia coli , and is used to treat a type of cancer called epithelial cells , which are found in the mouth , digestive tract and tissues under the skin . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will tell you how to use a different type of treatment : oral mucositis ( soreness , dryness ) and inflammation of the mouth ( side effect of treatments to treat your blood cancer ). your doctor may decide to reduce the number of the type of blood cancer that you have been treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( hsct ).
do not take kepivance : - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 18 years of age . tell your doctor or pharmacist if this applies to you . other medicines you may be taking , have recently taken , or might take any other medicines . your doctor will tell you what to do . this includes any medicines not listed in this leaflet . you may also take heparin with or without food , drink or alcohol . pregnancy and breast - feeding this medicine is not recommended for use in women who are pregnant , are planning to have a baby , think they may be pregnant or are
kepivance will be given to you by a doctor or nurse who is experienced in the field of cancer treatment . the recommended dose is 60 mg / kilogram ( kg ) per day . it is given as an intravenous injection into a vein . your doctor will prescribe the dose for you based on how well you respond to the chemotherapy and radiotherapy you are receiving . if you are given three days of chemotherapy or radiotherapy , you will receive chemotherapy and radiation therapy within 24 to 48 hours after the chemotherapy , radiotherapy or the chemotherapy will be continued for a maximum of 48 hours . you will be monitored by your doctor , nurse or nurse if your cancer is being treated .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ) side effects skin rash , itching , redness ( pruritus ), erythaema , an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever , aching joints ( arthralgia ) altered taste , lipase and amylase levels . if you notice any of these , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliffermin in the other ingredients : mannitol , sucrose , l - histidine , polysorbate 20 ( e421 ) and diluted hydrochloric acid ( see section 2 , other ingredients in section 6 ). what ketivance looks like and contents of the pack ketivance is a white to off - white powder . it is available in packs containing 6 vials .
the active ingredient cinacalcet accordpharma contains calcium and phosphorous . it is used in adults to treat problems with organs called parathyroid glands , which are four small glands in the neck that connect to the thyroid gland . the purpose of the medicine is to reduce the risk of secondary hyperparathyroidism in patients with serious kidney disease who are on dialysis and who have waste products that contain calcium in the blood ( hypercalcaemia ). this is the same as for patients with a higher risk of having a lower risk of developing a high risk of getting a low risk of a condition known as primary hyperparatoxic disease . removal of the gland is also recommended for use in children and adolescents 3 years of age and over . adults and children aged 18 years and older who are at risk for secondary hyperparothyroidia . this is a very rare but serious kidney
do not take cinacalcet accordpharma : - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . low levels of calcium in your blood may occur . your doctor will check your blood calcium levels before you are taken to a hospital . if this applies to you , tell your doctor as soon as possible . you may experience seizures , convulsions or seizures . these may be signs of liver problems or heart failure . take special care with cinacaca accordpharma to reduce calcium levels , which can lead to life threatening events or fatal outcomes . in patients with low calcium levels ( hypocalcaemia ) your doctor may decide to reduce your dose . it is very important that you take this medicine exactly as your doctor tells you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . the tablets should be swallowed whole with a glass of water . you can take the tablets with or without food . your doctor will take regular blood samples during treatment for secondary hyperparathyroidism . if necessary , your doctor may prescribe a different dose , depending on your condition . it is important that you take the tablet at least 30 minutes before each meal . children and adolescents 3 to 18 years of age , the dose should not exceed 0 . 20 mg . do not take more tablets than your doctor tells you to take , as this medicine may affect the way your body reacts to it . this will help you remember to take it as soon as you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : numbness , tingling around the mouth , muscle aches , cramps or seizures . your calcium levels may be too low ( hypocalcaemia ). swelling of the face , lips ,mouth , tongue or throat , difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea , vomiting . these side effects have been reported in patients treated with cinacalcet accordpharma . very common : may affect up to 1 in 100 people : dizziness . uncommonly , diarrhoea . not known ( frequency cannot be estimated from the available data ). the following side effects may occur with this medicine : very
what cinacalcet accordpharma contains - the active substance is cinacacet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacalcet ( as hydrochloride ). the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake , iron oxide yellow ( see section 2 ). what the pack looks like and contents of the pack cinacalce accordpharma 30 mg is a clear , light green colored , oval shaped , 9 . 65 x 6 . 00 mm , biconvex , round tablet . not all pack sizes may be marketed .
jentadueto contains the active substance linagliptin . it belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase -4 inhibitors ). it is used in combination with metformin and biguanides to lower blood sugar levels in patients with diabetes , called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of sugar in your blood . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may prescribe this medicine together with certain other medicines used to treat diabetes such as sulphonylureas or empagliflozin , which are used to make insulin , for the treatment of type2 diabetes .
do not take jentadueto : - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severely reduced kidney function , you have uncontrolled diabetes , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis . if this applies to you , tell your doctor as soon as possible . your doctor may prescribe ketoacidosis ( a condition in which your body does not produce enough ' ketone bodies ') which can lead to diabetic pre - compa with symptoms such as stomach pain , fast and deep breathing .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of jentadueto is one tablet once a day . your doctor will tell you how many tablets to take . you will be given the tablet with or without food . currently taking metformin , your doctor may prescribe individual tablets containing linagliptin . this medicine is for oral use only . taking this medicine can cause an upset stomach . the usual dose is five mg / ml , or 2 , 000 mg , if your doctor tells you to . if this is the case , you may need to take five or six tablets . it is important that you follow your doctor ' s advice and follow your diet and exercise plan . do not take more than the recommended daily dose 
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may require immediate medical attention . stop taking jentadueto and tell your doctor straight away if you notice any of the following symptoms : low blood sugar ( hypoglycaemia ) - trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . this is a very common ( may affect up to 1 in 10 people ) side effect . if this happens , talk to your doctor , pharmacist or nurse . the frequency of this side effect is not known ( frequency cannot be estimated from the available data ): very common : may affect more than 1 in 1 , 000 people . other possible side effect reported in patients treated with jenteduet plus sulphon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the original package in order to protect from light . if you notice any visible signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . a single tablet contains 2 . 5 mg and 850 mg / ml . the other ingredients are : - one 2.5 mg tablet containing 1 , 000 mg ( 0 mg ) or 0 , 5 mg ( 1 mg ). - two 2.5 mg tablets containing 2 mg and 1000 mg ( 2 mg ), each tablet contains 1 mg and 1 mg ( 3 mg ); - three mg ( 4 mg , 4 mg and 5 mg respectively ), - four mg ( 5 mg ; - five mg ( 6 mg : 1 g ) - six mg ( 8 mg - 20 mg linagliptin ) and 2 mg ( 7 mg l ) ( 8 gl ), as metform
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrti ). it is used in adults , adolescents and children 12 years of age and older who are infected with hiv and who are not taking hiv medicines . if you are not sure , talk to your doctor or pharmacist .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . take the following medicines : carbamazepine ( oxcarbazepine ), phenobarbital , phenytoin ( medicines used to treat epilepsy and to prevent seizures ) rifampicin ( equilibrium ) ( medicines to treat some bacterial infections ( such as tuberculosis )) omeprazole ( also known as esomeprezole ). lansoprazola , pantoprazole , and rabeprazol , proton pump inhibitors . tell your doctor as soon as possible if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . children and adolescents ( aged 18 years and over ) edurant contains the active substance rifabutin , which is a medicine used to treat some bacterial infections . your doctor will tell you how many tablets you need to take to make sure that you are taking the right dose . if your doctor tells you not to take , talk to your doctor , pharmacist or nurse . do not take more than one tablet at once . take the tablet at the same time each day , with or without food . this will help you remember to take the next dose as soon as you remember . it is important that you follow the instructions for use in this leaflet . see also section 2 . an antacid is
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : headache , nausea , difficulty falling asleep , insomnia , dizziness . your routine liver tests may show an increase in transaminase , increase in cholesterol , pancreatic amylase in your blood , abnormal dreams , rash , stomach pain . these may be signs of depression , tiredness ( vomiting ), drowsiness , decreased appetite , sleep disorders such as stomach discomfort , depressed mood . if any of these occur , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on
what edurant contains - the active substance is rilpivirine . - each film - coated tablet contains a single syringe ( ml ). - one tablet contains one tablet ( tablet core ) containing 25 milligrams ( millilitres ) ( s ). the other ingredients are : tablets : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the tablet core is a clear , colourless to slightly opalescent tablet - white , round - shaped tablet . tablet coating : hypromellose 2910 , 6 mm , titanium dioxide ( e171 ), macrogol 3000 , triacetin .
avandamet tablets contain two different medicines , rosiglitazone and metformin . these two medicines help control the level of sugar in your blood . type 2 diabetes is a condition in which your body does not produce enough insulin to control blood sugar levels . insulin - containing substances , such as rosilgitazone , is not enough to control your blood sugar . if you are taking a sulphonylurea to control diabetes , talk to your doctor , pharmacist or nurse .
do not take avandamet - if you are allergic ( hypersensitive ) to rosiglitazone , metformin , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist if : you have had a heart attack , severe angina or heart failure in the past . you have severe breathing difficulties , liver disease , diabetic ketoacidosis ( a complication of diabetes characterized by rapid weight loss , nausea or vomiting ) or kidney disease 107 you are very dehydrated . this medicine is not recommended for use in children and adolescents under 6 years of age . if this applies to you , tell your doctor , pharmacist or nurse . it is important that you drink plenty of water before you take it . your doctor will tell you if any of these apply to
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone , 1000 mg metformin , once a day . this dose is 1 to 8 mg / ml . your doctor will decide the maximum dose , based on how you respond to the medicine . you should take this dose at least 4 hours after the last dose . take the tablet with a glass of water . do not take more tablets than you should if your doctor tells you otherwise . if the dose is too high or too low , talk to your doctor , pharmacist or nurse . it is recommended that you take the tablets at the same time each day , at least 2 hours apart . swallow the tablets whole with water , with or without food . taking avand
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions : some patients who have had a reaction to avandat have raised and itchy rash ( hives ) swelling of the face and mouth ( angioedema ) and difficulty in breathing collapse . if you have any of these symptoms , contact your doctor or go to your nearest hospital immediately . you may also experience lactic acidosis . this is a common side effect of metformin . in patients with severe kidney disease , symptoms of lacticacidosis include rapid breathing and cold . these may be signs of rapid breathing , cold and flu . other side effects include : very common side effects ( may affect more than 1 in 10 people ): nausea , vomiting , diarrhoea , stomach pain , abdominal pain
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions .
what avandamet contains - the active substances are rosiglitazone and metformin . each of the two tablets contains one tablet containing : 1 ml ( equivalent to 500 mg ) of the active substance . the other ingredients are : tablet core : metformine . - tablet number : 2 mg / 0 . 5 mm . tablet size : one tablet contains a single dose of one tablet of one containing one dose of two containing two doses of one or both of the other . in the other hand , the other ingredient is : sodium starch glycolate , hypromellose , microcrystalline cellulose , lactose monohydrate . not all pack sizes may be marketed in your country .
clopidogrel mylan belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together to prevent blood clotting . by reducing the amount of platelets that form , the body ' s own clots , it prevents the blood from forming again , resulting in a process called thrombosis . if you are not sure what to do , talk to your doctor , pharmacist or nurse . this is called " thrombi ", which are formed in hardened blood vessels ( arteries ), which can lead to atherothrombosis ( a type of atherotrombotic events such as stroke , heart attack , or death ) , you should not have to take any of the other medicines that are not listed in this leaflet
do not take clopidogrel mylan 31 - if you are allergic to the active substance or to any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding ( such as a stomach ulcer , bleeding within the brain ) or severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking , or have recently taken or might take any other medicines that are not listed in this leaflet . if any of these apply to you , tell your doctor or pharmacist if : you have ever had or might have had a history of bleeding . this includes : - you are currently at risk of bleeding such as an ulcer of the stomach or a blood vessel in the blood . you are at increased risk for bleeding inside any tissues , organs or joints of the body . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) should take at least 75 mg clopidogrel mylan once a day . your doctor will tell you how much to take . the recommended dose is one 75 mg tablet once daily . if your doctor decides to increase your dose , your doctor may prescribe a lower dose . for severe chest pain ( unstable angina ) or heart attack , the usual starting dose is 300 mg / ml . you can take the tablet with or without food , drink , or a glass of water . however , if it is too strong or too weak , talk to your doctor , pharmacist or nurse as soon as possible . it is recommended that you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking clopidogrel mylan and contact your doctor immediately if you experience : - fever , signs of infection , extreme tiredness , rare decrease of some blood cells , liver problems , yellowing of the skin and / or the eyes , jaundice , bleeding under the skin , red pinpoint dots , confusion ( see section 2 ' warnings and precautions '), swelling in the mouth or skin disorders such as rashes , itching , blisters of the surface of an allergic reaction . if this happens , tell your doctor , pharmacist or nurse .
what clopidogrel mylan contains - the active substance in each film - coated tablet contains 75 milligrams / ml ( mcg ).  the other ingredients are : hydrochloride , microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ) and talc ( e421 ) - tablet core : polyvinyl alcohol , titanium dioxide , red iron oxide and yellow iron oxide .  tablet coating : aloe vera colourless to off - white , round , oval - shaped tablets . macrogol 3000 tablets are supplied in a glass vial . not all pack sizes may be marketed .
it belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat adults with chronic liver disease with low platelet count . it is used in adults , adolescents and children of all ages , in adults and adolescents , and in children and adolescents who are undergoing a medical procedure to prevent bleeding by reducing the amount of platelets in the blood . platelets are blood cells that help the blood to clot and reduce the risk of bleeding .
doptelet should not be used : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . blood clots may form in the veins or arteries . this can lead to the formation of blood coagulates . if this happens to you , tell your doctor straight away . you may also need medical attention if any of these apply to you or your child ' s doctor . your doctor may need to adjust your dose if your child is not able to tolerate the drug . children and adolescents do not give this medicine to children under the age of 18 years . do not use this medicine in children or adolescents under the influence of other medicines . pregnancy and breast - feeding do not take dop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 5 mg tablet once a day . your doctor will tell you how many tablets to take depending on your procedure . the usual starting dose is 8 mg once daily . doptelet can be taken with or without food . if your doctor decides to increase your dose , your doctor may prescribe a higher or lower dose based on your platelet counts . this medicine is available in packs containing 20 mg , 40 mg or 60 mg . it is recommended that you take the tablet at the same time each day , at least 5 minutes apart . you may need to increase or decrease the dose of this medicine . take it as soon as you remember . however , if it is too strong or too weak , you should take it
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired . common : may affect up to 1 in 100 people : low red blood cell count ( anaemia ) - blood clot in the portal vein ( a blood vessel that connects the liver and intestines ). - upper abdominal pain - swelling bone pain , muscle aches and fever . reporting of side effects tell your doctor or pharmacist if you get any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag maleate . each film - coated tablet contains 20 mg dextrose . the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e . g . silica , colloidal anhydrous ), magnesium stearate , vinyl alcohol ( e421 ), talc , macrogol 3350 , titanium dioxide , and iron oxide yellow . what doppelet looks like and contents of the pack dopptelet 20 mg tablets are white to off - white , pale yellow , round and rounded . they are marked with ' 20 '. the tablets are supplied in one aluminium blister . not all pack sizes may be marketed
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the flow of blood through the heart arteries , which increases heart rate , and relaxes the muscles in your heart . rapiscan is used to perform a heart scan ( ' myocardial perfusion imaging '). the scan contains a radioactive substance called a ' radiopharmaceutical ' . these images are taken using a treadmill to work out how well your heart is working . after a scan , you will be given a small amount of radio pharmaceutical product injected into your body through a vein . it is important that you follow the instructions of your doctor .
do not use rapiscan - if you have a slow heart rate or high degree heart block ( sinus node disease ). if your doctor has prescribed a pacemaker for chest pain ( unstable angina ). warnings and precautions talk to your doctor , pharmacist or nurse before you start treatment . low blood pressure ( hypotension ), heart failure , are allergic to regadenoson or any of the other ingredients of the medicine ( listed in section 6 ). children and adolescents : if any of these apply to you , tell your doctor as soon as possible if : you have recently had a serious heart problem , such as a heart attack , or you have abnormal heart rhythms . your doctor will tell you how often your heart beat is very fast or uneven . if this applies to you or your child ' s doctor will advise you when to stop treatment with 
rapiscan will be given to you by a doctor who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein using 400 micrograms of a 5 ml solution . the injection will take 5 to 10 minutes depending on your weight . you will receive an injection of sodium chloride 9 mg , 9 mg or 5 mg a radioactive substance ( radiopharmaceutical ). your doctor will check your heart rate , blood pressure and the time of the injection . your doctor may decide to increase or decrease your dose if you need to have a dose that is right for you . if this happens , you will be monitored by your doctor , nurse or nurse . this is to make sure that your doctor has given you the right dose , depending on how well your heart is working and how well you are able to control blood pressure with the 
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects may be serious and need immediate medical attention . if you experience any of these , talk to your doctor , pharmacist or nurse straight away . it is important that you tell your doctor as soon as possible if any of the following happen to you : - a sudden stoppage of the heart ( a sign of damage to the heart ) - heart block , which is a disorder of the liver ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face or inability to speak . warnings and precautions talk to a doctor or nurse before you are given rapiscan , in case of a stroke or cerebrovascular accident , an allergic reaction ( rash , wheals 
viagra contains the active substance sildenafil , which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by blocking the activity of a protein in the blood vessels in the penis . this helps to keep your penis in order . viagra is used to help you get an erection if you are sexually stimulated . what is viagra used for viagra is a treatment for erectile dysfunction ( impotence ), a condition in which you cannot get , or keep , a re - errect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking viagra if : you are taking medicines containing nitrates , which can cause a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). the medicines are given to you by nitric oxide donors . you may be given amyl . riociguat . your doctor may prescribe this drug to treat pulmonary arterial hypertension ( high blood pressure in the lungs ). you are also at risk of chronic thromboembolic pulmonary hypertension , a condition that can lead to a build - up of blood clots ( pde ). 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet of viagra a day . you can take viagra film - coated tablets or viagra orodispersible tablets with or without food . swallow the tablets whole with a glass of water . viagra is for oral use only . it is not recommended that you take viagra if your erection is not clear or you are sexually stimulated . your doctor will tell you how long you should take it . if it is more than one hour before you start taking viagra , talk to your doctor , pharmacist or nurse . do not take more viagra than you should unless your doctor tells you otherwise . this is because it may take longer than usual for the first time . taking viagra may cause an increase in side effects , which may be fatal
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any of the side effects not listed in this leaflet . you may need to stop taking viagra and seek medical help immediately . the following side effects have been reported with viagra : an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness or swelling of the eyelids , face , lips or throat . chest pains may occur when you are in a semi - sitting position . your doctor may prescribe nitrates to relieve your chest pain . prolonged and sometimes painful erections are uncommon . very common : may affect more than 1 in 1 , 000 people . a woman may have a slight increase in the number of men having an er
what viagra contains the active substance in the tablet is sildenafil . each tablet contains 25 mg of silenafil ( as the citrate salt ). the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets are a rounded - diamond shape with 25 mg . the tablets are supplied in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole . it belongs to a group of medicines called dopamine agonists , which work in the brain . these are involved in the production of nerve impulses . this leads to the symptoms of primary parkinson ' s disease . in levodopa , the body produces a higher level of activity in the body , resulting in the worsening of the symptoms in patients with moderate to severe primary restless legs syndrome .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given . if this applies to you , tell your doctor or nurse straight away if : you have any medical conditions that may cause symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ) are very common . these may be symptoms of dyskinesia ( abnormal , uncontrolled movements of the limbs ) in patients with advanced parkinson ' s disease who are taking levodopa . you may also be at increased risk of dyskinesia , but you may not be able to keep your body and neck straight and upright . dystonia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 mg once a day for the first week of your first week . your doctor will tell you how many tablets to take and how often to take . you will start with 0 . 088 mg once daily for a period of one week , followed by one week at a time . it is recommended that you take one tablet at the same time each day . this is to be taken with or without food . if your doctor tells you to take more tablets than you should , talk to your doctor , pharmacist or nurse as soon as possible . take the tablets with you on day 1 of each day at the usual time , with a daily dose of 1 , 8 , 088
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects has been carried out on a regular basis . very common ( may affect more than 1 in 10 people ): may affect up to 1 in 100 people 1 in 1 , 000 or 1 in 10,000 people parkinson ' s disease side effects include dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ), confusion , tiredness . these effects are usually mild to moderate . the following side effects have been reported in patients treated with sifrol include : - tremors , vomiting , diarrhoea , abdominal pain , indigestion ,
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 ml of solution . the other ingredients are : - tablet core : 0.18 mg , - tablets : 1 . 35 mg and - one . 7 mg tablet per tablet . - a tablet with a content containing a maximum of 0 ( 125 mg ), a minimum of 0.25 mg and one , 5 . 5 mg tablet each . one tablet contains 1 mg pramipexole dihydrochloride monohydrate ; mannitol ; maize starch ; anhydrous colloidal silica ; povidone k 25 ; magnesium stearate . what the pack looks like and contents of the pack siffrol 0 8 . 8 mg tablets
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye caused by allergic conditions in the eye . the allergic reaction is caused by the presence of some materials ( allergens ) which can cause allergic reactions such as itching , redness and swelling on the surface of your eye , which may make you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents ( aged 3 years and above ) benzalkonium chloride may be present in the solution . if this applies to you , please tell your doctor or pharmacist . clinical trials have not shown any benefit to children or adolescents under the age of 6 years . in clinical trials , your doctor may need to adjust your dose . your doctor will monitor you closely for kidney or liver problems . you should not take , or have recently taken , any other medicines . other eye drops should not be used in children under 3 years of age . pregnancy , breast feeding or breast feeding , think you may be pregnant or are planning to have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much emadine to use the recommended dose is one drop in the eye once a day . your doctor will tell you how many drops of this medicine to use and how often to use them . do not use more than your doctor tells you to use . it is very important that you keep this medicine out of the sight and reach of your eyes ( see section 3 ). use in children and adolescents aged 1 to 2 years of age . if your child is older than 1 year , contact your doctor , pharmacist or nurse straight away . the dose may vary depending on your child ' s age , body weight and body weight . keep the bottle tightly closed with the cap and cap closed with a snap collar . open the bottle with your thumb or finger . use the bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the following : common side effects ( may affect more than 10 people ) in the eye : eye pain , itchy eye , eye redness . uncommon side effects that may affect up to 1 in 100 people eye effects : corneal disorder , abnormal eye sensation , increased tear production , tired eyes eye irritation , blurred vision , corneal staining . these effects are usually mild to moderate , but can be serious and can be life - threatening . the following side effects have been reported in patients treated with emadine : allergic reactions , such as rash , numbness , redness and tingling of the eyes . other side effects reported in children and adolescents ( less than 1
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . from a microbiological point of view , the product should be used immediately .
what emadine contains each ml of solution contains : 0 . 5 mg difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride ( see section 2 ), hypromellose , purified water , hydrochloric acid , and sodium hydroxide ( for acidity levels ) and ph levels . what hemadine looks like and contents of the pack amadine is presented as a liquid ( a solution ) , packaged in a 5 mg or 10 mg plastic ( drop - container ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam actavis is an antiepileptic medicine . it is a medicine used to treat seizures in epilepsy in adults , adolescents and children from 16 years of age with newly diagnosed epileptic syndrome . if you have a history of , or think you may have , a higher chance of having , repeated fits ( seizures ) than you should , your doctor will decide if this is the right treatment for you . your doctor may decide to increase your dose , depending on how you respond to the medicine , and how long you need to keep taking it . this is to treat adults and adolescents aged 16 years and over . children and adolescents : if your child has recently diagnosed or suspected that your child suffers from , have recently diagnosed , suspected or suspected , epilepsia ( a condition in which your child is suffering from repeated fits
do not take levetiracetam actavis - if you are allergic to the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . - you have kidney problems , if there is any slow down in the growth during puberty . you are taking anti - epileptics . your doctor will tell you exactly what to do . before you are given the medicine , you may have thoughts of harming or killing themselves , or any symptoms of depression or suicidal ideation . other side effects include : - abnormal thoughts , feeling irritable or reacting to changes in mood or behaviour . it is important that you tell your doctor or pharmacist if any of the above apply to you . this includes any possible side effects not listed in this leaflet . children and adolescents le
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose the usual starting dose is 16 mg / ml once a day . the usual dose is 3 , 000 mg once daily . your doctor will tell you how many tablets to take and when to take them . therapy dose the recommended starting dose for children and adolescents is 17 years of age and older . you can take the tablets at any time of the day , with or without food . if your doctor prescribes a higher or lower dose , your doctor may prescribe a lower or higher dose . for adults and adolescents , the dose may be increased or decreased depending on your child ' s ability to swallow the tablet 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or go to your nearest emergency department if you notice any of the following : weakness , feeling light - headed , dizzy or having difficulty breathing . this may be a sign of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms , a rash on the face or an extended rash with a high temperature , increased levels of liver enzymes in blood tests . increase in the number of white blood cell 56 ( eosinophilia ) or enlarged lymph nodes ( drug reaction ). if this happens , talk to your doctor , pharmacist or nurse . it is important that you tell your
what levetiracetam actavis contains - the active substance is levetiractam . each 250 ml vial contains 250 mg delci . - each 500 mb / m2 tablet contains 500 mg deleci ( the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate ). - one 750 mcg tablet contains 750 mg della , the other ingredient being clopidogrel ( a type of medicine used to treat adults and children ). each 1000 m3 tablet contains 1 , 000 micrograms ( 0 . 1 mg delection ) deletion . delectoratam acts as a single - use tablet . it is supplied in a glass vial . not all pack
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition that affects the lining of the lungs . it causes breathing difficulties , difficulties in breathing , and tightening of the muscles that attach to the airways . using this medicine , tightens these muscles , reduces your breathing difficulties and reduces the risk of copd in adults . when used alone , in combination with food , alcohol or alcohol , you may experience a sudden attack of breathlessness or wheezing . if you are not sure , talk to your doctor , pharmacist or nurse .
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma . if this applies to you , tell your doctor immediately . your doctor may prescribe this medicine for you . you have heart problems , an eye problem ( narrow - angle glaucoma ), an enlarged prostate , difficulty passing urine , a blockage in your bladder , or severe liver problems . immediate breathing difficulties , such as tightness of the chest , coughing , wheezing or breathlessness . contact your doctor or pharmacist if any of these apply to you ( or you are not sure ), ask your doctor for advice . do not stop using incru
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every 24 hours . do not use incruse ellipta more than once a day . your doctor will tell you how many inhalations to use . how much to inhale the dose you need depends on how you respond to this medicine . symptoms of this medicine may include a sudden attack of breathlessness or wheezing . if this happens , your doctor may prescribe you a quick - acting reliever inhaler ( such as salbutamol ). if your doctor tells you to use it , tell your doctor , pharmacist , or nurse . this will help you to remember to use the inhaled dose . it is important that you use the correct dose based on your condition 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may affect up to 1 in 100 people . tell your doctor straight away if you notice any of the following symptoms while taking incruse ellipta : itching skin rash , hives , redness 29 common side effects ( may affect more than 1 in 10 people ): faster heart beat painful , frequent urination ( a urinary tract infection ). common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the lining of the skin , swelling of the hands and feet . these may be signs of infection . other side effects are listed below : very common : not known ( frequency cannot be estimated from the available data ). uncommon : may affect as many as 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . if not used immediately , store in the original package at room temperature ( not above 25 ) for a single period not exceeding 6 months . from a microbiological point of view , it is important that you do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation dose contains 55 micrograms ( i . e 5 mg ) if the other ingredients are not listed in this leaflet . the recommended dose for adults and children aged 65 years and over , the dose for children under the age of 65 years is 0 . 5 ml , corresponding to the dose recommended by your doctor , pharmacist , or nurse , is a white to off - white powder , which is supplied in a blister containing 7 or 30 inhalers . not all pack sizes may be marketed in your country .
nucala contains the active substance mepolizumab , a monoclonal antibody , which is a type of protein used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by the presence of many eosinophils , the type of white blood cell that attaches to the airways in the lungs . this type of asthma is referred to as e . g . asthma nucala is used for the treatment of asthma attacks caused by medicines , such as high dose inhalers , to treat your asthma . these medicines are used in combination with medicines called oral corticosteroids . you should tell your doctor or pharmacist if you have any questions on the use of this medicine , ask your doctor , pharmacist or nurse . your doctor will tell you if your asthma is getting worse 
do not use nucala : - if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects affecting their asthma . if this applies to you , tell your doctor or nurse immediately . your doctor may decide to reduce the amount of the medicine you are given . you may be allergic to other types of injection site reactions medicines of this type ( monoclonal antibodies ), which can cause severe allergic reactions to parts of the body ( see section 4 for more information ). if any of these apply to you or your child , or you think you may have a similar reaction , ask your doctor for advice . do not take nucalal unless your doctor tell
always use nucala exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one injection under the skin ( subcutaneous injection ). the recommended dose is 12 mg ( 100 mg / 1 ml ) once a day . do not use the pre - filled pen after the expiry date which is stated on the pen label and carton after exp . your doctor will tell you how many injections you need . if your doctor decides to change the dose , your doctor may decide to increase or decrease your dose . it is important that you follow your doctor ' s instructions for use . you will be given the medicine at the same time each day , depending on how you respond to treatment , and how long you need to be given . however , if the treatment is not working properly , you may be given nucal
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) when the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( a drop in blood pressure ), swelling of eyelids , face , lips , tongue , mouth hives rash . contact your doctor immediately if you notice any of the following : - a reaction to a similar reaction to the injection . - not known ( frequency cannot be estimated from the available data ): very common : may affect more than 1 in 100 people if the injection has been given to you . tell your doctor straight away if any of these
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and the pre - filled pen after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucala pen in the outer carton in order to protect from light . after first opening , the pen should be used within 7 days . if not used immediately , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nucala contains - the active substance is mepolizumab . each vial contains 1 mg or 100 mg / ml . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e460 ), polysorbate 80 , edta disodium dihydrate and water for injections ( see section 2 ), water for infusions and syringe for more information on the contents of the pack nocala 1 mg is supplied as a pack containing 1 or a multipack containing 3 vials of 1 . not all pack sizes may be marketed .
ninlaro is a cancer medicine that contains the active substance ixazomib , also known as a ' proteasome inhibitor '. it is used in adults to treat a type of cancer of the bone marrow called multiple myeloma , in which the immune system ( the body ' s natural defence system ) does not work well enough to fight the disease . if this applies to you , or if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine , see section 2 ' how to take it ' below . this medicine is used for cell survival in adult patients , who have a lot of proteins called proteasoms , which are important in the survival of their cells . in this case , your doctor may need to increase the amount of protein in your body .
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking the medicine . if any of these apply to you , ask your doctor for advice . take special care when you are being treated for bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash . these may be signs of liver or kidney problems . your doctor may need to adjust your dose if your kidney is not working properly . before starting treatment , your doctor will perform blood tests to check that you have enough blood cells . children and adolescents this medicine is not recommended for children under 18 years of age .
ninlaro is used to treat multiple myeloma in adults . this medicine can be used alone or in combination with lenalidomide , a medicine that contains the active substance dexamethasone , which is an anti - inflammatory medicine . if you are not sure , talk to your doctor , pharmacist or nurse before you are given , or if any of the above applies to you , ask your doctor for advice . your doctor will prescribe the right dose for you . it is important that you follow the advice given to you by your doctor as soon as possible after you have been given : - once a day , on the same day of the week , for the first 3 weeks and 4 weeks , after which you will be given a dose of lenaldomide ( 25 mg / m2 ). - first week
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds , easily bruise nausea , vomiting , diarrhoea , numbness or tingling , burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet , peripheral oedema ) skin rash , itchy all over the body . rare side effects may affect up to 1 in 1 , 000 people . ninlaro can cause a variety of allergic reactions . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the original package in order to protect from light . if not used immediately , the capsule may be stored at room temperature ( up to 30 ) for a single period of up to two weeks . this medicine does not require any special temperature storage conditions . any damage to the medicine packaging should be disposed of in accordance with local requirements .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg / ml of solution for injection . the other ingredients are : tablet core : x . 2 , 3 . 4 mg ( i . e . 1 mg ) xazomimib citrate . capsule shell : microcrystalline cellulose , magnesium stearate , talc and the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide [ e172 ) and shellac , propylene glycol , potassium hydroxide , and black iron oxide red ( gh ). if you are not sure , ask your doctor or pharmacist for advice before you are given the capsule . one capsule contains three capsules containing two capsules of
do not take palforzia : - if you are allergic to peanuts ( arachis hypogaea ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking palforizia . children and adolescents aged 4 to 17 years of age should not be treated for peanut allergy . peanut ( desensitisation ) is not recommended . if any of the above applies to you , please tell your doctor or pharmacist . allergic reactions are rare in children , adolescents and children of all ages . your doctor may decide to reduce the dose of palforzea if your child is more likely to develop food allergies . it is important that you tell your child ' s doctor as soon as possible if the dose is too high or too low . this will help to protect the environment .
do not take palforzia if you are allergic to severe asthma or any of the other ingredients of your asthma ( listed in section 6 ). if your asthma has a problem swallowing or long term problems with your digestive system , a severe mast cell disorder ( severe or life - threatening anaphylaxis ) that lasts more than 60 days . warnings and precautions talk to your doctor , pharmacist or nurse before you are taken . if this applies to you , tell your doctor or pharmacist if : you have been told that you have a history of any of these conditions . your doctor will monitor you closely during the first 60 days after you start treatment . you may need to stop your pal forzia for the symptoms of peanut allergy . it is important that you inform your doctor as soon as possible in case of an allergic reaction . this will help to prevent treatment with pal
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . allergy and allergic reactions ( anaphylaxis ) may occur at any time during the first 3 weeks of treatment with palforzia . initial dose escalation : these treatment phases are known as " up - dosing phases ". your doctor will tell you how much to take and when to stop . if necessary , your doctor may decide to increase your dose . you may need to take it as soon as you remember . it is important that you follow your doctor ' s instructions on how to take the first dose , which may take up to 4 to 5 hours , on the first day of your first day . this will help you to remember how long you should take , and how long to take . however , you should continue to take palfor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions . tell your doctor straight away if you notice any of the following symptoms while you are being treated at the same time : trouble breathing , throat tightness , feeling of fulness , trouble swallowing , speaking - changes in voice , dizziness - fainting - severe stomach cramps , pain , vomiting - diarrhoea , severe flushing and itching of the skin palforizia may cause problems with the stomach and digestive system . if any of these symptoms occur , talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 to 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice any hard lumps of powder , do not throw away any medicines via wastewater or household waste . these measures will help protect the environment .
what palforzia contains the active substance is 0 . 5 mg / ml . each capsule contains 1 , 10 or 20 mg of powder . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica ( e421 ), magnesium stearate and 100 mg oral powder in capsules . this powder is a clear , colourless , open - coated tablet . it is supplied in a glass vial containing colloidal ammonia , and a syringe , with or without lidded sachet . - the powder is white to off - white , opalescent , beige oral powder and initial dose escalation ( see section 3 , 13 , 5 , single - dose blisters ) are available . not all pack sizes may be marketed 
zerene contains the active substance benzodiazepine , which belongs to a group of medicinal products called hypnotic actions . it is used to treat sleeping problems after treatment . treatment should be stopped if you have problems sleeping .
do not take zerene - if you have hypersensitivity ( an allergy ) to zaleplon , or any of the other ingredients of the medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine , as zeene sleep apnoea syndrome is used to treat short periods of short durations of severe kidney or liver problems . myasthenia gravis is very weak , tired muscles , severe breathing , chest problems in patients under 18 years of age and older . your doctor will tell you about undesirable effects . you should not take any medicine or any medicines that may cause physical dependence during treatment . withdrawal symptoms may include headaches , muscle pain , extreme anxiety or tension . if any of these apply to you , tell your doctor or pharmacist straight away . children and adolescents zer
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 10 mg once a day . your doctor will tell you how many capsules to take and how often to take them . take the capsules with food and drink . do not take more than your doctor tells you to take . you may experience difficulty falling asleep . people over the age of 65 years have mild to moderate liver problems . if your dose is less than 5 mg once daily , your doctor may decide to reduce your dose to 5 mg twice daily . the capsule may become cloudy or cloudy . this may be a sign of an overdose . becoming increasingly drowsy , you may be in a coma . talk to your doctor , pharmacist or nurse straight away if this happens .
like all medicines , zerene can cause side effects , although not everybody gets them . talk to your doctor or pharmacist if you notice any other changes in your health . the frequency of the side effects listed below is based on the following : 36 common : may affect up to 1 in 10 people , may affect more than 1 in 100 people . uncommon : will affect 1 to 10 people in 1 , 000 people if not treated , will be monitored by a doctor or a nurse . not known : frequency cannot be estimated from the available data . other side effects may include : drowsiness , memory difficulties , sensations like tingling in the extremities . reporting of side effects you can help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
what zerene contains the active substance is zaleplon . each tablet contains 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine , titanium dioxide , gelatin , titanium dioxide , red iron oxide , yellow iron oxide and black iron oxide (e172 ) in the tablet shellac , lecithin , simethicone . - the colourless tablets are white to off - white , oval - shaped tablets , engraved with " s - 13050 " on one side and " z " on the other side . not all pack sizes may be marketed .
